{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<style>.container { width:100% !important; }</style>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from IPython.core.display import display, HTML\n",
    "display(HTML(\"<style>.container { width:100% !important; }</style>\"))\n",
    "import os\n",
    "from functools import reduce\n",
    "from itertools import chain\n",
    "import pandas as pd\n",
    "import json\n",
    "from tqdm import tqdm\n",
    "from pprint import pprint\n",
    "from collections import defaultdict\n",
    "from ema.utils import get_names_synonyms_doid, get_doid_names, clean_text, contains_word\n",
    "import pickle\n",
    "from wikidataintegrator import wdi_helpers, wdi_core\n",
    "import unicodedata\n",
    "pd.set_option('display.max_colwidth', -1)\n",
    "pd.set_option('display.max_rows', 100)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "site uses ridiculous coldfusion shit which Im not going to figure out, so go this url  \n",
    "http://www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfm\n",
    "\n",
    "change records per page to 9999, hit run search  \n",
    "save page as page.html"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "4015"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_html(\"page.html\", header=0, index_col=None)[2]\n",
    "del df['#']\n",
    "df = df.loc[df['Generic Name'].notnull(), :]\n",
    "len(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Generic Name</th>\n",
       "      <th>Orphan Designation</th>\n",
       "      <th>Designation Date</th>\n",
       "      <th>Designation Status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>(+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid</td>\n",
       "      <td>Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy</td>\n",
       "      <td>03/31/2003</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of Stage IIB through Stage IV malignant melanoma</td>\n",
       "      <td>02/01/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of cholangiocarcinoma</td>\n",
       "      <td>01/10/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>01/10/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>(-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester</td>\n",
       "      <td>Treatment of Fragile X syndrome</td>\n",
       "      <td>10/12/2011</td>\n",
       "      <td>Designated</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                     Generic Name  \\\n",
       "0  (+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid   \n",
       "1  (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                     \n",
       "2  (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                     \n",
       "3  (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                     \n",
       "4  (-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester                      \n",
       "\n",
       "                                                                                            Orphan Designation  \\\n",
       "0  Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy   \n",
       "1  Treatment of Stage IIB through Stage IV malignant melanoma                                                    \n",
       "2  Treatment of cholangiocarcinoma                                                                               \n",
       "3  Treatment of pancreatic cancer                                                                                \n",
       "4  Treatment of Fragile X syndrome                                                                               \n",
       "\n",
       "  Designation Date    Designation Status  \n",
       "0  03/31/2003       Designated/Withdrawn  \n",
       "1  02/01/2008       Designated/Withdrawn  \n",
       "2  01/10/2008       Designated/Withdrawn  \n",
       "3  01/10/2008       Designated/Withdrawn  \n",
       "4  10/12/2011       Designated            "
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "3148"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "products = list(set(list(df['Generic Name'])))\n",
    "len(products)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "# use OPSIN to convert IUPAC names to InChI keys https://bitbucket.org/dan2097/opsin/\n",
    "with open('input.txt', 'w') as f:\n",
    "    for x in products:\n",
    "        f.write(x + '\\n')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "!java -jar ../data/opsin-2.2.0-jar-with-dependencies.jar -ostdinchikey input.txt output.txt 2> output.err"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "prod_inchi = dict()\n",
    "with open('output.txt', 'r') as f:\n",
    "    for count, x in enumerate(f.readlines()):\n",
    "        ikey = x.strip()\n",
    "        if ikey:\n",
    "            prod_inchi[products[count]] = ikey"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "261"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(prod_inchi)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "inchi_wd = wdi_helpers.id_mapper(\"P235\")\n",
    "wd_inchi = {v:k for k,v in inchi_wd.items()}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "158"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# map inchikey back to wdid\n",
    "prod_wdid = {prod: inchi_wd[inchi] for prod,inchi in prod_inchi.items() if inchi in inchi_wd}\n",
    "len(prod_wdid)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "drug_qid_map = pickle.load(open(\"../data/drug_qid_map.pkl\", 'rb'))\n",
    "#drug_qid_map = get_drug_qid_map()\n",
    "wdid_search_name = {x:drug_qid_map[x.lower()] for x in products if x.lower() in drug_qid_map}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1061"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(wdid_search_name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "prod_wdid.update(wdid_search_name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df['drug_qid'] = df['Generic Name'].apply(prod_wdid.get)\n",
    "df['inchi'] = df['Generic Name'].apply(prod_inchi.get)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Generic Name</th>\n",
       "      <th>Orphan Designation</th>\n",
       "      <th>Designation Date</th>\n",
       "      <th>Designation Status</th>\n",
       "      <th>drug_qid</th>\n",
       "      <th>inchi</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>(+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid</td>\n",
       "      <td>Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy</td>\n",
       "      <td>03/31/2003</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27088744</td>\n",
       "      <td>ZVVCSBSDFGYRCB-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of Stage IIB through Stage IV malignant melanoma</td>\n",
       "      <td>02/01/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of cholangiocarcinoma</td>\n",
       "      <td>01/10/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>01/10/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>(-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester</td>\n",
       "      <td>Treatment of Fragile X syndrome</td>\n",
       "      <td>10/12/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q6589598</td>\n",
       "      <td>ZFPZEYHRWGMJCV-ZHALLVOQSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>(1,3)-ß-D-glucan synthesis inhibitor</td>\n",
       "      <td>Treatment of invasive Aspergillus infections</td>\n",
       "      <td>08/22/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-broethyl) diamidophosphate</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>06/05/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) diamidophosphate</td>\n",
       "      <td>Treatment of soft tissue sarcoma</td>\n",
       "      <td>03/09/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>(1OR)-7-amino-12-fluoro-2,10,16-trimethyl-15 oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile</td>\n",
       "      <td>Treatment of anaplastic lymphoma kinase (ALK)-positive or ROS1-positive non-small cell lung cancer</td>\n",
       "      <td>06/23/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>(1R,3R,4R,5S)-3-O-[2-O-benzoyl-3-O-(sodium(2S)-3-cyclohexyl-propanoate-</td>\n",
       "      <td>Treatment of vaso-occlusive crisis in patients with sickle cell disease.</td>\n",
       "      <td>02/17/2009</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride</td>\n",
       "      <td>Treatment of T-cell non-Hodgkin's lymphoma</td>\n",
       "      <td>01/29/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride</td>\n",
       "      <td>Treatment of acute lymphoblastic leukemia</td>\n",
       "      <td>08/13/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride</td>\n",
       "      <td>Treatment of chronic lymphocytic leukemia and related leukemias to include prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia</td>\n",
       "      <td>08/10/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>(1S, 2S, 3R, 4R)-3-(5-Fluoro-2-(3-methyl-4-(4-methylpiperazin-1-yl)-phenylamino)-pyrimidin-4-ylamino)bicycle[2.2.1]hept-5-ene-2-carboxamide benzoate</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>01/19/2010</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>(1S,3S)-3-amino-4-(difluoromethylene)cyclopentanecarboxylic acid hydrochloride, (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid hydrochloride</td>\n",
       "      <td>Treatment of infantile spasms</td>\n",
       "      <td>09/15/2010</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>(2'R,3'S)-2'-hydroxy-N-carboxy-3'-amino-5'-methyl-hexanoic,N-tert-butyl ester, 13 ester 5B-20-epoxy-1B,2a,4a,7B,9a,10a,13a-heptahydroxy-4,10-diacetate-2-benzoate-(1\"S)-7,9-acrolein acetal-11(15-1)-abeotaxane</td>\n",
       "      <td>Treatment of progressive supranuclear palsy</td>\n",
       "      <td>06/23/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>(2,2-diphenyl-tetrahydro-furan-3-yl-methyl)-dimethylamine hydrochloride</td>\n",
       "      <td>Treatment of Rett Syndrome.</td>\n",
       "      <td>05/18/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27252594</td>\n",
       "      <td>FEQOLYDPQKHFTD-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>(2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide)</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>11/29/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27258687</td>\n",
       "      <td>VLIUIBXPEDFJRF-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>(2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo [4,3-c] pyridine-3,6(2h,5h)-dione)</td>\n",
       "      <td>Treatment of systemic sclerosis.</td>\n",
       "      <td>10/14/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27258840</td>\n",
       "      <td>RGYQPQARIQKJKH-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>(2E, 4E, 6Z, 8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-l-yl) nona-2,4,6,8-tetraen-l-yl acetate</td>\n",
       "      <td>Treatment of retinitis pigmentosa</td>\n",
       "      <td>12/02/2010</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenyl acetate 9-cis-retinyl acetate (API)</td>\n",
       "      <td>Treatment of Leber congential amaurosis (LCA) due to inherited mutations in RPE65 (encoding the protein retinal pigment epithelial protein 65) or LRAT (encoding the enzyme lecithin:retinol acyltransferase)genes.</td>\n",
       "      <td>12/02/2010</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid</td>\n",
       "      <td>Treatment of primary biliary cirrhosis</td>\n",
       "      <td>10/31/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>XULSCZPZVQIMFM-IPZQJPLYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid</td>\n",
       "      <td>Treatment of progressive familial intrahepatic cholestatis</td>\n",
       "      <td>10/31/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>XULSCZPZVQIMFM-IPZQJPLYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>(2Z)-2-cyano-3-3hydroxy-N-[4-(trifluoromethly)phenyl]-2-hepten-6-ynamide</td>\n",
       "      <td>Prevention of acute rejection following kidney, heart, and liver transplantation</td>\n",
       "      <td>01/10/2005</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>(3'R,4'S,5'R)-N-[(3R,6S)-6-Carbamoyltetrahydro-2H-pyran-3-yl]-6''-chloro-4'-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2''-oxo-1'',2''-dihydrodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indole]-5'-carboxamide mono(4-methylbenzenesulfonate) monohydrate</td>\n",
       "      <td>Treatment of liposarcoma</td>\n",
       "      <td>02/13/2017</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>WPJOGWGXMTUHPW-CIPNXXNHSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide</td>\n",
       "      <td>Treatment of chronic myelogenous leukemia.</td>\n",
       "      <td>03/18/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>03/18/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamideNRC-AN-019</td>\n",
       "      <td>Treatment of Glioma</td>\n",
       "      <td>03/18/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>(3E,5E)-3,5-bis[(4-fluoro-3-nitrophenyl)methylidene]-1-(prop-2-enoyl)azepan-4-0ne</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>04/30/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>(3S)-(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one</td>\n",
       "      <td>Treatment of Fragile X Syndrome.</td>\n",
       "      <td>12/09/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>HWSLMIXAPNOWGU-AWEZNQCLSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>(3S)-1-azabicyclo[2.2.2]oct-3-yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate</td>\n",
       "      <td>Treatment of Gaucher disease</td>\n",
       "      <td>09/11/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27274745</td>\n",
       "      <td>YFHRCLAKZBDRHN-MRXNPFEDSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>(3S)-1-azabicylo[2.2.2]oct-3yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate</td>\n",
       "      <td>Treatment of Fabry's disease</td>\n",
       "      <td>08/26/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>(3S)-3-(4-trifluoromethoxybenzyloxy)-6-nitro-2H-3,4-dihydroimidazo[2,1-b]oxazine</td>\n",
       "      <td>Treatment of tuberculosis</td>\n",
       "      <td>07/05/2007</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>(3S)-3-[(2S)-2-({N-[2-tert-butyl)phenyl]carbamoyl}carbonylamino) propanoylamino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy) pentanoci acid</td>\n",
       "      <td>Treatment of patients undergoing solid organ transplantation.</td>\n",
       "      <td>08/19/2003</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>(3S)-3-[({1-(2-Chlorobenzyl)-4-hydroxy-5-methyl-2-oxo-1,2-dihydropyridin-3yl}amino)carbonyl]amino-3-(4-methylphenyl)propanoic acid monosodium salt</td>\n",
       "      <td>For mobilization of hematopoietic stem cells</td>\n",
       "      <td>04/25/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>QUXHOILDLMWREY-FYZYNONXSA-M</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide (2R,3R)-2,3-dihydroxybutanedioate</td>\n",
       "      <td>Treatment of pediatric (aged 0 through 16 years) juvenile idiopathic arthritis (JIA) ILAR categories excluding systemic JIA</td>\n",
       "      <td>09/18/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>WQDBPGWQDBPVQZ-NBCXFSEXSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>(4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride</td>\n",
       "      <td>Treatment of alagille syndrome</td>\n",
       "      <td>09/04/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>(4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride</td>\n",
       "      <td>Treatment of primary sclerosing cholangitis</td>\n",
       "      <td>09/04/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>(4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride</td>\n",
       "      <td>Treatment of primary biliary cirrhosis</td>\n",
       "      <td>09/04/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>(4S)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1-H-pyrano[3?,4?:6,7]-indolizino-[1,2-b]-quinoline-11-carbaldehyde O-(tert-butyl)-(E)-oxime</td>\n",
       "      <td>Treatment malignant glioma</td>\n",
       "      <td>11/29/2002</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>(5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride</td>\n",
       "      <td>Treatment of erythromelalgia</td>\n",
       "      <td>01/30/2017</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27268497</td>\n",
       "      <td>HEPUBAGOKRIZEO-PPPUBMIESA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>(5R)-5-(4-{[2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride</td>\n",
       "      <td>Treatment of trigeminal neuralgia</td>\n",
       "      <td>07/24/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>(5S,8S, 10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5] diazocine-8-carboxyamide</td>\n",
       "      <td>Treatment of ovarian cancer</td>\n",
       "      <td>04/14/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>XNLCCACCEOWFNQ-OSPRVTPDSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>(6-maleimidocaproyl)hydrazone of doxorubicin</td>\n",
       "      <td>Treatment of soft tissue sarcoma</td>\n",
       "      <td>06/29/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>(6-[4-Deoxy-4-[(2E,4E)-tetradecadienoylglycyl] amino-L-glyceroB-L-manno-heptopyranosyl]amino-9H-purine)</td>\n",
       "      <td>Parenteral treatment of painful, chronic, chemotherapy-induced peripheral neuropathy that is refractory to conventional analgesics</td>\n",
       "      <td>02/21/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>(6aR, 10aR)-3-(1’,1’-dimethylheptyl)-delta8-tetrahydro-cannabinol-9-carboxylic acid</td>\n",
       "      <td>Treatment of cystic fibrosis.</td>\n",
       "      <td>10/13/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>(6aR, 10aR)-3-(1â¿¿,1â¿¿-dimethylheptyl)-Î¿8-tetrahydro-cannabinol-9-carboxylic acid</td>\n",
       "      <td>Treatment of systemic sclerosis</td>\n",
       "      <td>06/10/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>(6R,S)5,10-methylene-tetrahydrofolic acid</td>\n",
       "      <td>For use in combination with 5-fluorouracil for the treatment of patients with pancreatic cancer</td>\n",
       "      <td>08/13/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q26995704</td>\n",
       "      <td>QYNUQALWYRSVHF-OLZOCXBDSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>(9-[N-(3-morpholinopropyl)-sulfonyl]-5,6-dihydro-5-oxo-11-H-indeno [1,2-c] isoquinoline methanesulfonic acid</td>\n",
       "      <td>Prevention of post-operative complications of aortic anuerysm surgical repair</td>\n",
       "      <td>12/08/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>(E)-N’-(1-(5-Chloro-2-hydroxy phenyl)Ethylidene)-3-((4-Methyl Piperazin-1-yl) Sulfonyl) Benzohydrazide Mesylate</td>\n",
       "      <td>Treatment of Ewing's sarcoma.</td>\n",
       "      <td>01/12/2017</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>JIPBQMGGMHCGBW-CWUUNJJBSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3965</th>\n",
       "      <td>Venetoclax</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>08/29/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3966</th>\n",
       "      <td>venetoclax</td>\n",
       "      <td>Treatment of chronic lymphocytic leukemia</td>\n",
       "      <td>09/20/2012</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3967</th>\n",
       "      <td>venetoclax</td>\n",
       "      <td>Treatment of acute myeloid leukemia.</td>\n",
       "      <td>02/04/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3968</th>\n",
       "      <td>verteporfin</td>\n",
       "      <td>Treatment of chronic or recurrent central serous chorioretinopathy</td>\n",
       "      <td>03/09/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q782318</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3969</th>\n",
       "      <td>Vibrio alginolyticus collagenase</td>\n",
       "      <td>Treatment of advanced Dupuytren's disease (Dupuytren's contracture)</td>\n",
       "      <td>10/12/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3970</th>\n",
       "      <td>vibriolysin</td>\n",
       "      <td>Debridement of severe, deep dermal burns in hospitalized patients</td>\n",
       "      <td>06/16/2006</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3971</th>\n",
       "      <td>vigabatrin</td>\n",
       "      <td>Treatment of infantile spasms.</td>\n",
       "      <td>06/12/2000</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q421663</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3972</th>\n",
       "      <td>viloxazine HCL</td>\n",
       "      <td>Treatment of cataplexy and narcolepsy</td>\n",
       "      <td>06/11/1984</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3973</th>\n",
       "      <td>vinCRIStine sulfate LIPOSOME injection</td>\n",
       "      <td>Treatment of acute lymphoblastic leukemia</td>\n",
       "      <td>01/08/2007</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3974</th>\n",
       "      <td>vincristine sulfate liposomes</td>\n",
       "      <td>Treatment of metastatic uveal melanoma.</td>\n",
       "      <td>06/24/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3975</th>\n",
       "      <td>vintafolide</td>\n",
       "      <td>Treatment of ovarian cancer</td>\n",
       "      <td>12/16/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7932801</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3976</th>\n",
       "      <td>Virulizin</td>\n",
       "      <td>Treatment of pancreatic cancer.</td>\n",
       "      <td>02/01/2001</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3977</th>\n",
       "      <td>vitamin A palmitate</td>\n",
       "      <td>Prevention of bronchopulmonary dysplasia.</td>\n",
       "      <td>07/14/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3978</th>\n",
       "      <td>volanesorsen sodium, apolipotrotein C-III antisense oligonucleotide</td>\n",
       "      <td>treatment of familial chylomicronemia syndrome</td>\n",
       "      <td>06/23/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3979</th>\n",
       "      <td>volasertib</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>04/14/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7939986</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3980</th>\n",
       "      <td>von Willebrand Factor Human Concentrate</td>\n",
       "      <td>Treatment of Von Willebrand Disease</td>\n",
       "      <td>05/29/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3981</th>\n",
       "      <td>vorinostat</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>06/12/2003</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q905901</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3982</th>\n",
       "      <td>vorinostat</td>\n",
       "      <td>Treatment of advanced melanoma (stages IIb, IIc, III, and IV)</td>\n",
       "      <td>10/13/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q905901</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3983</th>\n",
       "      <td>vorinostat</td>\n",
       "      <td>Treatment of mesothelioma</td>\n",
       "      <td>03/17/2004</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q905901</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3984</th>\n",
       "      <td>vorinostat</td>\n",
       "      <td>Treatment of T-cell non-Hodgkin's lymphoma</td>\n",
       "      <td>03/16/2004</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q905901</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3985</th>\n",
       "      <td>vosaroxin</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>10/28/2009</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q18395775</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3986</th>\n",
       "      <td>Water-miscible vitamin A palmitate</td>\n",
       "      <td>Prevention of bronchopulmonary dysplasia.</td>\n",
       "      <td>03/26/2010</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3987</th>\n",
       "      <td>Wharton's jelly mesenchymal stem cells</td>\n",
       "      <td>Treatment of graft-versus-host disease</td>\n",
       "      <td>09/27/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3988</th>\n",
       "      <td>Xenogeneic hepatocytes</td>\n",
       "      <td>Treatment of severe liver failure.</td>\n",
       "      <td>11/27/1998</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3989</th>\n",
       "      <td>xenon gas</td>\n",
       "      <td>Treatment of hypoxic ischemic encephalopathy</td>\n",
       "      <td>12/03/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3990</th>\n",
       "      <td>xenon gas</td>\n",
       "      <td>To improve neurological outcome in hospitalized cardiac arrest patients.</td>\n",
       "      <td>05/18/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3991</th>\n",
       "      <td>Yersinia pestis plague recombinant antigen (rF1V; F1 capsular protein fused to V antigen; E. coli) vaccine with aluminum hydroxide</td>\n",
       "      <td>Prevention of plague (Yersinia pestis)</td>\n",
       "      <td>11/30/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3992</th>\n",
       "      <td>Yttrium (90Y) antiferritin polyclonal antibodies</td>\n",
       "      <td>Treatment of Hodgkin's disease.</td>\n",
       "      <td>09/18/2006</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3993</th>\n",
       "      <td>Yttrium(90Y)-DTPA-radiolabelled chimeric monoclonal antibody against frizzled homologue 10</td>\n",
       "      <td>Treatment of soft tissue sarcoma</td>\n",
       "      <td>12/03/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3994</th>\n",
       "      <td>Yttrium-90 radiolabeled humanized monoclonal anti-carcinoembroyonic antigen IgG antibody</td>\n",
       "      <td>Treatment of ovarian carcinoma.</td>\n",
       "      <td>08/03/1999</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3995</th>\n",
       "      <td>Zalcitabine</td>\n",
       "      <td>Treatment of AIDS.</td>\n",
       "      <td>06/28/1988</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q2344582</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3996</th>\n",
       "      <td>Zalcitabine</td>\n",
       "      <td>Treatment of AIDS.</td>\n",
       "      <td>12/09/1986</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q2344582</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3997</th>\n",
       "      <td>zidovudine</td>\n",
       "      <td>Treatment of AIDS</td>\n",
       "      <td>07/17/1985</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q198504</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3998</th>\n",
       "      <td>Zinc acetate</td>\n",
       "      <td>Treatment of Wilson's disease.</td>\n",
       "      <td>11/06/1985</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q204639</td>\n",
       "      <td>DJWUNCQRNNEAKC-UHFFFAOYSA-L</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3999</th>\n",
       "      <td>Zoledronate</td>\n",
       "      <td>Treatment of tumor induced hypercalcemia.</td>\n",
       "      <td>08/18/2000</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q218507</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4000</th>\n",
       "      <td>zoledronate D,L-lysine monohydrate (ZLM)</td>\n",
       "      <td>Treatment of complex regional pain syndrome (CRPS)</td>\n",
       "      <td>04/15/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4001</th>\n",
       "      <td>zoledronic acid</td>\n",
       "      <td>Treatment of complex regional pain syndrome (CRPS).</td>\n",
       "      <td>05/06/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q218507</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4002</th>\n",
       "      <td>Zosuquidar trihydrochloride</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>12/15/2005</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27269191</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4003</th>\n",
       "      <td>[131I]-N-(2-(diethylamino) ethyl-4-(4 flurobenzamido)-5-(iodo)-2-methoxybenzamide</td>\n",
       "      <td>Treatment of metastatic melanoma, stages IIB, IIC, III and IV</td>\n",
       "      <td>09/17/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4004</th>\n",
       "      <td>[5,10,15,20-tetrakis(1,3-diethylimidazolium-2-yl)porphyrinato] manganese(III)pentachloride</td>\n",
       "      <td>Treatment of Amyotrophic Lateral Sclerosis</td>\n",
       "      <td>11/04/2003</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4005</th>\n",
       "      <td>[5-(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyridin-2-yl]-(6-trifluoromethyl-pyridin-3-ylmethyl)-amine hydrochloride salt</td>\n",
       "      <td>Treatment of pigmented villonodular synovitis/giant cell tumor of the tendon sheath</td>\n",
       "      <td>02/14/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>CJLUYLRKLUYCEK-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4006</th>\n",
       "      <td>[5-Amino-1-(4-fluoro-phenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxy-propoxy)-phenyl]-methanone</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>10/20/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>IJDQETGUEUJVTB-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4007</th>\n",
       "      <td>[a-N-(2'succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr</td>\n",
       "      <td>Treatment of glioblastoma multiforme</td>\n",
       "      <td>05/14/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4008</th>\n",
       "      <td>[AC3-yCD2(V)] and Flucytosine (5-FC XR)</td>\n",
       "      <td>Treatment of glioblastoma multiforme</td>\n",
       "      <td>01/12/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4009</th>\n",
       "      <td>[F18] florilglutamic acid</td>\n",
       "      <td>For the diagnosis of hepatocellular carcinoma</td>\n",
       "      <td>07/13/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4010</th>\n",
       "      <td>[F18] florilglutamic acid</td>\n",
       "      <td>Diagnostic for the management of hepatocellular carcinoma</td>\n",
       "      <td>07/13/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4011</th>\n",
       "      <td>[Lu-177]-DOTA-Tyr3-Octreotate</td>\n",
       "      <td>Treatment of gastro-entero-pancreatic neuroendocrine tumors</td>\n",
       "      <td>01/12/2009</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4012</th>\n",
       "      <td>[met5]-enkephalin</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>01/24/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4013</th>\n",
       "      <td>[Î±â¿¿N-(2â¿¿succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[Îµâ¿¿N-(2â¿¿succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[Îµâ¿¿N-(2â¿¿succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr</td>\n",
       "      <td>Treatment of breast cancer patients with brain metastases</td>\n",
       "      <td>04/15/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4014</th>\n",
       "      <td>{2-amino-8-[4-(pyrrolidinylcarbonyl)phenyl](3H-benzo[f]azepin-4-yl)}-N,N-dipropycarboxamide</td>\n",
       "      <td>Treatment of ovarian cancer</td>\n",
       "      <td>04/10/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>4015 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                       Generic Name  \\\n",
       "0     (+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid                                                                                                                                                  \n",
       "1     (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                                                                                                                                                                    \n",
       "2     (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                                                                                                                                                                    \n",
       "3     (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                                                                                                                                                                    \n",
       "4     (-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester                                                                                                                                                                     \n",
       "5     (1,3)-ß-D-glucan synthesis inhibitor                                                                                                                                                                                                                            \n",
       "6     (1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-broethyl) diamidophosphate                                                                                                                                                                                \n",
       "7     (1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) diamidophosphate                                                                                                                                                                              \n",
       "8     (1OR)-7-amino-12-fluoro-2,10,16-trimethyl-15 oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile                                                                                                      \n",
       "9     (1R,3R,4R,5S)-3-O-[2-O-benzoyl-3-O-(sodium(2S)-3-cyclohexyl-propanoate-                                                                                                                                                                                         \n",
       "10    (1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride                                                                                                                                                                                  \n",
       "11    (1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride                                                                                                                                                                                  \n",
       "12    (1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride                                                                                                                                                                                  \n",
       "13    (1S, 2S, 3R, 4R)-3-(5-Fluoro-2-(3-methyl-4-(4-methylpiperazin-1-yl)-phenylamino)-pyrimidin-4-ylamino)bicycle[2.2.1]hept-5-ene-2-carboxamide benzoate                                                                                                            \n",
       "14    (1S,3S)-3-amino-4-(difluoromethylene)cyclopentanecarboxylic acid hydrochloride, (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid hydrochloride                                                                                                        \n",
       "15    (2'R,3'S)-2'-hydroxy-N-carboxy-3'-amino-5'-methyl-hexanoic,N-tert-butyl ester, 13 ester 5B-20-epoxy-1B,2a,4a,7B,9a,10a,13a-heptahydroxy-4,10-diacetate-2-benzoate-(1\"S)-7,9-acrolein acetal-11(15-1)-abeotaxane                                                 \n",
       "16    (2,2-diphenyl-tetrahydro-furan-3-yl-methyl)-dimethylamine hydrochloride                                                                                                                                                                                         \n",
       "17    (2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide)                                                                                                                                                                    \n",
       "18    (2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo [4,3-c] pyridine-3,6(2h,5h)-dione)                                                                                                                                                         \n",
       "19    (2E, 4E, 6Z, 8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-l-yl) nona-2,4,6,8-tetraen-l-yl acetate                                                                                                                                                           \n",
       "20    (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenyl acetate 9-cis-retinyl acetate (API)                                                                                                                                         \n",
       "21    (2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid                                                                            \n",
       "22    (2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid                                                                            \n",
       "23    (2Z)-2-cyano-3-3hydroxy-N-[4-(trifluoromethly)phenyl]-2-hepten-6-ynamide                                                                                                                                                                                        \n",
       "24    (3'R,4'S,5'R)-N-[(3R,6S)-6-Carbamoyltetrahydro-2H-pyran-3-yl]-6''-chloro-4'-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2''-oxo-1'',2''-dihydrodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indole]-5'-carboxamide mono(4-methylbenzenesulfonate) monohydrate   \n",
       "25    (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide                                                                                                                                                                  \n",
       "26    (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide                                                                                                                                                                  \n",
       "27    (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamideNRC-AN-019                                                                                                                                                        \n",
       "28    (3E,5E)-3,5-bis[(4-fluoro-3-nitrophenyl)methylidene]-1-(prop-2-enoyl)azepan-4-0ne                                                                                                                                                                               \n",
       "29    (3S)-(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one                                                                                                                                                                     \n",
       "30    (3S)-1-azabicyclo[2.2.2]oct-3-yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate                                                                                                                                                                  \n",
       "31    (3S)-1-azabicylo[2.2.2]oct-3yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate                                                                                                                                                                    \n",
       "32    (3S)-3-(4-trifluoromethoxybenzyloxy)-6-nitro-2H-3,4-dihydroimidazo[2,1-b]oxazine                                                                                                                                                                                \n",
       "33    (3S)-3-[(2S)-2-({N-[2-tert-butyl)phenyl]carbamoyl}carbonylamino) propanoylamino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy) pentanoci acid                                                                                                                            \n",
       "34    (3S)-3-[({1-(2-Chlorobenzyl)-4-hydroxy-5-methyl-2-oxo-1,2-dihydropyridin-3yl}amino)carbonyl]amino-3-(4-methylphenyl)propanoic acid monosodium salt                                                                                                              \n",
       "35    (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide (2R,3R)-2,3-dihydroxybutanedioate                                                                                                             \n",
       "36    (4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride                                                                         \n",
       "37    (4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride                                                                         \n",
       "38    (4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-l-azoniabicyclo[2.2.2]octane Chloride                                                                         \n",
       "39    (4S)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1-H-pyrano[3?,4?:6,7]-indolizino-[1,2-b]-quinoline-11-carbaldehyde O-(tert-butyl)-(E)-oxime                                                                                                              \n",
       "40    (5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride                                                                                                                                                                                     \n",
       "41    (5R)-5-(4-{[2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride                                                                                                                                                                                      \n",
       "42    (5S,8S, 10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5] diazocine-8-carboxyamide                                                                                                                   \n",
       "43    (6-maleimidocaproyl)hydrazone of doxorubicin                                                                                                                                                                                                                    \n",
       "44    (6-[4-Deoxy-4-[(2E,4E)-tetradecadienoylglycyl] amino-L-glyceroB-L-manno-heptopyranosyl]amino-9H-purine)                                                                                                                                                         \n",
       "45    (6aR, 10aR)-3-(1’,1’-dimethylheptyl)-delta8-tetrahydro-cannabinol-9-carboxylic acid                                                                                                                                                                             \n",
       "46    (6aR, 10aR)-3-(1â¿¿,1â¿¿-dimethylheptyl)-Î¿8-tetrahydro-cannabinol-9-carboxylic acid                                                                                                                                                                            \n",
       "47    (6R,S)5,10-methylene-tetrahydrofolic acid                                                                                                                                                                                                                       \n",
       "48    (9-[N-(3-morpholinopropyl)-sulfonyl]-5,6-dihydro-5-oxo-11-H-indeno [1,2-c] isoquinoline methanesulfonic acid                                                                                                                                                    \n",
       "49    (E)-N’-(1-(5-Chloro-2-hydroxy phenyl)Ethylidene)-3-((4-Methyl Piperazin-1-yl) Sulfonyl) Benzohydrazide Mesylate                                                                                                                                                 \n",
       "...                                                                                                               ...                                                                                                                                                 \n",
       "3965  Venetoclax                                                                                                                                                                                                                                                      \n",
       "3966  venetoclax                                                                                                                                                                                                                                                      \n",
       "3967  venetoclax                                                                                                                                                                                                                                                      \n",
       "3968  verteporfin                                                                                                                                                                                                                                                     \n",
       "3969  Vibrio alginolyticus collagenase                                                                                                                                                                                                                                \n",
       "3970  vibriolysin                                                                                                                                                                                                                                                     \n",
       "3971  vigabatrin                                                                                                                                                                                                                                                      \n",
       "3972  viloxazine HCL                                                                                                                                                                                                                                                  \n",
       "3973  vinCRIStine sulfate LIPOSOME injection                                                                                                                                                                                                                          \n",
       "3974  vincristine sulfate liposomes                                                                                                                                                                                                                                   \n",
       "3975  vintafolide                                                                                                                                                                                                                                                     \n",
       "3976  Virulizin                                                                                                                                                                                                                                                       \n",
       "3977  vitamin A palmitate                                                                                                                                                                                                                                             \n",
       "3978  volanesorsen sodium, apolipotrotein C-III antisense oligonucleotide                                                                                                                                                                                             \n",
       "3979  volasertib                                                                                                                                                                                                                                                      \n",
       "3980  von Willebrand Factor Human Concentrate                                                                                                                                                                                                                         \n",
       "3981  vorinostat                                                                                                                                                                                                                                                      \n",
       "3982  vorinostat                                                                                                                                                                                                                                                      \n",
       "3983  vorinostat                                                                                                                                                                                                                                                      \n",
       "3984  vorinostat                                                                                                                                                                                                                                                      \n",
       "3985  vosaroxin                                                                                                                                                                                                                                                       \n",
       "3986  Water-miscible vitamin A palmitate                                                                                                                                                                                                                              \n",
       "3987  Wharton's jelly mesenchymal stem cells                                                                                                                                                                                                                          \n",
       "3988  Xenogeneic hepatocytes                                                                                                                                                                                                                                          \n",
       "3989  xenon gas                                                                                                                                                                                                                                                       \n",
       "3990  xenon gas                                                                                                                                                                                                                                                       \n",
       "3991  Yersinia pestis plague recombinant antigen (rF1V; F1 capsular protein fused to V antigen; E. coli) vaccine with aluminum hydroxide                                                                                                                              \n",
       "3992  Yttrium (90Y) antiferritin polyclonal antibodies                                                                                                                                                                                                                \n",
       "3993  Yttrium(90Y)-DTPA-radiolabelled chimeric monoclonal antibody against frizzled homologue 10                                                                                                                                                                      \n",
       "3994  Yttrium-90 radiolabeled humanized monoclonal anti-carcinoembroyonic antigen IgG antibody                                                                                                                                                                        \n",
       "3995  Zalcitabine                                                                                                                                                                                                                                                     \n",
       "3996  Zalcitabine                                                                                                                                                                                                                                                     \n",
       "3997  zidovudine                                                                                                                                                                                                                                                      \n",
       "3998  Zinc acetate                                                                                                                                                                                                                                                    \n",
       "3999  Zoledronate                                                                                                                                                                                                                                                     \n",
       "4000  zoledronate D,L-lysine monohydrate (ZLM)                                                                                                                                                                                                                        \n",
       "4001  zoledronic acid                                                                                                                                                                                                                                                 \n",
       "4002  Zosuquidar trihydrochloride                                                                                                                                                                                                                                     \n",
       "4003  [131I]-N-(2-(diethylamino) ethyl-4-(4 flurobenzamido)-5-(iodo)-2-methoxybenzamide                                                                                                                                                                               \n",
       "4004  [5,10,15,20-tetrakis(1,3-diethylimidazolium-2-yl)porphyrinato] manganese(III)pentachloride                                                                                                                                                                      \n",
       "4005  [5-(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyridin-2-yl]-(6-trifluoromethyl-pyridin-3-ylmethyl)-amine hydrochloride salt                                                                                                                                 \n",
       "4006  [5-Amino-1-(4-fluoro-phenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxy-propoxy)-phenyl]-methanone                                                                                                                                                                      \n",
       "4007  [a-N-(2'succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[epsilon-N-(2'succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr                                                                                  \n",
       "4008  [AC3-yCD2(V)] and Flucytosine (5-FC XR)                                                                                                                                                                                                                         \n",
       "4009  [F18] florilglutamic acid                                                                                                                                                                                                                                       \n",
       "4010  [F18] florilglutamic acid                                                                                                                                                                                                                                       \n",
       "4011  [Lu-177]-DOTA-Tyr3-Octreotate                                                                                                                                                                                                                                   \n",
       "4012  [met5]-enkephalin                                                                                                                                                                                                                                               \n",
       "4013  [Î±â¿¿N-(2â¿¿succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[Îµâ¿¿N-(2â¿¿succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[Îµâ¿¿N-(2â¿¿succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr                                                                               \n",
       "4014  {2-amino-8-[4-(pyrrolidinylcarbonyl)phenyl](3H-benzo[f]azepin-4-yl)}-N,N-dipropycarboxamide                                                                                                                                                                     \n",
       "\n",
       "                                                                                                                                                                                                       Orphan Designation  \\\n",
       "0     Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy                                                                                                           \n",
       "1     Treatment of Stage IIB through Stage IV malignant melanoma                                                                                                                                                            \n",
       "2     Treatment of cholangiocarcinoma                                                                                                                                                                                       \n",
       "3     Treatment of pancreatic cancer                                                                                                                                                                                        \n",
       "4     Treatment of Fragile X syndrome                                                                                                                                                                                       \n",
       "5     Treatment of invasive Aspergillus infections                                                                                                                                                                          \n",
       "6     Treatment of pancreatic cancer                                                                                                                                                                                        \n",
       "7     Treatment of soft tissue sarcoma                                                                                                                                                                                      \n",
       "8     Treatment of anaplastic lymphoma kinase (ALK)-positive or ROS1-positive non-small cell lung cancer                                                                                                                    \n",
       "9     Treatment of vaso-occlusive crisis in patients with sickle cell disease.                                                                                                                                              \n",
       "10    Treatment of T-cell non-Hodgkin's lymphoma                                                                                                                                                                            \n",
       "11    Treatment of acute lymphoblastic leukemia                                                                                                                                                                             \n",
       "12    Treatment of chronic lymphocytic leukemia and related leukemias to include prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia                                                                    \n",
       "13    Treatment of acute myeloid leukemia                                                                                                                                                                                   \n",
       "14    Treatment of infantile spasms                                                                                                                                                                                         \n",
       "15    Treatment of progressive supranuclear palsy                                                                                                                                                                           \n",
       "16    Treatment of Rett Syndrome.                                                                                                                                                                                           \n",
       "17    Treatment of multiple myeloma                                                                                                                                                                                         \n",
       "18    Treatment of systemic sclerosis.                                                                                                                                                                                      \n",
       "19    Treatment of retinitis pigmentosa                                                                                                                                                                                     \n",
       "20    Treatment of Leber congential amaurosis (LCA) due to inherited mutations in RPE65 (encoding the protein retinal pigment epithelial protein 65) or LRAT (encoding the enzyme lecithin:retinol acyltransferase)genes.   \n",
       "21    Treatment of primary biliary cirrhosis                                                                                                                                                                                \n",
       "22    Treatment of progressive familial intrahepatic cholestatis                                                                                                                                                            \n",
       "23    Prevention of acute rejection following kidney, heart, and liver transplantation                                                                                                                                      \n",
       "24    Treatment of liposarcoma                                                                                                                                                                                              \n",
       "25    Treatment of chronic myelogenous leukemia.                                                                                                                                                                            \n",
       "26    Treatment of pancreatic cancer                                                                                                                                                                                        \n",
       "27    Treatment of Glioma                                                                                                                                                                                                   \n",
       "28    Treatment of multiple myeloma                                                                                                                                                                                         \n",
       "29    Treatment of Fragile X Syndrome.                                                                                                                                                                                      \n",
       "30    Treatment of Gaucher disease                                                                                                                                                                                          \n",
       "31    Treatment of Fabry's disease                                                                                                                                                                                          \n",
       "32    Treatment of tuberculosis                                                                                                                                                                                             \n",
       "33    Treatment of patients undergoing solid organ transplantation.                                                                                                                                                         \n",
       "34    For mobilization of hematopoietic stem cells                                                                                                                                                                          \n",
       "35    Treatment of pediatric (aged 0 through 16 years) juvenile idiopathic arthritis (JIA) ILAR categories excluding systemic JIA                                                                                           \n",
       "36    Treatment of alagille syndrome                                                                                                                                                                                        \n",
       "37    Treatment of primary sclerosing cholangitis                                                                                                                                                                           \n",
       "38    Treatment of primary biliary cirrhosis                                                                                                                                                                                \n",
       "39    Treatment malignant glioma                                                                                                                                                                                            \n",
       "40    Treatment of erythromelalgia                                                                                                                                                                                          \n",
       "41    Treatment of trigeminal neuralgia                                                                                                                                                                                     \n",
       "42    Treatment of ovarian cancer                                                                                                                                                                                           \n",
       "43    Treatment of soft tissue sarcoma                                                                                                                                                                                      \n",
       "44    Parenteral treatment of painful, chronic, chemotherapy-induced peripheral neuropathy that is refractory to conventional analgesics                                                                                    \n",
       "45    Treatment of cystic fibrosis.                                                                                                                                                                                         \n",
       "46    Treatment of systemic sclerosis                                                                                                                                                                                       \n",
       "47    For use in combination with 5-fluorouracil for the treatment of patients with pancreatic cancer                                                                                                                       \n",
       "48    Prevention of post-operative complications of aortic anuerysm surgical repair                                                                                                                                         \n",
       "49    Treatment of Ewing's sarcoma.                                                                                                                                                                                         \n",
       "...                             ...                                                                                                                                                                                         \n",
       "3965  Treatment of multiple myeloma                                                                                                                                                                                         \n",
       "3966  Treatment of chronic lymphocytic leukemia                                                                                                                                                                             \n",
       "3967  Treatment of acute myeloid leukemia.                                                                                                                                                                                  \n",
       "3968  Treatment of chronic or recurrent central serous chorioretinopathy                                                                                                                                                    \n",
       "3969  Treatment of advanced Dupuytren's disease (Dupuytren's contracture)                                                                                                                                                   \n",
       "3970  Debridement of severe, deep dermal burns in hospitalized patients                                                                                                                                                     \n",
       "3971  Treatment of infantile spasms.                                                                                                                                                                                        \n",
       "3972  Treatment of cataplexy and narcolepsy                                                                                                                                                                                 \n",
       "3973  Treatment of acute lymphoblastic leukemia                                                                                                                                                                             \n",
       "3974  Treatment of metastatic uveal melanoma.                                                                                                                                                                               \n",
       "3975  Treatment of ovarian cancer                                                                                                                                                                                           \n",
       "3976  Treatment of pancreatic cancer.                                                                                                                                                                                       \n",
       "3977  Prevention of bronchopulmonary dysplasia.                                                                                                                                                                             \n",
       "3978  treatment of familial chylomicronemia syndrome                                                                                                                                                                        \n",
       "3979  Treatment of acute myeloid leukemia                                                                                                                                                                                   \n",
       "3980  Treatment of Von Willebrand Disease                                                                                                                                                                                   \n",
       "3981  Treatment of multiple myeloma                                                                                                                                                                                         \n",
       "3982  Treatment of advanced melanoma (stages IIb, IIc, III, and IV)                                                                                                                                                         \n",
       "3983  Treatment of mesothelioma                                                                                                                                                                                             \n",
       "3984  Treatment of T-cell non-Hodgkin's lymphoma                                                                                                                                                                            \n",
       "3985  Treatment of acute myeloid leukemia                                                                                                                                                                                   \n",
       "3986  Prevention of bronchopulmonary dysplasia.                                                                                                                                                                             \n",
       "3987  Treatment of graft-versus-host disease                                                                                                                                                                                \n",
       "3988  Treatment of severe liver failure.                                                                                                                                                                                    \n",
       "3989  Treatment of hypoxic ischemic encephalopathy                                                                                                                                                                          \n",
       "3990  To improve neurological outcome in hospitalized cardiac arrest patients.                                                                                                                                              \n",
       "3991  Prevention of plague (Yersinia pestis)                                                                                                                                                                                \n",
       "3992  Treatment of Hodgkin's disease.                                                                                                                                                                                       \n",
       "3993  Treatment of soft tissue sarcoma                                                                                                                                                                                      \n",
       "3994  Treatment of ovarian carcinoma.                                                                                                                                                                                       \n",
       "3995  Treatment of AIDS.                                                                                                                                                                                                    \n",
       "3996  Treatment of AIDS.                                                                                                                                                                                                    \n",
       "3997  Treatment of AIDS                                                                                                                                                                                                     \n",
       "3998  Treatment of Wilson's disease.                                                                                                                                                                                        \n",
       "3999  Treatment of tumor induced hypercalcemia.                                                                                                                                                                             \n",
       "4000  Treatment of complex regional pain syndrome (CRPS)                                                                                                                                                                    \n",
       "4001  Treatment of complex regional pain syndrome (CRPS).                                                                                                                                                                   \n",
       "4002  Treatment of acute myeloid leukemia                                                                                                                                                                                   \n",
       "4003  Treatment of metastatic melanoma, stages IIB, IIC, III and IV                                                                                                                                                         \n",
       "4004  Treatment of Amyotrophic Lateral Sclerosis                                                                                                                                                                            \n",
       "4005  Treatment of pigmented villonodular synovitis/giant cell tumor of the tendon sheath                                                                                                                                   \n",
       "4006  Treatment of pancreatic cancer                                                                                                                                                                                        \n",
       "4007  Treatment of glioblastoma multiforme                                                                                                                                                                                  \n",
       "4008  Treatment of glioblastoma multiforme                                                                                                                                                                                  \n",
       "4009  For the diagnosis of hepatocellular carcinoma                                                                                                                                                                         \n",
       "4010  Diagnostic for the management of hepatocellular carcinoma                                                                                                                                                             \n",
       "4011  Treatment of gastro-entero-pancreatic neuroendocrine tumors                                                                                                                                                           \n",
       "4012  Treatment of pancreatic cancer                                                                                                                                                                                        \n",
       "4013  Treatment of breast cancer patients with brain metastases                                                                                                                                                             \n",
       "4014  Treatment of ovarian cancer                                                                                                                                                                                           \n",
       "\n",
       "     Designation Date    Designation Status   drug_qid  \\\n",
       "0     03/31/2003       Designated/Withdrawn  Q27088744   \n",
       "1     02/01/2008       Designated/Withdrawn  None        \n",
       "2     01/10/2008       Designated/Withdrawn  None        \n",
       "3     01/10/2008       Designated/Withdrawn  None        \n",
       "4     10/12/2011       Designated            Q6589598    \n",
       "5     08/22/2016       Designated            None        \n",
       "6     06/05/2013       Designated            None        \n",
       "7     03/09/2012       Designated            None        \n",
       "8     06/23/2015       Designated            None        \n",
       "9     02/17/2009       Designated            None        \n",
       "10    01/29/2004       Designated            None        \n",
       "11    08/13/2004       Designated            None        \n",
       "12    08/10/2004       Designated            None        \n",
       "13    01/19/2010       Designated/Withdrawn  None        \n",
       "14    09/15/2010       Designated            None        \n",
       "15    06/23/2014       Designated            None        \n",
       "16    05/18/2016       Designated            Q27252594   \n",
       "17    11/29/2016       Designated            Q27258687   \n",
       "18    10/14/2015       Designated            Q27258840   \n",
       "19    12/02/2010       Designated            None        \n",
       "20    12/02/2010       Designated            None        \n",
       "21    10/31/2012       Designated            None        \n",
       "22    10/31/2012       Designated            None        \n",
       "23    01/10/2005       Designated            None        \n",
       "24    02/13/2017       Designated            None        \n",
       "25    03/18/2011       Designated            None        \n",
       "26    03/18/2011       Designated            None        \n",
       "27    03/18/2011       Designated            None        \n",
       "28    04/30/2014       Designated            None        \n",
       "29    12/09/2015       Designated            None        \n",
       "30    09/11/2014       Designated            Q27274745   \n",
       "31    08/26/2014       Designated            None        \n",
       "32    07/05/2007       Designated            None        \n",
       "33    08/19/2003       Designated            None        \n",
       "34    04/25/2016       Designated            None        \n",
       "35    09/18/2015       Designated            None        \n",
       "36    09/04/2013       Designated            None        \n",
       "37    09/04/2013       Designated            None        \n",
       "38    09/04/2013       Designated            None        \n",
       "39    11/29/2002       Designated/Withdrawn  None        \n",
       "40    01/30/2017       Designated            Q27268497   \n",
       "41    07/24/2013       Designated            None        \n",
       "42    04/14/2016       Designated            None        \n",
       "43    06/29/2011       Designated            None        \n",
       "44    02/21/2014       Designated            None        \n",
       "45    10/13/2015       Designated            None        \n",
       "46    06/10/2015       Designated            None        \n",
       "47    08/13/2004       Designated            Q26995704   \n",
       "48    12/08/2004       Designated            None        \n",
       "49    01/12/2017       Designated            None        \n",
       "...          ...              ...             ...        \n",
       "3965  08/29/2016       Designated            Q23671272   \n",
       "3966  09/20/2012       Designated/Approved   Q23671272   \n",
       "3967  02/04/2016       Designated            Q23671272   \n",
       "3968  03/09/2012       Designated            Q782318     \n",
       "3969  10/12/2016       Designated            None        \n",
       "3970  06/16/2006       Designated            None        \n",
       "3971  06/12/2000       Designated/Approved   Q421663     \n",
       "3972  06/11/1984       Designated/Withdrawn  None        \n",
       "3973  01/08/2007       Designated/Approved   None        \n",
       "3974  06/24/2008       Designated            None        \n",
       "3975  12/16/2013       Designated            Q7932801    \n",
       "3976  02/01/2001       Designated            None        \n",
       "3977  07/14/2015       Designated            None        \n",
       "3978  06/23/2015       Designated            None        \n",
       "3979  04/14/2014       Designated            Q7939986    \n",
       "3980  05/29/2014       Designated            None        \n",
       "3981  06/12/2003       Designated/Withdrawn  Q905901     \n",
       "3982  10/13/2016       Designated            Q905901     \n",
       "3983  03/17/2004       Designated/Withdrawn  Q905901     \n",
       "3984  03/16/2004       Designated/Approved   Q905901     \n",
       "3985  10/28/2009       Designated            Q18395775   \n",
       "3986  03/26/2010       Designated            None        \n",
       "3987  09/27/2016       Designated            None        \n",
       "3988  11/27/1998       Designated            None        \n",
       "3989  12/03/2014       Designated            None        \n",
       "3990  05/18/2015       Designated            None        \n",
       "3991  11/30/2016       Designated            None        \n",
       "3992  09/18/2006       Designated            None        \n",
       "3993  12/03/2012       Designated            None        \n",
       "3994  08/03/1999       Designated            None        \n",
       "3995  06/28/1988       Designated/Approved   Q2344582    \n",
       "3996  12/09/1986       Designated            Q2344582    \n",
       "3997  07/17/1985       Designated/Approved   Q198504     \n",
       "3998  11/06/1985       Designated/Approved   Q204639     \n",
       "3999  08/18/2000       Designated/Approved   Q218507     \n",
       "4000  04/15/2015       Designated            None        \n",
       "4001  05/06/2013       Designated            Q218507     \n",
       "4002  12/15/2005       Designated            Q27269191   \n",
       "4003  09/17/2008       Designated            None        \n",
       "4004  11/04/2003       Designated            None        \n",
       "4005  02/14/2014       Designated            None        \n",
       "4006  10/20/2014       Designated            None        \n",
       "4007  05/14/2014       Designated            None        \n",
       "4008  01/12/2011       Designated            None        \n",
       "4009  07/13/2016       Designated            None        \n",
       "4010  07/13/2016       Designated            None        \n",
       "4011  01/12/2009       Designated            None        \n",
       "4012  01/24/2013       Designated            None        \n",
       "4013  04/15/2015       Designated            None        \n",
       "4014  04/10/2014       Designated            None        \n",
       "\n",
       "                            inchi  \n",
       "0     ZVVCSBSDFGYRCB-UHFFFAOYSA-N  \n",
       "1     None                         \n",
       "2     None                         \n",
       "3     None                         \n",
       "4     ZFPZEYHRWGMJCV-ZHALLVOQSA-N  \n",
       "5     None                         \n",
       "6     None                         \n",
       "7     None                         \n",
       "8     None                         \n",
       "9     None                         \n",
       "10    None                         \n",
       "11    None                         \n",
       "12    None                         \n",
       "13    None                         \n",
       "14    None                         \n",
       "15    None                         \n",
       "16    FEQOLYDPQKHFTD-UHFFFAOYSA-N  \n",
       "17    VLIUIBXPEDFJRF-UHFFFAOYSA-N  \n",
       "18    RGYQPQARIQKJKH-UHFFFAOYSA-N  \n",
       "19    None                         \n",
       "20    None                         \n",
       "21    XULSCZPZVQIMFM-IPZQJPLYSA-N  \n",
       "22    XULSCZPZVQIMFM-IPZQJPLYSA-N  \n",
       "23    None                         \n",
       "24    WPJOGWGXMTUHPW-CIPNXXNHSA-N  \n",
       "25    None                         \n",
       "26    None                         \n",
       "27    None                         \n",
       "28    None                         \n",
       "29    HWSLMIXAPNOWGU-AWEZNQCLSA-N  \n",
       "30    YFHRCLAKZBDRHN-MRXNPFEDSA-N  \n",
       "31    None                         \n",
       "32    None                         \n",
       "33    None                         \n",
       "34    QUXHOILDLMWREY-FYZYNONXSA-M  \n",
       "35    WQDBPGWQDBPVQZ-NBCXFSEXSA-N  \n",
       "36    None                         \n",
       "37    None                         \n",
       "38    None                         \n",
       "39    None                         \n",
       "40    HEPUBAGOKRIZEO-PPPUBMIESA-N  \n",
       "41    None                         \n",
       "42    XNLCCACCEOWFNQ-OSPRVTPDSA-N  \n",
       "43    None                         \n",
       "44    None                         \n",
       "45    None                         \n",
       "46    None                         \n",
       "47    QYNUQALWYRSVHF-OLZOCXBDSA-N  \n",
       "48    None                         \n",
       "49    JIPBQMGGMHCGBW-CWUUNJJBSA-N  \n",
       "...                           ...  \n",
       "3965  None                         \n",
       "3966  None                         \n",
       "3967  None                         \n",
       "3968  None                         \n",
       "3969  None                         \n",
       "3970  None                         \n",
       "3971  None                         \n",
       "3972  None                         \n",
       "3973  None                         \n",
       "3974  None                         \n",
       "3975  None                         \n",
       "3976  None                         \n",
       "3977  None                         \n",
       "3978  None                         \n",
       "3979  None                         \n",
       "3980  None                         \n",
       "3981  None                         \n",
       "3982  None                         \n",
       "3983  None                         \n",
       "3984  None                         \n",
       "3985  None                         \n",
       "3986  None                         \n",
       "3987  None                         \n",
       "3988  None                         \n",
       "3989  None                         \n",
       "3990  None                         \n",
       "3991  None                         \n",
       "3992  None                         \n",
       "3993  None                         \n",
       "3994  None                         \n",
       "3995  None                         \n",
       "3996  None                         \n",
       "3997  None                         \n",
       "3998  DJWUNCQRNNEAKC-UHFFFAOYSA-L  \n",
       "3999  None                         \n",
       "4000  None                         \n",
       "4001  None                         \n",
       "4002  None                         \n",
       "4003  None                         \n",
       "4004  None                         \n",
       "4005  CJLUYLRKLUYCEK-UHFFFAOYSA-N  \n",
       "4006  IJDQETGUEUJVTB-UHFFFAOYSA-N  \n",
       "4007  None                         \n",
       "4008  None                         \n",
       "4009  None                         \n",
       "4010  None                         \n",
       "4011  None                         \n",
       "4012  None                         \n",
       "4013  None                         \n",
       "4014  None                         \n",
       "\n",
       "[4015 rows x 6 columns]"
      ]
     },
     "execution_count": 56,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahUKEwixz4Knh6PSAhVjrFQKHWr0C-QQFggaMAA&url=http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FForIndustry%2F...%2FHowtoapplyforOrphanProductDesignation%2FUCM162066.xls&usg=AFQjCNFnMUzkWwsJCPnmqzabQeAIUOicVQ&sig2=OD5moBW6BuDdi6K2PGag1A&bvm=bv.147448319,d.cGw"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Generic Name          4015\n",
       "Orphan Designation    4015\n",
       "Designation Date      4015\n",
       "Designation Status    4015\n",
       "drug_qid              1753\n",
       "inchi                 323 \n",
       "dtype: int64"
      ]
     },
     "execution_count": 61,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.count()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Indications"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "treatment      3306\n",
       "for            254 \n",
       "prevention     164 \n",
       "prophylaxis    29  \n",
       "to             28  \n",
       "management     20  \n",
       "diagnostic     17  \n",
       "1.             15  \n",
       "as             12  \n",
       "use            11  \n",
       "Name: Orphan Designation, dtype: int64"
      ]
     },
     "execution_count": 64,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "first_word = df['Orphan Designation'].str.split(\" \").apply(lambda x:x[0].lower())\n",
    "first_word.value_counts().head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/gstupp/projects/ema_indications/venv/lib/python3.5/site-packages/ipykernel/__main__.py:2: UserWarning: Boolean Series key will be reindexed to match DataFrame index.\n",
      "  from ipykernel import kernelapp as app\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "1801"
      ]
     },
     "execution_count": 84,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "baddies = ~first_word.isin({'treatment', 'prevention', 'diagnosis'})\n",
    "df = df[~baddies]\n",
    "df.loc[:, 'indication'] = df['Orphan Designation'].str.split(\" \").apply(lambda x: \" \".join(x[2:]).lower())\n",
    "df.indication = df.indication.str.lower()\n",
    "df.indication = df.indication.apply(lambda x:x[:-1] if x.endswith('.') else x)\n",
    "diseases = set(list(df['indication'].dropna().str.strip())) - {\"\"}\n",
    "len(diseases)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "262"
      ]
     },
     "execution_count": 85,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "## orphanet\n",
    "#http://data.bioontology.org/ontologies/ORDO/download?apikey=8b5b7825-538d-40e0-9e9e-5ab9274a9aeb&download_format=csv\n",
    "ordo = pd.read_csv(\"../data/ORDO.csv.gz\")\n",
    "ordo.dropna(subset=['Preferred Label'], inplace=True)\n",
    "name_ordo = dict(zip(ordo['Preferred Label'].str.lower(), ordo['Class ID']))\n",
    "name_ordo = {k: v for k,v in name_ordo.items()}\n",
    "for _, row in ordo[ordo.Synonyms.notnull()].iterrows():\n",
    "    for syn in row.Synonyms.split(\"|\"):\n",
    "        name_ordo[syn.lower()] = row['Class ID']\n",
    "del name_ordo['disease']\n",
    "ordo_matches = {x:name_ordo[x] for x in diseases if x in name_ordo}\n",
    "len(ordo_matches)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "21114\n",
      "26710\n"
     ]
    }
   ],
   "source": [
    "# match to DO or HPO\n",
    "def onto_synonyms(json_path):\n",
    "    doid = json.loads(open(json_path).read())\n",
    "    graph = doid['graphs'][0]\n",
    "    nodes = graph['nodes']\n",
    "    name_doid = dict()\n",
    "    for node in nodes:\n",
    "        if 'meta' in node and 'deprecated' in node['meta'] and node['meta']['deprecated']:\n",
    "            continue\n",
    "        if 'lbl' not in node:\n",
    "            continue\n",
    "        name_doid[node['lbl'].lower()] = node['id']\n",
    "        if 'meta' in node and 'synonyms' in node['meta']:\n",
    "            for syn in node['meta']['synonyms']:\n",
    "                name_doid[syn['val'].lower()] = node['id']\n",
    "    return name_doid\n",
    "name_doid = onto_synonyms(\"../data/doid.json\")\n",
    "name_hpo = onto_synonyms(\"../data/hp.json\")\n",
    "print(len(name_doid))\n",
    "print(len(name_hpo))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "297"
      ]
     },
     "execution_count": 87,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "doid_matches = {x:name_doid[x] for x in diseases if x in name_doid}\n",
    "len(doid_matches)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "124"
      ]
     },
     "execution_count": 88,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "hpo_matches = {x:name_hpo[x] for x in diseases if x in name_hpo}\n",
    "len(hpo_matches)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "# create mesh title synonyms dict\n",
    "# json is created from https://github.com/stuppie/mesh-parser\n",
    "mesh = json.load(open(\"/home/gstupp/projects/mesh/mesh.json\"))\n",
    "name_mesh = dict()\n",
    "for record in mesh.values():\n",
    "    if record['record_type'] == 'C':\n",
    "        continue\n",
    "    name_mesh[record['term'].lower()] = record['_id']\n",
    "    for syn in record.get('synonyms', []):\n",
    "        name_mesh[syn.lower()] = record['_id']\n",
    "mesh_name = {v:k for k,v in name_mesh.items()}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "375"
      ]
     },
     "execution_count": 90,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mesh_matches = {x:name_mesh[x] for x in diseases if x in name_mesh}\n",
    "len(mesh_matches)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 95,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\"multiple myeloma\" in hpo_matches"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1334"
      ]
     },
     "execution_count": 91,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "diseases_not_matched = {x for x in diseases if x not in doid_matches and x not in ordo_matches and x not in mesh_matches and x not in hpo_matches}\n",
    "len(diseases_not_matched)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'prophylaxis of bleeding episodes in patients with hemophilia a or b with inhibitors to factor viii or factor ix',\n",
       " 'full-term newborn infants with respiratory failure caused by meconium aspiration syndrome, persistent pulmonary hypertension of the newborn, or pneumonia and sepsis',\n",
       " 'mulitple myeloma and associated bone resorption',\n",
       " 'antibiotic-associated pseudomembranous enterocolitis caused by toxins a and b elaborated by clostridium difficile',\n",
       " 'hereditary and acquired methemoglobinemia',\n",
       " 'malignant melanoma stages iib through iv',\n",
       " 'nerve agent-induced seizures',\n",
       " 'patients with severe chronic neutropenia (absolute neutrophil count less than 500/mm3)',\n",
       " 'mitochondrial cytopathies',\n",
       " 'severe cerebral edema in patients with acute ischemic stroke',\n",
       " 'squamous non-small cell lung cancer',\n",
       " 'patients with diffuse large b-cell lymphoma',\n",
       " 'inflammatory complications of transthoracic esophagectomy',\n",
       " 'pediatric patients with ulcerative colitis',\n",
       " 'chronic/refractory anterior noninfectious uveitis, noninfectious intermediate uveitis, noninfectious panuveitis and non-infectious, uveitis affecting the posterior of the eye (nicups)',\n",
       " 'moderate/severe tardive dyskinesia',\n",
       " 'necrotizing enterocolitis in very low birth weight infants (birth weight less than or equal to 1500 grams)',\n",
       " 'somatostatin receptor positive neuroendocrine tumors',\n",
       " 'extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue',\n",
       " 'malignant hyperthermia syndrome',\n",
       " 'mucopolysaccharidosis (mps) type vi',\n",
       " 'pulmonary arterial hypertension associated with any new york heart association classification (class i, ii, iii, or iv)',\n",
       " 'intracranial malignancies',\n",
       " 'symptomatic stage of acute porphyria',\n",
       " 'andrenoleukodystrophy',\n",
       " 'serious adverse events associated with vascular leak syndrome caused by interleukin-2 therapy',\n",
       " 'chronic inflammatory demyelinating polyneuropathy (cidp)',\n",
       " 'patients with duchenne muscular dystrophy',\n",
       " 'behavioral abnormalities associated with fragile x syndrome',\n",
       " 'pediatric (0 through 16 years of age) ulcerative colitis',\n",
       " 'acute intermittent porphyria attacks',\n",
       " 'partial deep dermal and full thickness burn wounds',\n",
       " 'black widow spider envenomations',\n",
       " 'delayed graft function in solid organ transplant',\n",
       " 'melanoma stages iib through iv',\n",
       " 'cystine kidney stone formation in patients with homozygous cystinuria who are prone to stone development',\n",
       " 'sulfur mustard poisoning',\n",
       " 'stage iib through stage iv melanoma',\n",
       " 'cachexia associated with aids',\n",
       " 'primary mediastinal b-cell lymphoma',\n",
       " 'primary and secondary carnitine deficiency of genetic origin',\n",
       " 'pediatric hyperoxaluria',\n",
       " 'pediatric congestive heart failure',\n",
       " 'chronic functional vomiting to include functional vomiting and cyclic vomiting syndrome',\n",
       " 'pseudomonas aeruginosa lung infections in cystic fibrosis patients',\n",
       " 'symptomatic exophthalmos associated with thyroid related eye disease',\n",
       " 'chronic active hepatitis b',\n",
       " 'patients with angioimmunoblastic t-cell lymphoma',\n",
       " 'hepatocellular carcinoma (hcc)',\n",
       " \"patients with pediatric crohn's disease\",\n",
       " 'invasive cutaneous melanoma',\n",
       " 'symptomatic sickle cell disease in pediatric patients, less than 17 years of age',\n",
       " 'chronic non-infectious uveitis',\n",
       " 'mucopolysaccharidosis type i (msp i)',\n",
       " 'persistent pulmonary hypertension in the newborn',\n",
       " 'patients with sickle cell anemia as shown by the presence of hemoglobin s',\n",
       " 'of hepatocellular carcinoma',\n",
       " 'acute lymphoblastic leukemia in pediatric patients (0 through 16 years of age)',\n",
       " 'postherpetic neuralgia of the trigeminal nerve',\n",
       " 'type i diabetic patients who are already on immunosuppression',\n",
       " 'extranodal marginal zone lymphoma (mucosa-associated lymphatic tissue, malt)',\n",
       " 'spasticity associated with familial spastic paraparesis',\n",
       " 'patients having experienced a severe traumatic brain injury (glasgow coma scale 3 to 8) in order to decrease early mortality and improve long-term functional and neurological outcome',\n",
       " 'recessive dystrophic epidermolysis bullosa (rdeb)',\n",
       " 'hunter syndrome (mucopolysaccharidoses)',\n",
       " 'primary mediastinal b cell lymphoma',\n",
       " 'symptomatic transthyretin (ttr) amyloid cardiomyopathy',\n",
       " \"late stage parkinson's disease\",\n",
       " 'neimann-pick disease, type c',\n",
       " 'acute colonic pseudo-obstruction',\n",
       " 'alk-positive, met-positive, or ros-positive non-small cell lung cancer',\n",
       " 'schwannoma of the central nervous system',\n",
       " 'aids-myelopathy',\n",
       " 'duchenne muscular dystrophy patients bearing mutations that can be corrected by skipping exon 45',\n",
       " 'implantation failure and unexplained recurrent miscarriage',\n",
       " 'gastric cancer including cancer of the gastroesophageal junction',\n",
       " 'non-healing corneal ulcers or epithelial defects which have been unresponsive to conventional therapy and the underlying cause has been eliminated',\n",
       " 'symptomatic patients with aids including all patients with cd4 t-cell counts less than 200 cells per mm3',\n",
       " 'recurrent malignant glioma',\n",
       " 'acute and chronic rejection in patients who have received solid organ transplants',\n",
       " 'ischemia-reperfusion injury in solid organ transplants',\n",
       " \"diffuse non-hodgkin's lymphoma, including aids-related diffuse non-hodgkin's lymphoma\",\n",
       " 'parenteral nutrition-associated liver disease',\n",
       " 'severe thermal injuries in patients with greater than 40% full or partial thickness burns',\n",
       " 'hpv-positive associated anal cancer',\n",
       " 'philadelphia-positive acute lymphoblastic leukemia',\n",
       " 'philadelphia chromosome-positive chronic myelogenous leukemia',\n",
       " 'dilated cardiomyopathy, including dilated cardiomyopathy secondary to lamin a/c gene mutations',\n",
       " 'primary ventricular fibrillation',\n",
       " 'acute peripheral arterial occlusion',\n",
       " 'complex regional pain syndrome (crps-1, crps-ii, crps-nos)',\n",
       " 'gastro-entero-pancreatic neuroendocrine tumors',\n",
       " 'the active phase of ulcerative colitis with involvement restricted to the left side of the colon',\n",
       " 'acute chest syndrome in at-risk patients with sickle cell disease',\n",
       " 'partial onset or primary generalized tonic-clonic seizures for hospitalized epilepsy patients or epilepsy patients being treated in an emergency care setting who are unable to take oral topiramate',\n",
       " 'patients with autosomal recessive polycystic kidney disease (arpkd)',\n",
       " 'multiforme',\n",
       " 'sexual dysfunction in spinal cord injury patients',\n",
       " 'full thickness macular holes',\n",
       " 'medullary thyroid cancer, anaplastic thyroid cancer, and recurrent or metastatic follicular or papillary thyroid cancer',\n",
       " 'prophyllaxis of bleeding episodes in patients with congenital hemophilia and inhibitors to coagulation factor viii or ix',\n",
       " 'localization of primary, residual, recurrent and metastatic medullary thyroid carcinoma',\n",
       " 'oligoarticular juvenile idiopathic arthritis (persistent oligoarthritis, psoriatic juvenile idiopathic arthritis, enthesitis-related arthritis, or undifferentiated arthritis) and polyarticular juvenile idiopathic arthritis in children 0 through 16 years of age',\n",
       " 'patients with giant cell tumor of bone',\n",
       " 'emphysema secondary to congenital alpha1-antitrypsin deficiency',\n",
       " 'pediatriac patients with ulcerative colitis',\n",
       " 'bronchopulmonary dysplasia in premature neonates weighing less than 1500 grams',\n",
       " 'primary immunodeficiency disease associated with t-cell defects',\n",
       " 'acute graft-vs-host disease following bone marrow transplantation',\n",
       " 'pediatric patients (0 through 16 years of age) with dilated cardiomyopathy',\n",
       " 'heroin addicts suitable for maintenance on opiate agonists',\n",
       " 'advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy',\n",
       " \"still's disease including juvenile rheumatoid arthritis and adult-onset still's disease\",\n",
       " \"symptomatic paget's disease (osteitis deformans)\",\n",
       " 'seizures induced by organophosporous insecticide poisoning',\n",
       " 'myelodysplastic syndromes requiring therapy',\n",
       " 'peripheral arterial occlusion',\n",
       " 'intestinal giardiasis',\n",
       " 'faber disease',\n",
       " 'treatment-resistant schizophrenia',\n",
       " \"tourette's syndrome in school-age children, ages 5-16\",\n",
       " 'pediatric juvenile idiopathic arthritis',\n",
       " 'moderate to severe reflex sympathetic dystrophy and causalgia',\n",
       " 'invasive zygomycosis',\n",
       " 'anemias associated with myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasms',\n",
       " 'patients with extranodal marginal zone lymphoma (mucosa associated lymphoid tissue [malt type] lymphoma)',\n",
       " 'constitutional delay in growth and puberty in adolescent boys (14-17 yrs of age)',\n",
       " 'capillary leakage syndrome',\n",
       " 'primary immune thrombocytopenia',\n",
       " 'children with eosinophilic esophagitis',\n",
       " 'severe hirsutism',\n",
       " 'persistent corneal epithelial defects',\n",
       " 'plague (yersinia pestis)',\n",
       " 'herpes simplex encephalitis in individuals afflicted with aids',\n",
       " \"pediatric (0 to 16 years of age) crohn's disease\",\n",
       " 'hypercalcemia in patients with parathyroid carcinoma',\n",
       " 'systemic lupus erythematosus (sle) and the reduction in the use of steroids in steroid-dependent sle patients',\n",
       " 'infant respiratory distress syndrome associated with prematurity',\n",
       " 'acute limb ischemia',\n",
       " 'patients with recent onset (<15 years)with type 1a diabetes mellitus with residual beta-cell function',\n",
       " 'sleep-wake disorder in smith-magenis syndrome associated with diurnal melatonin secretion',\n",
       " 'hyperammonemia and resultant hepatic encephalopathy (he) in patients with acute liver failure or acute on chronic liver disase',\n",
       " 'duchenne and becker muscular dystrophies',\n",
       " 'primary myelofibrosis (mf), post-polycythemia vera mf, and post-essential thrombocythemia mf',\n",
       " 'adenocarcinoma of the esophagus and stomach',\n",
       " \"duchennes and becker's muscular dystrophy\",\n",
       " 'acute respiratory distress disease (ards) in adults',\n",
       " \"short stature associated with turner's syndrome\",\n",
       " 'hemorrhagic fever with renal syndrome caused by hantaan virus and puumala virus',\n",
       " 'chronic radiation proctitis',\n",
       " 'ischemia reperfusion injury to donor organ tissue associated with solid organ transplantation',\n",
       " 'nondystrophic myotonia',\n",
       " 'leptin deficiency secondary to generalized lipodystrophy and partial familial lipodystrophy',\n",
       " 'patients with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination',\n",
       " 'bronchopulmonary pseudomonas aeruginosa infections in cystic fibrosis patients',\n",
       " 'beta-hemoglobinopathies and beta-thalassemia',\n",
       " 'retinopathy of prematurity in preterm infants at risk for developing retinopathy of prematurity',\n",
       " 'adult tay-sachs disease',\n",
       " 'severe complications from the smallpox vaccine',\n",
       " 'pediatric hyperparathyroidism',\n",
       " 'refractory glaucoma as an adjunct to ab externo glaucoma surgery',\n",
       " 'severe human cytomegalovirus infections in specific immunosuppressed patient populations',\n",
       " 'non-infectious intermediate, posterior, or pan-uveitis, or chronic non-infectious anterior uveitis',\n",
       " 'chlorine gas poisoning',\n",
       " 'pediatric patients 0 to <18 yrs of age with oligoarticular-course and polyarticular-course juvenile idiopathic arthritis',\n",
       " 'thymic epithelial tumors',\n",
       " 'oral drug overdosage to speed lower bowel evacuation',\n",
       " 'patients at risk of developing myelosuppression following a radiological or nuclear incident',\n",
       " 'recurrent respiratory papillomatosis (rrp)',\n",
       " 'non-life threatening, mild to severe bleeding episodes due to cutaneous injuries or dental procedures in patients with von willebrand disease',\n",
       " 'anaplastic lymphoma kinase-positive (alk+), c-ros 1 oncogene positive (ros1+), or epidermal growth factor receptor positive (egfr+) non-small cell lung cancer (nsclc)',\n",
       " 'metastatic or locally advanced inoperable transitional cell carcinoma of the urothelium (stage iii and iv bladder cancer)',\n",
       " 'systemic mastocytosis without the d816v c-kit mutation',\n",
       " 'malignancy-associated or chemotherapy-induced hyperuricemia',\n",
       " 'human papillomavirus (hpv)-associated head and neck squamous cell carcinoma (hnscc)',\n",
       " 'leakage from the surgical site following penetrating keratoplasty',\n",
       " 'sickle cell disease and beta thalassemia',\n",
       " 'aids patients with neutropenia due to the disease, aztor ganciclovir',\n",
       " 'patients with congenital factor ix deficiency (hemophilia b)',\n",
       " 'dynamic muscle contracture in pediatric cerebral palsy patients',\n",
       " 'chronic iron overload in patients with transfusion-dependent anemias',\n",
       " 'visceral leishmaniasis (kala-azar)',\n",
       " 'early postoperative complications following pancreatic resection',\n",
       " 'invasive candida infections, including candidemia',\n",
       " 'cysticercosis (including neurocysticercosis)',\n",
       " 'congential hyperinsulinenic hypoglycemia and other causes of hyperinsulinemic hypoglycemia in adults and children',\n",
       " 'increased intracranial pressure in patients with severe, closed-head injury, also known as traumatic brain coma, for whom no other effective treatment is available',\n",
       " 'aids associated pneumocystis carinii pneumonia',\n",
       " 'iib-iv melanoma',\n",
       " 'recurrence of primary ventricular fibrillation',\n",
       " 'x-linked hypophosphatemia (formerly known as vitamin d-resistant rickets)',\n",
       " 'x linked severe combined immune deficiency disease',\n",
       " \"cushing's syndrome secondary to ectopic acth secretion\",\n",
       " 'follicular non-hodgkin lymphoma',\n",
       " 'mucopolysaccharidosis type i (mps i)',\n",
       " 'pediatric patients with crohn disease',\n",
       " \"levodopa-induced dyskinesia associated with parkinson's disease\",\n",
       " 'thrombotic thrombocytopenic purpura including its congential, acquired idiopathic, and secondary forms',\n",
       " 'advanced or metastatic transitional cell carcinoma of the urinary bladder',\n",
       " 'aquired immunodeficiency syndrome',\n",
       " 'tumor lysis syndrome in cancer patients undergoing chemotherapy',\n",
       " \"severe keratoconjunctivitis sicca associated with sjogren's syndrome\",\n",
       " 'pediatric multiple sclerosis in patients less than or equal to 16 years of age',\n",
       " 'life-threatening ventricular arrhythmias in pediatric patients',\n",
       " 'tricyclic antidepressant poisoning',\n",
       " 'peripheral t-cell lymphoma (ptcl)',\n",
       " 'mucopolysaccharidosis type iva (morquio syndrome)',\n",
       " 'hiv-infected pediatric patients',\n",
       " 'congenital adrenal hyperpasia',\n",
       " 'acute attacks of angioedema in individuals with hereditary angioedema',\n",
       " 'patients with known or suspected internal contamination with plutonium, americium, or curium',\n",
       " 'adults with growth hormone deficiency',\n",
       " 'aids-associated catabolism/weight loss',\n",
       " 'oral ulcerations and dysphagia in patients with epidermolysis bullosa',\n",
       " 'inherited retinal dystrophy due to biallelic rpe65 gene mutations',\n",
       " 'acute repetitive seizures',\n",
       " 'delayed graft function after renal transplantation',\n",
       " 'duchenne muscular dystrophy (dmd.)',\n",
       " 'charcot-marie tooth disease',\n",
       " \"aids-related kaposi's sarcoma\",\n",
       " 'severe preeclampsia and eclampsia',\n",
       " 'paroxysmal nocturnal hemoglobinuria (pnh)',\n",
       " 'advanced metastatic melanoma',\n",
       " 'invasive carcinoma of the cervix',\n",
       " 'egfrviii-expressing glioblastoma multiforme',\n",
       " 'globoid cell leukodystrophy (krabbe disease)',\n",
       " 'thymidine kinase 2 deficiency',\n",
       " 'glycogen storage disease type ia (von gierke disease)',\n",
       " 'prevention of recurrent aphthous ulcers in severely, terminally immunocompromised patients',\n",
       " 'pain associated with postherpetic neuralgia',\n",
       " 'melanoma stages iib through iv as part of a combination chemotherapy regimen',\n",
       " 'pediatric multiple sclerosis (0 through 16 years of age)',\n",
       " 'pediatric schizophrenia (pediatrics is defined as 0 through 16 years of age)',\n",
       " 'laryngeal (respiratory) papillomatosis',\n",
       " 'metastatic melanoma, stages iib, iic, iii and iv',\n",
       " 'severe combined immune deficiency-x1',\n",
       " 'graft versus host disease and/or rejection in patients who have received bone marrow transplants',\n",
       " 'pediatric nephrotic syndrome',\n",
       " 'pediatric (0 to 16 years of age) ulcerative colitis',\n",
       " 'acute porphyric syndromes',\n",
       " 'idiopathic membranous glomerular nephropathy',\n",
       " 'mucopolysaccharidosis iiib (sanfilippo b syndrome)',\n",
       " \"tourette's syndrome in pediatric patients\",\n",
       " 'potentially life threatening digitalis intoxication in patients who are refractory to management by conventional therapy',\n",
       " 'the comorbidities associated with sickle cell disease',\n",
       " 'complications of vaccinia vaccination',\n",
       " \"intermetatarsal neuroma (morton's neuroma) that does not respond to conservative treatment and requires either neurectomy or neurolysis\",\n",
       " 'uveitis of the posterior segment of non-infectious etiology, and uveitis of the anterior segment of non-infectious etiology and refractory to conventional therapy',\n",
       " 'gastrointestinal and pancreatic fistulas',\n",
       " 'secondary pulmonary hypertension due to intrinsic precapillary pulmonary vascular disease',\n",
       " 'lipase deficiencies, including wolman disease and cholesteryl ester storage disease',\n",
       " 'perinatal asphyxia',\n",
       " 'constitutional delay of growth and puberty in adolescent boys 14 to 17 years of age',\n",
       " 'chronic lymphocytic leukemia (cll)',\n",
       " 'hiv infection in pediatric patients under the age of 16 years',\n",
       " 'hepatocellular carcinoma in combination with dna-damaging agents',\n",
       " 'prevention of angioedema caused by c1-esterase inhibitor deficiency',\n",
       " 'death following a potentially lethal dose of total body irradiation during or after a radiation disaster',\n",
       " 'congenital factor vii deficiency which includes treatment and prophylaxis of bleeding episodes in patients with congenital factor vii deficiency',\n",
       " 'glycogen storage disease type ia',\n",
       " 'patients with known or suspected internal contamination with radioactive or non-radioactive cesium or thallium',\n",
       " 'progressive-relapsing multiple sclerosis',\n",
       " 'mitochondrial neurogastrointestinal encephalomyopathydue to thymidine phosphorylase deficiency',\n",
       " 'onchocerhiasis (\"river blindness\") caused by the filarial nematode onchocerca volvulus',\n",
       " 'pulmonary and hepatic metastases in patients with colorectal adenocarcinoma',\n",
       " 'maintenance of reactional lepromatous leprosy',\n",
       " 'secondary-progressive multiple sclerosis',\n",
       " 'intractable spasticity in children with cerebral palsy',\n",
       " 'neonates and infants undergoing cardiopulmonary bypass during surgical repair of congenital heart lesions',\n",
       " 'malignant tumors of the central nervous system',\n",
       " 'patients with neurotrophic keratopathy',\n",
       " \"advanced (involutional or residual stage) dupuytren's disease\",\n",
       " 'vaso-occlusive crisis associated with sickle cell disease',\n",
       " 'patients with cystic fibrosis',\n",
       " 'graft versus host disease following allogeneic hematopoietic stem cell transplant',\n",
       " 'neonates for disseminated group b streptococcal infection',\n",
       " 'acute renal graft rejection episodes',\n",
       " \"ewing's sarcoma family of tumors\",\n",
       " 'stage iib to stage iv melanoma',\n",
       " 'congenital alpha-1 antitrypsin deficiency',\n",
       " 'persistent pulmonary hypertension in newborns',\n",
       " 'peripheral arterial occlusion (pao)',\n",
       " 'primary periodic paralyses',\n",
       " 'primary amebic encephalitis (pam)',\n",
       " 'extranodal marginal zone lymphoma',\n",
       " 'arterial hypertension',\n",
       " 'severe chemotherapy-induced thrombocytopenia',\n",
       " 'nonparenchymatous sarcomas',\n",
       " 'cytomegalovirus retinitis in patients with aids',\n",
       " 'lcat deficiency syndromes',\n",
       " 'pediatric (0-16 yrs old inclusive) cerebral palsy due to acquired brain injury',\n",
       " 'rejection of solid organ transplants',\n",
       " 'neurocysticercosis due to taenia solium as: 1) chemotherapy of parenchymal, subarachnoidal and racemose (cysts in spinal fluid) neurocysticercosis in symptomatic cases and 2) prophylaxis of epilepsy and other sequelae in asymptomatic neurocysticercosis',\n",
       " 'patients with hiv-associated adipose redistribution syndrome',\n",
       " 'vitamin e deficiency resulting from malabsorption due to prolonged cholestatic hepatobiliary disease',\n",
       " 'mucopolysaccharidosis type vi (mps vi; maroteaux-lamy syndrome)',\n",
       " 'mercury toxicity',\n",
       " 'cutaneous t-cell lymphomas, acute t-cell leukemia-lymphoma, and related mature t-cell malignancies',\n",
       " 'b-cell leukemia and b-cell lymphoma',\n",
       " 'acute renal allograft rejection',\n",
       " 'leber congential amaurosis (lca) due to inherited mutations in rpe65 (encoding the protein retinal pigment epithelial protein 65) or lrat (encoding the enzyme lecithin:retinol acyltransferase)genes',\n",
       " 'invasive malignant melanoma',\n",
       " 'acute rejection in patients requiring allogenic lung transplants',\n",
       " 'pediatric (aged 0 through 16 years) juvenile idiopathic arthritis (jia) ilar categories excluding systemic jia',\n",
       " 'follicular, medullary and anaplastic thyroid carcinoma and metastatic or locally advanced papillary thyroid cancer',\n",
       " 'patients with hepatocellular carcinoma',\n",
       " 'pulmonary infections due to pseudomonas aeruginosa in patients with cystic fibrosis',\n",
       " 'moderate to very severe clinical forms of transfusion reactions arising from abo incompatible transfusions of blood, blood products, and blood derivatives',\n",
       " 'palmar-plantar erythrodysethesia syndrome',\n",
       " 'patients with gram-negative sepsis which has progressed to shock',\n",
       " 'new-onset type i diabetes mellitus',\n",
       " 'non-infectious ocular inflammation of the posterior segment in patients with intermediate, posterior, and panuveitis',\n",
       " 'chronic or recurrent central serous chorioretinopathy',\n",
       " 'brain metastases when used in combination with dna-damaging agents',\n",
       " \"t-cell non-hodgkin's lymphoma\",\n",
       " 'type i gaucher disease',\n",
       " 'gastric cancer and gastro-esophageal junction cancer',\n",
       " 'esophageal dysplasia',\n",
       " 'invasive sporotrichosis',\n",
       " 'patients with lymphatic malformations',\n",
       " 'patients with ocular (uveal) melanoma',\n",
       " 'epithelial ovarian cancer',\n",
       " 'high altitude pulmonary edema',\n",
       " 'pediatric ulcerative colitis (0 through 16 years of age)',\n",
       " 'single or mixed gastrointestinal infestations by trichuris trichiura (whipworm), ascaris lumbricoides (large roundworm), and ancylostoma duodenale and nectar americanus (hookworm)',\n",
       " 'assessment of rejection status in heart, heart-lung, single lung, or bilateral lung transplants',\n",
       " 'periprosthetic joint infection',\n",
       " 'obsessive compulsive disorder in pediatric patients (0 to 16 years of age)',\n",
       " 'waldenstrom macroglobulinemia (also known as lymphoplasmacytic lymphoma)',\n",
       " 'intraventricular hemorrhage associated with intracerebral hemorrhage',\n",
       " 'metastatic malignant melanoma',\n",
       " 'cystathionine beta-synthase deficient homocystinuria',\n",
       " 'advanced melanoma (stages iib, iic, iii, and iv)',\n",
       " 'liver transplant recipients with reestablished fibrosis to delay the progression to cirrhosis and end stage liver disease',\n",
       " 'moderate to severe traumatic brain injury',\n",
       " 'neuropathic pain associated with spinal cord injury',\n",
       " 'mild to moderate acute malaria caused by susceptible strains of p. falciparum and p. vivax',\n",
       " 'myeloproliferative disorders/myelodysplastic syndromes associated with platelet-derived growth factor gene re-arrangements',\n",
       " 'patients with cutaneous t-cell lymphoma',\n",
       " 'reperfusion injury to donor organ tissue',\n",
       " 'neurogenic symptomatic orthostatic hypotension in patients with primary autonomic failure, dopamine-beta-hydroxylase deficiency, and nondiabetic autonomic neuropathy',\n",
       " 'chronic diarrhea in short bowel syndrome patients with an inadequate response to anti-diarrheal treatment',\n",
       " 'preterm neonatal respiratory distress syndrome',\n",
       " 'alpha1-antitrypsin deficiency',\n",
       " 'pigmented villonodular synovitis/giant cell tumor of the tendon sheath',\n",
       " 'acute cyanide poisoning',\n",
       " 'ototoxicity caused by platinum-based chemotherapeutic agents used to treat pediatric cancers',\n",
       " 'glioblastoma in conjunction with radiotherapy',\n",
       " 'pulmonary infections caused by burkholderia cepacia',\n",
       " 'lung dysfunction following lung transplant',\n",
       " \"tourette's syndrome in children 0-16 years old\",\n",
       " 'oral mucositis and stomatitis following radiation therapy for head and neck cancer',\n",
       " 'atypical hemolytic uremic syndrome associated with an inherited abnormality of the complement system',\n",
       " 'acute iron poisoning',\n",
       " 'respiratory distress syndrome',\n",
       " 'autosomal dominant polycystic kidney disease',\n",
       " 'delayed graft function in renal transplant recipients',\n",
       " 'lymphatic malformations',\n",
       " 'glioblastoma multiforme (gbm)',\n",
       " 'renal cell carcinoma in hla-a*2 positive patients',\n",
       " 'anatomically accessible oral cancers (lip, tongue, gum, floor of mouth, salivary gland, and other oral cavity)',\n",
       " 'brain and cns tumors',\n",
       " 'multiple sclerosis patients who are both hla-dr2 positive and autoreactive to myelin oligodendrocyte glycoprotein residues 35-55',\n",
       " 'hyperbilirubinemia in newborn infants unresponsive to phototherapy',\n",
       " 'hiv-associated sensory neuropathy',\n",
       " 'achromatopsia caused by mutations in the cnga3 gene',\n",
       " 'intractable spasticity due to multiple sclerosis or spinal cord injury',\n",
       " 'scarring post ab externo glaucoma surgery',\n",
       " 'hepatitis d virus infection',\n",
       " 'mucopolysaccharidosis type ii (hunter syndrome)',\n",
       " 'incessant ventricular tachycardia',\n",
       " 'cystic fibrosis liver disease',\n",
       " 'hypertension in pediatric patients 0 through 16 years of age',\n",
       " 'patients with symptomatic orthostatic hypotension',\n",
       " 'dental caries due to radiation-induced xerostomia in patients with head and neck cancer',\n",
       " 'patients with braf mutation positive non-small cell lung cancer',\n",
       " 'epstein-barr virus-positive post-transplant lymphoproliferative disorders',\n",
       " 'von willebrand disease except for surgical and/or invasive procedures in patients with von willebrand disease in whom desmopressin is either ineffective or contraindicated',\n",
       " 'primary hypertension with complications and secondary hypertension in pediatric patients (ages 0 through 16 years of age)',\n",
       " 'muscular dystrophy resulting from premature stop mutations in the dystrohin gene',\n",
       " 'hiv associated anemia related to hiv infection or hiv treatment',\n",
       " 'primary fallopian tube cancer',\n",
       " 'suppression of toxoplasma gondii encephalitis',\n",
       " 'invasive metastatic melanoma (stage iib, iii, iv)',\n",
       " 'pulmonary arterial hypertension (who group 1)',\n",
       " 'spasticity associated with cerebral palsy',\n",
       " 'poliovirus infection',\n",
       " \"hoehn and yahr stage 3 and 4 parkinson's disease\",\n",
       " 'human african trypanosomiasis (hat) or sleeping sickness',\n",
       " 'soil transmitted helminth infection strongyloidiasis',\n",
       " 'non-tuberculous mycobacteria (ntm) infections',\n",
       " 'hemophilia a and hemophilia b',\n",
       " 'exposure to b. anthracis spores',\n",
       " 'mucopolysaccharidosis iii type b (mps iiib, sanfilippo syndrome type b)',\n",
       " 'malignant brain tumors',\n",
       " 'non-life threatening, mild to severe bleeding episodes due to cutaneous injuries or dental procedures in hemophiliac patients',\n",
       " 'necrotizing enterocolitis in preterm infants with birth weight less than or equal to 1,500 grams',\n",
       " 'congenital and acquired methemoglobinemia',\n",
       " 'adult t-cell leukemia/lymphoma (atll)',\n",
       " 'stage iib through stage iv malignant melanoma',\n",
       " 'dermal injury due to nuclear/radiation incident',\n",
       " 'japanese encephalitis virus in pediatric patients',\n",
       " 'hormone refractory prostate carcinoma',\n",
       " 'epstein-barr virus positive head and neck cancers (which includes nasopharyngeal carcinoma)',\n",
       " 'clinical sequelae of acute lung injury induced by cardiopulmonary bypass in pediatric patients',\n",
       " 'well-differentiated papillary, follicular or combined papillary/follicular carcinomas of the thyroid gland',\n",
       " 'chronic active hepatitis b infection in hla-a2 positive patients',\n",
       " 'chronic iron overload in alpha-thalassemia',\n",
       " 'acid sphingomyelinase deficiency (niemann-pick disease)',\n",
       " 'hypoglycemia in the congenital hyperinsulinism population',\n",
       " 'levodopa-induced dyskinesia',\n",
       " 'papillomavirus warts in the oral cavity of hiv positive patients',\n",
       " 'pulmonary arterial hypertention',\n",
       " 'opiate addiction in opiate users',\n",
       " 'persistent methicillin-resistant s. aureus lung infection in patients with cystic fibrosis',\n",
       " 'sickling disorders, which include s-s hemoglobinopathy, s-c hemoglobinopathy, and s-thalassemia hemoglobinopathy',\n",
       " 'acute lymphoblastic leukemia in the pediatric population',\n",
       " 'spinocereballar ataxia',\n",
       " 'metastatic colorectal adenocarcinoma',\n",
       " 'malignant glioma with braf v600 mutation',\n",
       " \"the on-off fluctuations associated with late-stage parkinson's disease\",\n",
       " 'stargardt macular degeneration',\n",
       " 'rabies virus infections',\n",
       " 'mutliple myeloma',\n",
       " 'bleeding in patients experiencing intracranial hemorrhage',\n",
       " 'patients with anorexia, cachexia, or significant weight loss (=/>10% of baseline body weight) and confirmed diagnosis of aids',\n",
       " 'anthracycline extravasation during chemotherapy',\n",
       " \"perforating diseases, including kyrle's disease, reactive perforating collangenosis, perforating folliculitis and elastosis perforans serpiginosa\",\n",
       " 'bile duct tumors',\n",
       " 'hepatitis delta virus (hdv)infection',\n",
       " 'antibody mediated organ rejection in solid organ transplant patients',\n",
       " 'molybdenum cofactor deficiency type a (mocd)',\n",
       " 'growth hormone insensitivity syndrome (ghis)',\n",
       " 'type i diabetes mellitus with residual beta cell function',\n",
       " 'pompe disease (glycogen storage disease type ii)',\n",
       " 'epithelial neoplasias of the vulva positive for human papilloma virus type 16',\n",
       " 'hypoplasminogenemia, or type i plasminogen deficiency',\n",
       " 'pediatric patients with chronic hepatitis c virus infection',\n",
       " 'bacterial corneal ulcers',\n",
       " 'x-linked juvenile retinoschisis (xlrs)',\n",
       " 'of complement-mediated thrombotic microangiopathy',\n",
       " 'stage iii melanoma not amenable to surgical resection',\n",
       " 'scarring following glaucoma filtration surgery',\n",
       " 'hpv-16 expressing head and neck squamous cell carcinoma',\n",
       " 'fibrosis-associated chronic allograft nephropathy in kidney transplant patients',\n",
       " 'respiratory syncytial virus lower respiratory tract infections in hospitalized infants and young children',\n",
       " 'polymyositis/dermatomyositis',\n",
       " 'limb girdle muscular dystrophy type 2b',\n",
       " 'patients with esophageal varices that have recently bled, to prevent rebleeding',\n",
       " 'carcinoid syndrome in patients with neuroendocrine tumors',\n",
       " 'neuroleptic-induced tardive dyskinesia in schizophrenia patients',\n",
       " 'small cell lung cancer (sclc)',\n",
       " 'essential blepharospasm',\n",
       " 'patients with non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase(alk)-positive',\n",
       " 'neuropathic pain in patients with sarcoidosis',\n",
       " 'primary brain malignancies (grade iii and iv astrocytomas)',\n",
       " 'bronchiectasis in patients with pseudomonas aeruginosa or other susceptible microbial pathogens',\n",
       " 'gastric cancer, including cancer of the gastroesophageal junction',\n",
       " \"pediatric crohn's disease (0 through 16 years of age)\",\n",
       " 'neutropenia due to hairy cell leukemia',\n",
       " \"acute flares in pediatric patients with ileo-cecal crohn's disease\",\n",
       " 'ischemia/reperfusion injury associated with solid organ transplantation',\n",
       " 'osteogenesis imperfecta in pediatric patients 4 years of age and older',\n",
       " 'stage iii - iv melanoma',\n",
       " 'lactic acidosis in patients with severe malaria',\n",
       " 'non-hodgkin t-cell lymphomas',\n",
       " 'epilepsy patients who cannot take anything by mouth (npo)',\n",
       " 'congenital adrenal hyperplasia (cah)',\n",
       " 'arteriovenous fistula or arteriovenous graft failure in patients with end satge renal disease receiving hemodialysis or preparing for hemodialysis',\n",
       " 'increased bone resorption due to malignancy',\n",
       " 'gastric neuroendocrine tumors (gastric nets)',\n",
       " 'fanconi anemia type a patients',\n",
       " 'acute antibody mediated rejection following kidney transplantation',\n",
       " 'esophageal ulcers',\n",
       " 'complex regional pain syndrome (crps)',\n",
       " 'treatment of acute attacks of hereditary angioedema',\n",
       " 'hyperuricemia in patients with gout refractory to conventional therapy or in whom conventional therapy is contraindicated',\n",
       " 'ischemia reperfusion injury in patients undergoing solid organ transplantation',\n",
       " 'patients with frederickson type i or v hyperlipoproteinemia',\n",
       " 'esophageal variceal hemorrhage patients with portal hypertension',\n",
       " 'painful hiv-associated neuropathy',\n",
       " 'hospitalized patients with deep partial and full thickness burns requiring grafting',\n",
       " 'epidermal growth factor receptor mutation-positive non-small cell lung cancer',\n",
       " 'acromegly',\n",
       " 'chronic lymphocytic leukemia (cll), including refractory cll',\n",
       " 'brain metastasis',\n",
       " 'prevention of episodic bleeding in patients with inhibitor antibodies to human coagulation factor viii',\n",
       " 'polyarticular juvenile idiopathic arthritis in patients 0 through 18 years of age',\n",
       " 'pediatric patients with sickle cell anemia',\n",
       " 'wilson’s disease',\n",
       " 'spinal muscular atrophies',\n",
       " 'acute subarachnoid hemorrhage',\n",
       " 'generalized systemic pseudohypoaldosteronism type 1 (also known as autosomal recessive pha-i or pha-ib)',\n",
       " 'pneumocystis carinii pneumonia in aids patients',\n",
       " 'acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle',\n",
       " 'skin blistering and erosions associated with inherited epidermolysis bullosa',\n",
       " 'chronic lymphocytic leukemia to increase granulocyte count',\n",
       " 'stage iib, iic, iii, and iv melanoma with brafv600 mutation',\n",
       " 'rabies virus infection including post-exposure prophylaxis (pep) for rabies',\n",
       " 'chronic myelogenous leukemia (cml)',\n",
       " 'progressive familial intrahepatic cholestatis',\n",
       " 'mucopolysaccharidosis type 1 (mps i)',\n",
       " 'methanol or ethylene glycol poisoning',\n",
       " 'prevention of cerebral vasospasm following subarachnoid hemorrhage',\n",
       " 'pseudomonas aeruginosa pulmonary infections in cystic fibrosis patients',\n",
       " 'metastatic melanoma',\n",
       " 'upper tract urothelial carcinoma',\n",
       " 'vulvar dystrophies',\n",
       " 'preterm birth in singleton pregnancies',\n",
       " 'hypoprolactinemia in breastfeeding mothers, and in some hypoprolactinemic conditions following the use of cabergoline or bromocriptine in mothers who wish to initiate or return to breastfeeding',\n",
       " 'cytomegalovirus infections in allogenic bone marrow transplant patients',\n",
       " 'erythema nodosum leprosum',\n",
       " 'patients undergoing vitrectomy',\n",
       " 'diarrhea associated with vasoactive intestinal peptide tumors (vipoma)',\n",
       " 'post-transplantation lymphoproliferative disorders in pediatric recipients of solid-organ transplantation',\n",
       " 'recurrent clostridium difficile infection (clostridium difficile gastrointestinal disease)',\n",
       " 'acute lymphoblastic leukemia. (all)',\n",
       " 'mucopolysaccharidosis type iiib (sanfilippo syndrome type b)',\n",
       " 'active tuberculosis (tb)',\n",
       " 'anaplastic glioma',\n",
       " 'treatment of factor viii/factor ix inhibitors in patients with hemophilia a or b',\n",
       " 'homozygous familial hypercholesterolemia (hofh)',\n",
       " 'histologically confirmed advanced or metastatic pancreatic cancer',\n",
       " 'acute myeloid (myelogenous) leukemia',\n",
       " 'delayed graft function following renal transplant',\n",
       " 'pediatric ulcerative colitis',\n",
       " 'facial angiofibromas (fa) associated with tuberous sclerosis complex (tsc)',\n",
       " 'diffuse large b-cell lymphoma (dlbcl)',\n",
       " \"stargardt's disease\",\n",
       " 'moderate/severe acute alcoholic hepatitis in the presence of moderate protein calorie malnutrition',\n",
       " 'burn injury progression of acute, deep dermal burns in hospitalized patients',\n",
       " 'hypoxic-ischemic encephalopathy to prevent siezures in neonates',\n",
       " 'severe aphthous stomatitis in severely, terminally immunocompromised patients',\n",
       " 'subjects at risk of developing myelosuppression after a radiological or nuclear incident',\n",
       " 'severe steroid-requiring asthma',\n",
       " 'cutaneous leishmaniasis (old world and new world)',\n",
       " 'stage iib, iic, iii & iv melanoma',\n",
       " 'secondary hyperparathyroidism (hpt) in pediatric patients with chronic kidney disease receiving dialysis',\n",
       " 'lymphatic filariasis caused by nematodes of the family filariodidea, in children and adults',\n",
       " 'pneumocystis jiroveci pneumonia',\n",
       " 'pediatric patients with schizophrenia',\n",
       " 'patients with fredrickson type i or v hyperlipoproteinemia',\n",
       " \"patients with acute liver failure presenting with encephalopathy deteriorating beyond parson's grade 2\",\n",
       " 'ischemia reperfusion injury in the lung during lung tranplantation',\n",
       " 'v600 mutation positive stage iib through iv melanoma',\n",
       " 'painful vaso-occlusive episodes associated with sickle cell disease',\n",
       " 'pediatric (age 16 and under) juvenile rheumatoid arthritis',\n",
       " 'tuberous sclerosis complex including tsc-associated subependymal giant cell astrocytoma (sega), tsc-associated angiomyolipoma and tsc-associated lymphangioleiomyomatosis (lam)',\n",
       " 'sickle cell disease (this includes the treatment and prevention of complications of sickle cell disease)',\n",
       " 'hiv-1 infection in treatment experienced adult patients with documented multi-antiretroviral class resistance and evidence of hiv-1 replication despite ongoing antiretroviral therapy',\n",
       " 'short-bowel syndrome as a result of resection of the small bowel or as a result of congenital dysfunction of the intestines',\n",
       " 'stages iib, iic, iii, and stage iv melanoma',\n",
       " \"anti-neutrophil cytoplasmic autoantibodies associated vasculitides (granulomatosis with polyangiitis or wegener's granulomatosis), microscopic polyangiitis, and churg-strauss syndrome\",\n",
       " 'bronchiectasis patients infected with pseudomonas aeruginosa',\n",
       " 'chronic osteomyelitis of post-traumatic, postoperative, or hematogenous origin',\n",
       " 'philadelphia chromosome-positive acute lymphoblastic leukemia (ph+all)',\n",
       " 'known or suspected cyanide poisoning',\n",
       " 'newly diagnosed high grade glioma',\n",
       " 'symtomatic myoclonus',\n",
       " 'patients undergoing solid organ transplantation',\n",
       " 'psuedomonas aeruginosa infections in patients with cystic fibrosis',\n",
       " 'hiv-associated wasting syndrome',\n",
       " 'those patients having end stage renal disease and requiring peritoneal dialysis treatment',\n",
       " 'invasive coccidioidomycosis',\n",
       " 'cd22-positive chronic lymphocytic leukemia',\n",
       " 'sickle cell disease (scd)',\n",
       " 'reduction of adult respiratory distress syndrome',\n",
       " 'primary brain malignant cancer',\n",
       " 'pneumocystis carinii pneumonia in patients at high risk of developing this disease',\n",
       " 'stage iib-iv melanoma positive for braf mutation',\n",
       " 'patients requiring stem cell transplantation to accelerate the mobilization of hematopoietic stem cells (cd34+) from the bone marrow to the peripheral blood when combined with a granulocyte colony-stimulating factor',\n",
       " 'acute lymphoblastic leukemia in pediatric patients aged 0 through 16 years',\n",
       " 'myxedema coma/precoma',\n",
       " 'pediatric neuroblastoma',\n",
       " 'preterm birth in women with a singleton pregnancy',\n",
       " 'tuberous sclerosis complex-related facial angiofibromas',\n",
       " 'thrombocytopenia associated with myelodysplasia syndrome',\n",
       " 'spasticity associated with multiple sclerosis and spinal cord injury',\n",
       " 'recurrent clostridium difficile infection (cdi)',\n",
       " 'ovarian cancer refractory or resistant to standard chemotherapy',\n",
       " 'patients with acute renal failure',\n",
       " 'acute intermittent porphyria preventing attacks',\n",
       " 'patients with chondrosarcoma',\n",
       " 'extreme insulin resistance syndromes (type a, rabson-mendenhall syndrome, leprechaunism, type b syndrome)',\n",
       " 'primary central nervous system malignancies',\n",
       " 'retinopathy of prematurity in premature infants born at risk for the disease',\n",
       " 'trka-positive, trkb-positive, trkc-positive, ros1-positive, or alk-positive colorectal cancer',\n",
       " 'pneumocystis carinii pneumonia (pcp) in high-risk, hiv-infected patients defined by a history of one or more episodes of pcp and/or a peripheral cd4+ (t4 helper/inducer) lymphocyte count less than or equal to 200/mm3',\n",
       " 'bleeding episodes in patients with hemophilia a or b, with or without inhibitors',\n",
       " 'type 1 diabetes mellitus patients with residual beta cell function',\n",
       " 'glioblastoma multiforme and anaplastic astrocytoma',\n",
       " 'hypertriglyceridemia in te setting of type i hyperlipoproteinemia, also known as familial chylomicronemia syndrome',\n",
       " 'pediatric (0 through 16 years of age) juvenile idiopathis arthritis (jia) international league of associations for rheumatology (ilar) categories excluding systemic jia',\n",
       " 'spinal cord injury patients with asia impairment grades a, b, or c',\n",
       " 'patients with high-risk stage ii, stage iii, and stage iv malignant melanoma',\n",
       " 'short stature in patients with noonan syndrome',\n",
       " 'tuberculosis infections',\n",
       " 'moderate to severe hidradenitis suppurativa (hurley stage 2 and hurley stage 3 disease)',\n",
       " 'cancers of the kidney and renal pelvis',\n",
       " 'patients with known or suspected internal contamination with plutonium, americium, or curium to increase the rate of elimination',\n",
       " 'moderate to severe symptomatic hypertrophic cardiomyopathy',\n",
       " 'mucopolysaccharidosis type iiia (sanfilippo a syndrome)',\n",
       " 'persons with aids and in patients with symptomatic hiv infection and a cd4 count less than 200/mm3',\n",
       " 'cataplexy and narcolepsy',\n",
       " 'manifestations of carnitine deficiency in patients with end stage renal disease who require dialysis',\n",
       " 'constitutional delay of growth and puberty',\n",
       " 'hypercalcemia in malignancy',\n",
       " 'graft rejection during pancreatic islet transplantation',\n",
       " 'duchenne muscular dystrophy patients bearing mutations that can be corrected by skipping exon 55',\n",
       " 'carcinoma in situ (cis) of the urinary bladder',\n",
       " \"alpha-galactosidase a deficiency (fabry's disease)\",\n",
       " 'type i diabetes with residual beta cell function',\n",
       " 'treatment of delayed graft function after solid organ transplantation',\n",
       " \"pediatric patients with tourette's syndrome (0 through 16 years of age)\",\n",
       " 'life-threatening acute cardiac glycoside intoxication manifested by conduction disorders, ectopic ventricular activity and (in some cases) hyperkalemia',\n",
       " 'trypanosoma brucei gambiense infection (sleeping sickness)',\n",
       " 'patients with peripheral t-cell lymphoma, not otherwise specified',\n",
       " 'high risk stage ii, stage iii, and stage iv melanoma',\n",
       " 'fatty acid oxidation disorders',\n",
       " 'cias1-associated periodic syndromes',\n",
       " 'aids resulting from infection with hiv-1',\n",
       " 'aids myelopathy',\n",
       " 'b-thalassemia major and intermedia',\n",
       " 'adenosine deaminase deficiency in patients with severe combined immunodeficiency',\n",
       " 'hypercalcemia of malignancy',\n",
       " 'erbb2 positive esophageal cancer',\n",
       " 'patients with cutaneous melanoma',\n",
       " 'post-ischemic pulmonary reperfusion edema following surgical treatment for chronic thromboembolic pulmonary hypertension',\n",
       " 'pediatric schizophrenia',\n",
       " 'bleeding in patients deficient in fibrinogen',\n",
       " 'patients with advanced non-small cell carcinoma of the lung',\n",
       " 'congenital antithrombin deficiency to prevent the occurrence of serious, potentially life-threatening venous thromboembolisms which may develop as a result of surgical or obstetrical procedures',\n",
       " 'patients with gram-negative bacteremia which has progressed to endotoxin shock',\n",
       " 'circadian rhythm sleep disorders in blind people with no light perception',\n",
       " 'anaplastic lymphoma kinase (alk)-positive or ros1-positive non-small cell lung cancer',\n",
       " 'acute promyelocytic leukemia (apl)',\n",
       " 'primary cutaneous cd30-positive t-cell lymphoproliferative disorders',\n",
       " 'acute respiratory distress syndrome in adults',\n",
       " 'non-24-hour sleep-wake disorder in blind individuals without light perception',\n",
       " 'cardiomyopathy associated with dystrophinopathies; duchenne muscular dystrophy (dmd), becker muscular dystrophy bmd), and x-linked dilated cardiomyopathy (xl-dcmp)',\n",
       " 'patients with aids who, in addition, are afflicted with cytomegalovirus retinitis and are being treated with ganciclovir',\n",
       " 'achromatopsia due to mutations in the cngb3 gene',\n",
       " 'recent-onset type i diabetes',\n",
       " 'active cytomegalovirus infections',\n",
       " 'non-small cell lung cancer with egfr, her2, her4, or ddr2 mutations',\n",
       " 'patients with benign epilepsy of childhood with centrotemporal spikes (bects) also known as rolandic epilepsy',\n",
       " 'symptomatic carcinoid tumors',\n",
       " 'high-risk stage ii, stage iii, and stage iv melanoma',\n",
       " 'acute spinal cord injury',\n",
       " 'constitutional delay of growth and puberty in boys',\n",
       " \"mild hemophilia a and von willebrand's disease\",\n",
       " 'meconium aspiration syndrome in newborn infants',\n",
       " 'neuronal ceroid lipofuscinosis type 2',\n",
       " 'acute sensorineural hearing loss',\n",
       " 'fatty acid disorders',\n",
       " 'stages iib-iv melanoma',\n",
       " 'scarring post glaucoma filtration surgery',\n",
       " 'human african trypanosomiasis (sleeping sickness)',\n",
       " 'chronic lymphocytic leukemia and related leukemias to include prolymphocytic leukemia, adult t-cell leukemia, and hairy cell leukemia',\n",
       " 'prevention of respiratory failure due to pulmonary surfactant deficiency in preterm infants',\n",
       " 'ulcerative colitis in pediatric patients age 0 through 16 years',\n",
       " 'vasospasm in subarachnoid hemorrhage patients following surgical repair of a ruptured cerebral aneurysm',\n",
       " 'active chronic pouchitis',\n",
       " 'oral complications of chemotherapy in bone marrow transplant patients',\n",
       " 'progressive multifocal leukencephalopathy',\n",
       " 'patients with idiopathic pulmonary fibrosis',\n",
       " 'pulmonary infections associated with cystic fibrosis',\n",
       " 'amatoxin poisoning, which includes the prevention and treatment of amatoxin induced hepatic failure',\n",
       " 'peritumoral brain edema',\n",
       " 'autoimmune uveitis',\n",
       " 'cystic fibrosis patients with pseudomonas aeruginosa lung infections',\n",
       " 'malaria caused by plasmodium falciparum, plasmodium vivax, plasmodium ovale, or plasmodium malariae',\n",
       " 'advanced adenocarcinoma of the ovary',\n",
       " 'cutaneous variants of porphyria (which includes treatment and prevention of cutaneous manifestations of disease)',\n",
       " 'hyperphosphatemia in end stage renal failure',\n",
       " \"active (dynamic) phase grave's orbitopathy\",\n",
       " 'stage iib-iv melanoma positive for the braf mutation',\n",
       " 'bleeding episodes in hemophilia a or b subjects with inhibitors',\n",
       " 'treatment of neonatal respiratory distress syndrome',\n",
       " 'gne myopathy (hereditary inclusion body myopathy type 2)',\n",
       " 'acute attacks of angioedema',\n",
       " 'her2-expressing advanced adenocarcinoma of the stomach and gastroesophageal junction',\n",
       " 'scorpion envenomations requiring medical attention',\n",
       " 'pain and fever secondary to sickle cell disease crisis',\n",
       " 'neuromyelitis optica and neuromyelitis optica spectrum disorders',\n",
       " 'patients with systemic sclerosis',\n",
       " 'the neuroleptic malignant syndrome',\n",
       " 'aa amyloidosis and al amyloidosis',\n",
       " 'breast cancer patients with brain metastases',\n",
       " 'acute attacks of angioedema, including short-term prophylaxis for patients requiring dental or other surgical procedures',\n",
       " \"type ii leber's congential amaurosis\",\n",
       " 'b-thalassemia',\n",
       " \"coat's disease\",\n",
       " 'chronic lymphocytic leukemia and small lymphocytic lymphoma',\n",
       " 'pediatric cardiomyopathy',\n",
       " '1 diabetes mellitus patients with residual beta cell function',\n",
       " 'primary immunodeficiencies associated with t-cell defects',\n",
       " 'hyperphosphatemia in patients with end stage renal disease',\n",
       " 'recurrence of pterygium after its surgical excision',\n",
       " 'well-differentiated papillary, follicular or combined papillary/follicular carcinomas of the thyroid',\n",
       " 'hyperuricemia in patients intolerant to allopurinol',\n",
       " 'merosin (laminin-alpha2) deficient congential muscular dystrophy type 1a',\n",
       " 'congenital primary ichthyosis',\n",
       " \"rasmussen's encephalitis\",\n",
       " 'follicullar, medullary, anaplastic, and metastatic or locally advanced papillary thyroid cancer',\n",
       " 'post-surgical apnea',\n",
       " 'of transplant related mortality (trm, which is caused by graft versus host disease and/or infections) following mismatched (haploidentical) allogeneic hematopoietic stem cell transplantation',\n",
       " 'all uncomplicated cutaneous leishmaniasis (both new world and old world)',\n",
       " 'adrenal insufficiency in pediatric patients',\n",
       " 'pediatric hiv infection/aids',\n",
       " 'ascites due to all etiologies except cancer',\n",
       " 'epithelial ovarian cancer in combination with dna-damaging agents',\n",
       " 'arteriovenous(av) fistula or av graft failure in patients with end stage renal disease, receiving hemodialysis or preparing for hemodialysis',\n",
       " 'stage ii (t4), iii or iv malignant melanoma',\n",
       " 'invasive protothecosis',\n",
       " 'hypercalcemia in patients with primary hyperparathyroidism for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo surgery',\n",
       " 'chronic pouchitis',\n",
       " 'stage iib to iv melanoma',\n",
       " 'pulmonary fungal infections in patients with cystic fibrosis',\n",
       " 'gastrointestinal disturbances (to include constipation, diarrhea, and abdominal pain) associated with regression-onset autism in pediatric patients',\n",
       " 'pediatric multiple sclerosis',\n",
       " 'acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia',\n",
       " \"leber's congential amaurosis\",\n",
       " \"malignant non-hodgkin's lymphomas\",\n",
       " 'multiforme in pediatric patients',\n",
       " 'cln2 disease (neuronal ceroid lipofuscinosis (ncl)) caused by tpp1 deficiency',\n",
       " 'advanced melanoma stages iib through iv',\n",
       " 'paralysis due to spinal cord injury',\n",
       " 'noninfected painful total joint without mechanical complication',\n",
       " 'weight loss in aids patients with hiv-associated wasting',\n",
       " 'her2-expressing adenocarcinoma of the esophagus',\n",
       " 'epidermal growth factor receptor (egfr) mutation-positive non-small cell lung cancer (nsclc)',\n",
       " 'mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome (melas)',\n",
       " 'individuals acutely exposed to myelosuppressive doses of radiation (hematopoietic syndrome of acute radiation syndrome)',\n",
       " 'acute and chronic leukemia',\n",
       " 'hypertension in pediatric patients',\n",
       " 'amyotrophic lateral sclerosis (als)',\n",
       " 'ischemia/reperfusion injury associated with solid organ tranplantation',\n",
       " 'idiopathic pulmonary fibrosis (ipf)',\n",
       " 'graft loss in pancreatic islet transplantation',\n",
       " 'obesity associated with prader willi syndrome',\n",
       " 'invasive rare mold infections caused by scedosporium spp., fusarium spp., and mucorales fungi (including mucor spp., and rhizopus spp.)',\n",
       " 'ischemic ulceration of the lower limbs due to peripheral arterial disease',\n",
       " 'symptoms of grade 2 and grade 3 late xerostomia from parotid gland hypofunction caused by radiotherapy for cancer of the oral cavity',\n",
       " 'patients with acute myocarditis',\n",
       " 'bouts of increased seizure activity in selected refractory patients with epilepsy who are on stable regimens of anti-epileptic drugs and who require intermittent use of midazolam',\n",
       " 'recurrent acute repetitive seizures',\n",
       " 'duchenne muscular dystrophy in patients who have a mutation correctable by skipping of exon 44of the dystrophin gene',\n",
       " 'severe head injury',\n",
       " 'patients with severe dermal burns',\n",
       " 'patients with pancreatic cancer that overexpress p185her2',\n",
       " 'short stature associated with turner syndrome',\n",
       " \"friedreich's and other inherited ataxias\",\n",
       " 'patients with brain stem glioma',\n",
       " 'common variable immunodeficiency (cvid)',\n",
       " 'severe peripheral arterial occlusive disease (critical limb ischemia) in patients where other procedures, grafts or angioplasty, are not indicated',\n",
       " 'congenital cytomegalovirus (cmv) infection following primary cmv infection in pregnant women',\n",
       " 'patients with pancreatic cancer',\n",
       " 'juvenile rheumatoid arthritis joint and related tissue inflammation in the pediatric population',\n",
       " 'thrombotic thrombocytopenic purpura including its congential, acquired idiopathic and secondary forms',\n",
       " 'pediatric patients (age 16 years and younger) with polyarticular-course juvenile idiopathic arthritis',\n",
       " 'acute herpetic keratitis (dendritic and geographic ulcers)',\n",
       " 'severe acute cyanide poisoning',\n",
       " 'gastric cancer including gastroesophageal junction adenocarcinoma',\n",
       " \"fuch's dystrophy, pseudophakic bullous keratopathy, and bullous keratopathy\",\n",
       " 'chronic iron overload resulting from conventional transfusional treatment of beta-thalassemia major and sickle cell anemia',\n",
       " 'cytomegalovirus retinitis in immunocompromised patients with aids',\n",
       " 'hcg producing tumors such as germ cell and trophoblastic cell tumors',\n",
       " 'onchocerciasis volvulus in children and adults',\n",
       " 'invasive carcinoma of the uterine cervix',\n",
       " 'duchenne muscular dystrophy (dmd)',\n",
       " 'duchenne muscular dystrophy and becker muscular dystrophy',\n",
       " 'transient aplastic crisis in patients with sickle cell anemia',\n",
       " 'envenomation by poisonous snakes belonging to the crotalidae family',\n",
       " \"patients with von willebrand's disease\",\n",
       " 'short stature in pediatric patients with short stature homeobox-containing gene (shox) deficiency',\n",
       " 'acute painful sickling crises in patients with sickle cell disease',\n",
       " 'neonatal seizures',\n",
       " 'neoplastic meningitis',\n",
       " 'sickle cell disease in patients under 18 years of age',\n",
       " 'mucopolysaccharidosis ii, also called hunter syndrome a',\n",
       " \"immunoglobulin a nephropathy (igan, berger's disease)\",\n",
       " \"b-cell non-hodgkin's lymphoma\",\n",
       " 'hypercalcemia of malignancy inadequately managed by dietary modification and/or oral hydration',\n",
       " 'short stature in patients with prader-willi syndrome',\n",
       " 'severe diarrhea and flushing associated with malignant carcinoid tumors',\n",
       " 'the chronic progressive form of multiple sclerosis',\n",
       " 'duchenne muscular dystrophy patients bearing mutations that can be corrected by skipping exon 53',\n",
       " 'intrauterine fetal death not accompanied by complete expulsion of the products of conception in the second and third trimesters of pregnancy',\n",
       " 'treatment of choline deficiency in patients on long-term parenteral nutrition',\n",
       " 'active tuberculosis',\n",
       " 'antibody-mediated growth hormone resistance in patients with isolated growth hormone deficiency ia',\n",
       " 'chronic severe forms of alopecia areata (alopecia totalis [at]/alopecia universalis [au])',\n",
       " 'abo medical hemolytic reactions arising from abo-incompatible bone marrow transplantation',\n",
       " 'chronic control of non-infectious posterior, intermediate and pan-uveitis',\n",
       " 'hormone refractory prostate cancer',\n",
       " 'rejection in kidney, liver or heart transplant in pediatric patients',\n",
       " \"patients with wilson's disease who are intolerant, or inadequately responsive to penicillamine\",\n",
       " 'excessive daytime sleepiness in narcolepsy',\n",
       " \"buerger's disease (thromboangiitis obliterans)\",\n",
       " 'chronic malignant pleural effusion',\n",
       " 'neurofibromatosis type 2 (nf2)',\n",
       " \"seizures associated with pyridox(am)ine 5'-phosphate oxidase (pnpo) deficiency\",\n",
       " 'the bone manifestations of gaucher disease',\n",
       " 'idiopathic thrombocytopenia purpura',\n",
       " 'serious burns requiring hospitalization',\n",
       " 'primary bone marrow failure',\n",
       " 'systemic sclerosis (including the associated interstitial lung disease)',\n",
       " 'myeloid leukemia, including aml, and blast crisis of cml',\n",
       " 'astrocytic tumors',\n",
       " 'upper tract urothelial cell cancers (transitional cell carcinoma of the renal pelvis and ureter)',\n",
       " 'liver and intrahepatic bile duct cancer',\n",
       " 'spasticity associated with spinal cord injury or multiple sclerosis',\n",
       " \"patients with advanced hiv-associated kaposi's sarcoma\",\n",
       " 'severe intrapartum hypertension (diastolic blood pressure greater than or equal to 110 or systolic blood pressure greater than or equal to 160) associated with severe preeclampsia/eclampsia of pregnancy',\n",
       " 'metachromatic leukodystrophy (mld)',\n",
       " \"the clinical manifestations of endogenous cushing's syndrone\",\n",
       " 'acute graft rejection of human organ transplants',\n",
       " 'gastrointestinal symptoms with chronic graft versed host disease in patients undergoing allogenic hematopoietic cell transplantation',\n",
       " 'pathologic (chronic moderate to severe) drooling in pediatric patients',\n",
       " 'acute non-a, non-b hepatitis',\n",
       " 'glucose transporter type-1 deficiency syndrome',\n",
       " 'tnf-receptor associated periodic syndrome (traps)',\n",
       " 'patients needing urgent reversal of vitamin k antagonist therapy for treatment of major bleeding and/or surgical procedures',\n",
       " 'patients with prosthetic joint infections',\n",
       " 'necrotizing soft tissue infections (nsti)',\n",
       " 'spinal cerebellar ataxia type 3 (also known as sca3 or machado joseph disease)',\n",
       " 'inherited mitochondrial respiratory chain disease',\n",
       " 'disease relapse in patients with chronic pouchitis',\n",
       " 'duchenne muscular dystrophy in patients with a deletion, duplication or frame shift mutation correctable by skipping of exon 50 of the dystrophin gene to allow restoration of the reading frame (including mutations within exons 51, 51-53, or 51-55)',\n",
       " \"stargardt's macular dystrophy\",\n",
       " 'mitchondrial disease',\n",
       " 'severe congential factor xi deficiency',\n",
       " 'ischemia-reperfusion injury in kidney transplant recipients',\n",
       " 'soft tissue and bone sarcomas',\n",
       " 'graft rejection following solid organ transplantation',\n",
       " 'uremic and non-uremic calciphylaxis',\n",
       " 'chronic, incomplete spinal cord injury',\n",
       " 'primary brain malignancies',\n",
       " 'mobilze progenitor cells prior to stem cell transplantation',\n",
       " 'xerostomia induced by radiation therapy for head and neck cancer',\n",
       " 'patients with iib to stage iv melanoma positive for the braf(v600) mutation',\n",
       " \"still's disease including systemic juvenile idiopathic arithritis and adult-onset still's disease\",\n",
       " 'acute and chronic respiratory symptoms of bronchiectasis',\n",
       " 'rare congenital ichthyoses',\n",
       " 'symptomatic intradialytic hypotension, including symptomatic hypotension in the immediate post-dialytic period',\n",
       " 'cystic fibrosis (cf)',\n",
       " 'cryptosporidiosis caused by the presence of cryptosporidium parvum in the gastrointestinal tract of patients who are immunodeficient/immunocompromised or immunocompetent',\n",
       " 'telomerase reverse transcriptase (tert) positive non-small cell lung cancer in hla-a*0201 positive patients',\n",
       " 'idiopathic thrombocytopenic purpura (also known as primary immune thrombocytopenia)',\n",
       " 'hemophilia a and hemophilia b patients with or without inhibitors, which includes routine prophylaxis to prevent or reduce the frequency of bleeding in hemophilia a and hemophilia b patients',\n",
       " 'ocular surface diseases that are characterized by total limbal stem cell deficiency',\n",
       " 'prevention of recurrence) of ovarian cancer',\n",
       " 'gastric cancer, including gastroesophageal junction adenocarcinoma',\n",
       " 'anemia associated with end stage renal disease',\n",
       " 'systemic light chain (al) amyloidosis',\n",
       " 'mucopolysaccharidosis type iiia or sanfilippo type a syndrome',\n",
       " 'lepromatous leprosy, including dapsone-resistant lepromatous leprosy and lepromatous leprosy complicated by erythema nodosum leprosum',\n",
       " 'moderate to severe clinical forms of hemolytic disease of the newborn arising from placental transfer of antibodies against blood group substances a and b',\n",
       " 'stage iib through iv melanoma',\n",
       " 'duchenne muscular dystrophy patients bearing mutations that can be corrected by skipping exon 52',\n",
       " 'the behavorial abnormalities associated with fragile x syndrome',\n",
       " 'pro-opiomelanocortin (pomc) deficiency due to mutations in the pomc gene',\n",
       " 'persons with myeloproliferative neoplasm-associated myelofibrosis and anemia who are red blood cell tranfusion dependent',\n",
       " 'maternal-fetal transmission of congenital cmv in pregnant women who acquire cmv infection during pregnancy',\n",
       " 'uremic osteodystrophy',\n",
       " 'neutropenia associated with bone marrow transplants',\n",
       " 'stage iib to stage iv metastatic melanoma',\n",
       " \"active crohn's disease in the pediatric population\",\n",
       " 'selected, refractory patients with epilepsy who are on stable regimens of antiepileptic drugs (aed) and who require intermittent use of diazepam to control bouts of increased seizure activity (acute repetitive seizures)',\n",
       " 'postanoxic intention myoclonus',\n",
       " 'patients undergoing induction therapy for acute myeloid leukemia',\n",
       " 'diarrhea in aids patients caused by infection with cryptosporidium parvum',\n",
       " 'flavivirus infections including those due to west nile, japanese encephalitis, dengue, st. louis encephalitis, yellow fever, murray valley, and banzai viruses',\n",
       " 'fibrinogen deficient patients',\n",
       " 'pantothenate kinase associated neurodegeneration (pkan)',\n",
       " 'clinically significant cytomegalovirus (cmv) viremia, cmv disease and associated complications in at-risk hematopoietic cell transplant and solid transplant populations',\n",
       " 'type 1 diabetes in dq8 positive patients with residual beta cell function',\n",
       " 'patients with chronic lymphocytic leukemia/small lymphocytic lymphoma',\n",
       " 'patients at risk of methotrexate toxicity',\n",
       " 'ascites due to all etiologies except for cancer',\n",
       " 'hepatitis b recurrence following orthotopic liver transplant',\n",
       " 'mucopolysaccharidosis type iiia (sanfilippo type a syndrome)',\n",
       " 'pulmonary arterial hypertension excluding persistent pulmonary hypertension of the newborn',\n",
       " 'primary peritoneal cancer',\n",
       " 'cardiomyopathy for chilren and adolescents 0 through 16 years of age treated with anthracyclines',\n",
       " 'intractable pain at end-stage disease',\n",
       " 'non-superficial urothelial cancer',\n",
       " 'zidovudine-induced mitochondrial myopathy',\n",
       " 'gastric cancer and gastric-esophageal junction cancer',\n",
       " 'sickle cell disease crisis',\n",
       " 'disseminated mycobacterium avium-intracellulare infection',\n",
       " 'respiratory distress syndrome in premature infants',\n",
       " 'post-operative complications of aortic anuerysm surgical repair',\n",
       " 'radiation induced oral mucositis',\n",
       " 'occulopharyngeal muscular dystrophy',\n",
       " 'squamous cell cancer of the head and neck in patients who express epidermal growth factor receptor',\n",
       " 'orthopox virus infections',\n",
       " 'stage iib to iv malignant melanoma',\n",
       " 'acute myeloid leukemia (aml)',\n",
       " 'solid organ graft rejection',\n",
       " 'pediatric hiv/aids (age through 16 years)',\n",
       " 'mage-a3 expressing head and neck squamous cell carcinoma',\n",
       " 'glycogen storage disease types ia and ib',\n",
       " 'invasive and metastatic melanoma (stages ii, iii, and iv)',\n",
       " 'stage llb, llc, lll and iv melanoma',\n",
       " 'hereditary factor x deficiency',\n",
       " 'beta-thalassemia intermedia and major',\n",
       " 'allograft rejection, including solid organ (kidney, liver, heart, lung, and pancreas) and bone marrow transplantation',\n",
       " 'follicular, medullary, and anaplastic thyroid carcinoma and metastatic or locally advanced papillary thyroid cancer',\n",
       " 'patients with a confirmed traumatic complete spinal cord injury where no motor or sensory function is preserved below the injury(scale a)',\n",
       " 'proliferating infantile hemangiomas requiring systemic therapy',\n",
       " 'patients with primary biliary cirrhosis',\n",
       " 'acute hepatitis b',\n",
       " 'hydatid disease (cystic echinococcosis due to e. granulosus larvae or alveolar echinococcosis due to e. multilocularis larvae)',\n",
       " 'erbb2 positive gastric cancer',\n",
       " 'adenosine deaminase deficient severe combined immunodeficiency',\n",
       " 'b-cell acute lymphoblastic leukemia',\n",
       " 'aids-associated diarrhea unresponsive to initial antidiarrheal therapy',\n",
       " 'treatment of graft versus host disease in transplant recipients',\n",
       " 'body dysmorphic disorder in children and adolescents',\n",
       " 'malignant melanoma stage iib to iv',\n",
       " 'cocaine overdose',\n",
       " \"endogenous cushing's syndrome\",\n",
       " 'functional motor and sensory deficits from guillain-barre syndrome',\n",
       " 'the respiratory symptoms of cystic fibrosis',\n",
       " 'chronic hepatitis c in pediatric patients',\n",
       " 'acute graft-versus-host disease in patients undergoing bone marrow transplantation',\n",
       " 'gastric cancer, including gastroesophageal junction cancer',\n",
       " 'metastatic renal cell carcinoma',\n",
       " 'amyotropic lateral sclerosis',\n",
       " 'congenital venous malformations',\n",
       " 'human papilloma virus-associated head and neck cancer',\n",
       " 'emphysema due to alpha1-antitrypsin deficiency',\n",
       " 'recurrent corneal erosion unresponsive to conventional therapy',\n",
       " 'symptomatic patients with the aids including all patients with cd4 t-cell counts less than 200 cells per mm3',\n",
       " 'onchocerciasis caused by onchocerca volvulus',\n",
       " 'bleeding episodes in hemophilia a or b patients with inhibitors to factor viii or factor ix',\n",
       " 'beta-thalassemia major and beta-thalassemia intermedia',\n",
       " 'lama2-related muscular dystrophy',\n",
       " 'non-small cell lung cancer with squamous histology',\n",
       " 'amyotrophic lateral sclerosis and its variants',\n",
       " 'spasmodic torticollis (cervical dystonia)',\n",
       " 'progesterone receptor negative endometrial cancer in conjunction with progesterone therapy',\n",
       " 'patients with secondary progressive multiple sclerosis',\n",
       " \"xerostomia and keratoconjunctivitis sicca in sjogren's syndrome patients\",\n",
       " 'clinically significant cytomegalovirus viremia and disease in at-risk patients',\n",
       " 'acute lymphoblastic leukemia (inclusive of b-cell acute lymphoblastic leukemia)',\n",
       " 'smith-magenis syndrome in combination with a beta-blocker',\n",
       " 'growth retardation associated with chronic renal failure',\n",
       " 'pulmonary arterial hypertension (pah)',\n",
       " 'delayed graft function after solid organ transplantation',\n",
       " 'human cytomegalovirus viremia and disease in at risk populations',\n",
       " 'renal and bladder calculi of the apatite or struvite variety',\n",
       " 'mage-a3 positive stages iib to iv malignant melanoma',\n",
       " \"hoehn and yahr stage 4 and 5 parkinson's disease\",\n",
       " 'stage ii to iv invasive cervical carcinoma',\n",
       " 'primary focal segmental glomerulosclerosis',\n",
       " 'patients 16 years of age and younger with immune-mediated t1dm and preserved pancreatic beta cell function',\n",
       " 'metastatic uveal melanoma',\n",
       " 'critical limb ischemia in no-option patients where other procedures, grafts, or angioplasty are not indicated',\n",
       " 'macular telangiectasia type 2 (mactel)',\n",
       " 'velocardiofacial syndrome associated psychosis',\n",
       " 'mps-1, including hurler syndrome',\n",
       " 'pediatic polycystic ovary syndrome (0 through 16 years of age)',\n",
       " 'hyperekplexia (startle disease)',\n",
       " 'radiation- or chemotherapy-induced oral mucositis in cancer patients',\n",
       " 'stage iib through iv metastatic melanoma',\n",
       " 'corneal cystine crystal accumulation in cystinosis patients',\n",
       " 'bleeding episodes in patients with congenital factor vii deficiency',\n",
       " 'chronic pulmonary infection due to p. aeruginosa in cystic fibrosis patients',\n",
       " 'ileal pouch anal anastomosis related fecal incontinence',\n",
       " 'patients with non-small cell lung cancer (nsclc) with braf v600 mutation',\n",
       " 'symptomatic enteroviral infection in the neonate',\n",
       " 'lead poisoning in children',\n",
       " 'motor neuron disease (including amyotrophic lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, and primary lateral sclerosis)',\n",
       " 'burns requiring skin grafting',\n",
       " 'gastric cancer including gastroesophageal junction cancer',\n",
       " 'neuronal ceroid lipofuscinoses (batten disease)',\n",
       " 'beta-hemoglobinopathies and beta-thalassemia syndromes',\n",
       " 'primary and metastatic brain tumors',\n",
       " 'glioblastoma multiforme when used in combination with dna-damaging agents',\n",
       " 'pulmonary infections in patients with cystic fibrosis including infections due to pseudomonas aeruginosa,burkholderia cepacia and other bacteria',\n",
       " 'gastric carcinoids',\n",
       " 'acute ischemic stroke patients presenting within 3 hours of symptom onset',\n",
       " 'frontotemporal dementia, including all subvariants',\n",
       " 'platinum-induced toxicities in pediatric patients (0 through 16 years of age)',\n",
       " 'tourette syndrome in the pediatric population (defined as 0 through 16 years of age)',\n",
       " 'pigmented villonodular synovitis, including giant cell tumor of the tendon sheath',\n",
       " 'familial benign chronic pemphigus (hailey-hailey disease)',\n",
       " 'retinitis pigmentosa due to pde6b gene mutations',\n",
       " 'malignant rhabdoid tumors (mrts)',\n",
       " 'pediatric polycystic ovary syndrome',\n",
       " 'malginant glioma',\n",
       " 'malignant brain and central nervous system tumors',\n",
       " 'orthopoxvirus infections',\n",
       " 'hepatic intoxication by amanita phalloides (mushroom poisoning)',\n",
       " 'patients with invasive (malignant) brain and central nervous system tumors lacking alpha 2,6 sialyltransferase',\n",
       " 'narcolepsy and the auxiliary symptoms of cataplexy, sleep paralysis, hypnagogic hallucinations and automatic behavior',\n",
       " 'neutropenia associated with autologous bone marrow transplantation',\n",
       " ...}"
      ]
     },
     "execution_count": 92,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "diseases_not_matched"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df['doid'] = df.indication.apply(doid_matches.get)\n",
    "df['hpo'] = df.indication.apply(hpo_matches.get)\n",
    "df['ordo'] = df.indication.apply(ordo_matches.get)\n",
    "df['mesh'] = df.indication.apply(mesh_matches.get)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "doid_wd = wdi_helpers.id_mapper(\"P699\")\n",
    "ordo_wd = wdi_helpers.id_mapper(\"P1550\")\n",
    "mesh_wd = wdi_helpers.id_mapper(\"P486\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "\"squamous non-small cell lung cancer\"\n",
    "# http://www.ebi.ac.uk/ols/ontologies/hp/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FHP_0030359"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df.loc[:,'indication_qid_doid'] = df.doid.dropna().apply(lambda x:doid_wd.get(x.split(\"/\")[-1].replace(\"_\",\":\")))\n",
    "df.loc[:,'indication_qid_ordo'] = df.ordo.dropna().apply(lambda x:ordo_wd.get(x.split(\"_\")[-1]))\n",
    "df.loc[:,'indication_qid_mesh'] = df.mesh.dropna().apply(mesh_wd.get)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Generic Name</th>\n",
       "      <th>Orphan Designation</th>\n",
       "      <th>Designation Date</th>\n",
       "      <th>Designation Status</th>\n",
       "      <th>drug_qid</th>\n",
       "      <th>inchi</th>\n",
       "      <th>indication</th>\n",
       "      <th>doid</th>\n",
       "      <th>hpo</th>\n",
       "      <th>ordo</th>\n",
       "      <th>mesh</th>\n",
       "      <th>indication_qid_doid</th>\n",
       "      <th>indication_qid_ordo</th>\n",
       "      <th>indication_qid_mesh</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>(+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid</td>\n",
       "      <td>Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy</td>\n",
       "      <td>03/31/2003</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27088744</td>\n",
       "      <td>ZVVCSBSDFGYRCB-UHFFFAOYSA-N</td>\n",
       "      <td>serious adverse events associated with vascular leak syndrome caused by interleukin-2 therapy</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of Stage IIB through Stage IV malignant melanoma</td>\n",
       "      <td>02/01/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>stage iib through stage iv malignant melanoma</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of cholangiocarcinoma</td>\n",
       "      <td>01/10/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>cholangiocarcinoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_4947</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0030153</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_70567</td>\n",
       "      <td>D018281</td>\n",
       "      <td>Q124292</td>\n",
       "      <td>None</td>\n",
       "      <td>Q18556554</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>01/10/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>pancreatic cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1793</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0002894</td>\n",
       "      <td>None</td>\n",
       "      <td>D010190</td>\n",
       "      <td>Q212961</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q212961</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>(-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester</td>\n",
       "      <td>Treatment of Fragile X syndrome</td>\n",
       "      <td>10/12/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q6589598</td>\n",
       "      <td>ZFPZEYHRWGMJCV-ZHALLVOQSA-N</td>\n",
       "      <td>fragile x syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_14261</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_908</td>\n",
       "      <td>D005600</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                     Generic Name  \\\n",
       "0  (+/-)-7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid   \n",
       "1  (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                     \n",
       "2  (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                     \n",
       "3  (+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol                                     \n",
       "4  (-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester                      \n",
       "\n",
       "                                                                                            Orphan Designation  \\\n",
       "0  Prevention of serious adverse events associated with vascular leak syndrome caused by Interleukin-2 therapy   \n",
       "1  Treatment of Stage IIB through Stage IV malignant melanoma                                                    \n",
       "2  Treatment of cholangiocarcinoma                                                                               \n",
       "3  Treatment of pancreatic cancer                                                                                \n",
       "4  Treatment of Fragile X syndrome                                                                               \n",
       "\n",
       "  Designation Date    Designation Status   drug_qid  \\\n",
       "0  03/31/2003       Designated/Withdrawn  Q27088744   \n",
       "1  02/01/2008       Designated/Withdrawn  None        \n",
       "2  01/10/2008       Designated/Withdrawn  None        \n",
       "3  01/10/2008       Designated/Withdrawn  None        \n",
       "4  10/12/2011       Designated            Q6589598    \n",
       "\n",
       "                         inchi  \\\n",
       "0  ZVVCSBSDFGYRCB-UHFFFAOYSA-N   \n",
       "1  None                          \n",
       "2  None                          \n",
       "3  None                          \n",
       "4  ZFPZEYHRWGMJCV-ZHALLVOQSA-N   \n",
       "\n",
       "                                                                                      indication  \\\n",
       "0  serious adverse events associated with vascular leak syndrome caused by interleukin-2 therapy   \n",
       "1  stage iib through stage iv malignant melanoma                                                   \n",
       "2  cholangiocarcinoma                                                                              \n",
       "3  pancreatic cancer                                                                               \n",
       "4  fragile x syndrome                                                                              \n",
       "\n",
       "                                        doid  \\\n",
       "0  None                                        \n",
       "1  None                                        \n",
       "2  http://purl.obolibrary.org/obo/DOID_4947    \n",
       "3  http://purl.obolibrary.org/obo/DOID_1793    \n",
       "4  http://purl.obolibrary.org/obo/DOID_14261   \n",
       "\n",
       "                                         hpo  \\\n",
       "0  None                                        \n",
       "1  None                                        \n",
       "2  http://purl.obolibrary.org/obo/HP_0030153   \n",
       "3  http://purl.obolibrary.org/obo/HP_0002894   \n",
       "4  None                                        \n",
       "\n",
       "                                       ordo     mesh indication_qid_doid  \\\n",
       "0  None                                      None     NaN                  \n",
       "1  None                                      None     NaN                  \n",
       "2  http://www.orpha.net/ORDO/Orphanet_70567  D018281  Q124292              \n",
       "3  None                                      D010190  Q212961              \n",
       "4  http://www.orpha.net/ORDO/Orphanet_908    D005600  Q221472              \n",
       "\n",
       "  indication_qid_ordo indication_qid_mesh  \n",
       "0  NaN                 NaN                 \n",
       "1  NaN                 NaN                 \n",
       "2  None                Q18556554           \n",
       "3  NaN                 Q212961             \n",
       "4  Q221472             Q221472             "
      ]
     },
     "execution_count": 100,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df.to_csv(\"fda_orphan_match.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Generic Name</th>\n",
       "      <th>Orphan Designation</th>\n",
       "      <th>Designation Date</th>\n",
       "      <th>Designation Status</th>\n",
       "      <th>drug_qid</th>\n",
       "      <th>inchi</th>\n",
       "      <th>indication</th>\n",
       "      <th>doid</th>\n",
       "      <th>hpo</th>\n",
       "      <th>ordo</th>\n",
       "      <th>mesh</th>\n",
       "      <th>indication_qid_doid</th>\n",
       "      <th>indication_qid_ordo</th>\n",
       "      <th>indication_qid_mesh</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>(-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester</td>\n",
       "      <td>Treatment of Fragile X syndrome</td>\n",
       "      <td>10/12/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q6589598</td>\n",
       "      <td>ZFPZEYHRWGMJCV-ZHALLVOQSA-N</td>\n",
       "      <td>fragile x syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_14261</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_908</td>\n",
       "      <td>D005600</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>(2,2-diphenyl-tetrahydro-furan-3-yl-methyl)-dimethylamine hydrochloride</td>\n",
       "      <td>Treatment of Rett Syndrome.</td>\n",
       "      <td>05/18/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27252594</td>\n",
       "      <td>FEQOLYDPQKHFTD-UHFFFAOYSA-N</td>\n",
       "      <td>rett syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1206</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_778</td>\n",
       "      <td>D015518</td>\n",
       "      <td>Q917357</td>\n",
       "      <td>None</td>\n",
       "      <td>Q917357</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>(2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide)</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>11/29/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27258687</td>\n",
       "      <td>VLIUIBXPEDFJRF-UHFFFAOYSA-N</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>(2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo [4,3-c] pyridine-3,6(2h,5h)-dione)</td>\n",
       "      <td>Treatment of systemic sclerosis.</td>\n",
       "      <td>10/14/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27258840</td>\n",
       "      <td>RGYQPQARIQKJKH-UHFFFAOYSA-N</td>\n",
       "      <td>systemic sclerosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_418</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_90291</td>\n",
       "      <td>D012595</td>\n",
       "      <td>Q5340515</td>\n",
       "      <td>None</td>\n",
       "      <td>Q5340515</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>(3S)-1-azabicyclo[2.2.2]oct-3-yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate</td>\n",
       "      <td>Treatment of Gaucher disease</td>\n",
       "      <td>09/11/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27274745</td>\n",
       "      <td>YFHRCLAKZBDRHN-MRXNPFEDSA-N</td>\n",
       "      <td>gaucher disease</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1926</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_355</td>\n",
       "      <td>D005776</td>\n",
       "      <td>Q861645</td>\n",
       "      <td>Q861645</td>\n",
       "      <td>Q861645</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>(5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride</td>\n",
       "      <td>Treatment of erythromelalgia</td>\n",
       "      <td>01/30/2017</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27268497</td>\n",
       "      <td>HEPUBAGOKRIZEO-PPPUBMIESA-N</td>\n",
       "      <td>erythromelalgia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9240</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_1956</td>\n",
       "      <td>D004916</td>\n",
       "      <td>Q524353</td>\n",
       "      <td>None</td>\n",
       "      <td>Q524353</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>(R)-2-methyl-6-nitro-2-{4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole</td>\n",
       "      <td>Treatment of pulmonary tuberculosis.</td>\n",
       "      <td>07/12/2007</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q15408413</td>\n",
       "      <td>XDAOLTSRNUSPPH-XMMPIXPASA-N</td>\n",
       "      <td>pulmonary tuberculosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_2957</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D014397</td>\n",
       "      <td>Q18555243</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q18555243</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>(R)-4-(3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enylmethyl]-piperazin-1-yl}-benzoyl)-3-trifluoromethanesulfonylbenzenesulfonamide bis-hydrochloride</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>05/05/2008</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27292463</td>\n",
       "      <td>WDVGRPCSLPVWKC-VROLVAQFSA-N</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>(S)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>11/05/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27236818</td>\n",
       "      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>(S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one</td>\n",
       "      <td>Treatment of follicular lymphoma</td>\n",
       "      <td>08/01/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27077129</td>\n",
       "      <td>SJVQHLPISAIATJ-ZDUSSCGKSA-N</td>\n",
       "      <td>follicular lymphoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050873</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_545</td>\n",
       "      <td>D008224</td>\n",
       "      <td>Q123251</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>(S)-4-(8-amino-3-(1-but-2-ynoylpyrrolidin-2-yl)-imidazo[1,5-a]pyrazine-1-yl)-N-(pyridine-2-yl)-benzamide</td>\n",
       "      <td>Treatment of mantle cell lymphoma.</td>\n",
       "      <td>09/21/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q23668732</td>\n",
       "      <td>WDENQIQQYWYTPO-IBGZPJMESA-N</td>\n",
       "      <td>mantle cell lymphoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050746</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_52416</td>\n",
       "      <td>D020522</td>\n",
       "      <td>Q268713</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>(S)-7-(1-(9H-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one</td>\n",
       "      <td>Treatment of Hodgkin lymphoma</td>\n",
       "      <td>04/29/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27254856</td>\n",
       "      <td>RSIWALKZYXPAGW-NSHDSACASA-N</td>\n",
       "      <td>hodgkin lymphoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_8567</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0012189</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_98293</td>\n",
       "      <td>D006689</td>\n",
       "      <td>Q209369</td>\n",
       "      <td>Q209369</td>\n",
       "      <td>Q18557991</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>1-(6-benzothiazolylsulfonyl)-5-chloro-1H-indole-2-butanoic acid</td>\n",
       "      <td>Treatment of systemic sclerosis</td>\n",
       "      <td>03/31/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27896056</td>\n",
       "      <td>OQDQIFQRNZIEEJ-UHFFFAOYSA-N</td>\n",
       "      <td>systemic sclerosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_418</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_90291</td>\n",
       "      <td>D012595</td>\n",
       "      <td>Q5340515</td>\n",
       "      <td>None</td>\n",
       "      <td>Q5340515</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>1-Cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>11/12/2009</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27453557</td>\n",
       "      <td>LOLPPWBBNUVNQZ-UHFFFAOYSA-N</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione</td>\n",
       "      <td>Treatment of idiopathic pulmonary fibrosis.</td>\n",
       "      <td>09/21/2010</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27258840</td>\n",
       "      <td>RGYQPQARIQKJKH-UHFFFAOYSA-N</td>\n",
       "      <td>idiopathic pulmonary fibrosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050156</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_2032</td>\n",
       "      <td>D054990</td>\n",
       "      <td>Q2290446</td>\n",
       "      <td>None</td>\n",
       "      <td>Q2290446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>2-chloroethyl-3-sarcosinamide-1-nitrosourea</td>\n",
       "      <td>Treatment for malignant glioma</td>\n",
       "      <td>11/15/2001</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27274664</td>\n",
       "      <td>None</td>\n",
       "      <td>malignant glioma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_3070</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D005910</td>\n",
       "      <td>Q1365309</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q18556612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>2-methoxyestradiol</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>07/10/2001</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q4596897</td>\n",
       "      <td>None</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>2-methoxyestradiol</td>\n",
       "      <td>Treatment of ovarian cancer</td>\n",
       "      <td>04/04/2005</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q4596897</td>\n",
       "      <td>None</td>\n",
       "      <td>ovarian cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_2394</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_213500</td>\n",
       "      <td>D010051</td>\n",
       "      <td>Q172341</td>\n",
       "      <td>None</td>\n",
       "      <td>Q172341</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160</th>\n",
       "      <td>2-[(3-methyl-4-(2,2,2-trifluoroethoxy) pyridin-2-yl)methylsulfinyl] -1H-benzoimidazole</td>\n",
       "      <td>Treatment of hepatocellular carcinoma.</td>\n",
       "      <td>08/27/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q254296</td>\n",
       "      <td>MJIHNNLFOKEZEW-UHFFFAOYSA-N</td>\n",
       "      <td>hepatocellular carcinoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_684</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0001402</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_88673</td>\n",
       "      <td>D006528</td>\n",
       "      <td>Q1148337</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1148337</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>3'-azido-2',3'dideoxyuridine</td>\n",
       "      <td>Treatment of acquired immunodeficiency syndrome.</td>\n",
       "      <td>11/20/1989</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27286725</td>\n",
       "      <td>ZSNNBSPEFVIUDS-SHYZEUOFSA-N</td>\n",
       "      <td>acquired immunodeficiency syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_635</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D000163</td>\n",
       "      <td>Q12199</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q12199</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>3,4-diaminopyridine</td>\n",
       "      <td>Treatment of Lambert-Eaton myasthenic syndrome.</td>\n",
       "      <td>12/18/1990</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q411707</td>\n",
       "      <td>OYTKINVCDFNREN-UHFFFAOYSA-N</td>\n",
       "      <td>lambert-eaton myasthenic syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050214</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_43393</td>\n",
       "      <td>D015624</td>\n",
       "      <td>Q1756898</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1756898</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>186</th>\n",
       "      <td>3,5-diiodothyropropionic acid</td>\n",
       "      <td>Treatment of Allan-Herndon-Dudley syndrome</td>\n",
       "      <td>05/14/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27252433</td>\n",
       "      <td>None</td>\n",
       "      <td>allan-herndon-dudley syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050631</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_59</td>\n",
       "      <td>None</td>\n",
       "      <td>Q4731121</td>\n",
       "      <td>Q4731121</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>3-aminopropyl-butyl phosphinic acid</td>\n",
       "      <td>Treatment of succinic semialdehyde dehydrogenase deficiency.</td>\n",
       "      <td>12/13/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27075900</td>\n",
       "      <td>ONNMDRQRSGKZCN-UHFFFAOYSA-N</td>\n",
       "      <td>succinic semialdehyde dehydrogenase deficiency</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0060175</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_22</td>\n",
       "      <td>None</td>\n",
       "      <td>Q2823333</td>\n",
       "      <td>Q2823333</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>3-bromopyruvate</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>04/29/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27073726</td>\n",
       "      <td>PRRZDZJYSJLDBS-UHFFFAOYSA-M</td>\n",
       "      <td>pancreatic cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1793</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0002894</td>\n",
       "      <td>None</td>\n",
       "      <td>D010190</td>\n",
       "      <td>Q212961</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q212961</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>3-chloro-4-fluorophenyl-[4-fluoro-4-[[(5-methylpyrimidin-2-ylmethyl)amino]methyl]piperidin-1yl]methanone</td>\n",
       "      <td>Treatment of Rett syndrome</td>\n",
       "      <td>10/25/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q5423588</td>\n",
       "      <td>WAAXKNFGOFTGLP-UHFFFAOYSA-N</td>\n",
       "      <td>rett syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1206</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_778</td>\n",
       "      <td>D015518</td>\n",
       "      <td>Q917357</td>\n",
       "      <td>None</td>\n",
       "      <td>Q917357</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>208</th>\n",
       "      <td>4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol</td>\n",
       "      <td>Treatment of Angelman syndrome.</td>\n",
       "      <td>09/06/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4130924</td>\n",
       "      <td>ZXRVKCBLGJOCEE-UHFFFAOYSA-N</td>\n",
       "      <td>angelman syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1932</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_120365</td>\n",
       "      <td>D017204</td>\n",
       "      <td>Q535364</td>\n",
       "      <td>None</td>\n",
       "      <td>Q535364</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>212</th>\n",
       "      <td>4-(3-Methanesulfonyl-phenyl)-1-propylpiperidine HCl</td>\n",
       "      <td>Treatment of Huntington's disease.</td>\n",
       "      <td>12/12/2005</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27287263</td>\n",
       "      <td>YGRHOYQMBLLGEV-UHFFFAOYSA-N</td>\n",
       "      <td>huntington's disease</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_12858</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D006816</td>\n",
       "      <td>Q190564</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q190564</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>214</th>\n",
       "      <td>4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide</td>\n",
       "      <td>Treatment of diffuse large B-cell lymphoma.</td>\n",
       "      <td>03/27/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>LQBVNQSMGBZMKD-UHFFFAOYSA-N</td>\n",
       "      <td>diffuse large b-cell lymphoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050745</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_544</td>\n",
       "      <td>None</td>\n",
       "      <td>Q2626074</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>230</th>\n",
       "      <td>4-[131I]iodo-L-phenylalanine</td>\n",
       "      <td>Treatment of glioma.</td>\n",
       "      <td>01/04/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27263179</td>\n",
       "      <td>PZNQZSRPDOEBMS-WPUCPVGPSA-N</td>\n",
       "      <td>glioma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_3070</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0009733</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_182067</td>\n",
       "      <td>D005910</td>\n",
       "      <td>Q1365309</td>\n",
       "      <td>Q1365309</td>\n",
       "      <td>Q18556612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>236</th>\n",
       "      <td>4-{[(2R,3S,4R,5S)-4-(4-Chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic acid</td>\n",
       "      <td>Treatment of Acute Myeloid Leukemia</td>\n",
       "      <td>05/19/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27287480</td>\n",
       "      <td>TVTXCJFHQKSQQM-LJQIRTBHSA-N</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>244</th>\n",
       "      <td>5,6-dihydro-5-azacytidine</td>\n",
       "      <td>Treatment of malignant mesothelioma.</td>\n",
       "      <td>05/11/1992</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27236168</td>\n",
       "      <td>LJIRBXZDQGQUOO-KVTDHHQDSA-N</td>\n",
       "      <td>malignant mesothelioma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1790</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0100001</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1077603</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248</th>\n",
       "      <td>5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine hydrochloride</td>\n",
       "      <td>Treatment of progressive supranuclear palsy.</td>\n",
       "      <td>04/18/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27265266</td>\n",
       "      <td>FVWAMONNJGNNHY-UHFFFAOYSA-N</td>\n",
       "      <td>progressive supranuclear palsy</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_678</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_683</td>\n",
       "      <td>D013494</td>\n",
       "      <td>Q945930</td>\n",
       "      <td>Q945930</td>\n",
       "      <td>Q945930</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>253</th>\n",
       "      <td>5-aza-2'-deoxycytidine</td>\n",
       "      <td>Treatment of acute leukemia.</td>\n",
       "      <td>08/03/1987</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q1181878</td>\n",
       "      <td>XAUDJQYHKZQPEU-KVQBGUIXSA-N</td>\n",
       "      <td>acute leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_12603</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0002488</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q976388</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>258</th>\n",
       "      <td>5-[(E)-2-(4-hydroxyphenyl)-ethenyl] benzene-1,3 diol</td>\n",
       "      <td>Treatment of MELAS syndrome</td>\n",
       "      <td>03/13/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q407329</td>\n",
       "      <td>LUKBXSAWLPMMSZ-OWOJBTEDSA-N</td>\n",
       "      <td>melas syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_3687</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D017241</td>\n",
       "      <td>Q2666433</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q2666433</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>259</th>\n",
       "      <td>5-[1-(2,6-Dichlorobenzyl)-piperidin-4-yl]methoxyquinazoline-2,4-diamine</td>\n",
       "      <td>Treatment of spinal muscular atrophy</td>\n",
       "      <td>08/25/2009</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27282418</td>\n",
       "      <td>MNLHFGXIUJNDAF-UHFFFAOYSA-N</td>\n",
       "      <td>spinal muscular atrophy</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_12377</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0007269</td>\n",
       "      <td>None</td>\n",
       "      <td>D009134</td>\n",
       "      <td>Q580290</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q7577466</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>260</th>\n",
       "      <td>5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6yl]-2-pyrimidinamine</td>\n",
       "      <td>Treatment of malignant mesothelioma</td>\n",
       "      <td>02/10/2015</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27089164</td>\n",
       "      <td>QYBGBLQCOOISAR-UHFFFAOYSA-N</td>\n",
       "      <td>malignant mesothelioma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1790</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0100001</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1077603</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>265</th>\n",
       "      <td>6,8-bis-benzylsulfanyl-octanoic acid</td>\n",
       "      <td>Treatment of acute myeloid leukemia.</td>\n",
       "      <td>08/22/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27276958</td>\n",
       "      <td>ZYRLHJIMTROTBO-UHFFFAOYSA-N</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>266</th>\n",
       "      <td>6,8-bis-benzylsulfanyl-octanoic acid</td>\n",
       "      <td>Treatment of pancreatic cancer</td>\n",
       "      <td>02/06/2006</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27276958</td>\n",
       "      <td>ZYRLHJIMTROTBO-UHFFFAOYSA-N</td>\n",
       "      <td>pancreatic cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1793</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0002894</td>\n",
       "      <td>None</td>\n",
       "      <td>D010190</td>\n",
       "      <td>Q212961</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q212961</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>267</th>\n",
       "      <td>6,8-bis-benzylsulfanyl-octanoic acid</td>\n",
       "      <td>Treatment of myelodysplastic syndrome</td>\n",
       "      <td>09/26/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27276958</td>\n",
       "      <td>ZYRLHJIMTROTBO-UHFFFAOYSA-N</td>\n",
       "      <td>myelodysplastic syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050908</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0002863</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_52688</td>\n",
       "      <td>D009190</td>\n",
       "      <td>Q954625</td>\n",
       "      <td>None</td>\n",
       "      <td>Q954625</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>6-methoxy-3-(3',4',5'-trimethoxybenzoyl) indole</td>\n",
       "      <td>Treatment of cholangiocarcinoma</td>\n",
       "      <td>05/11/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27292488</td>\n",
       "      <td>UZJVBXKFBQNDTQ-UHFFFAOYSA-N</td>\n",
       "      <td>cholangiocarcinoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_4947</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0030153</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_70567</td>\n",
       "      <td>D018281</td>\n",
       "      <td>Q124292</td>\n",
       "      <td>None</td>\n",
       "      <td>Q18556554</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>289</th>\n",
       "      <td>8 Cyclopentyl 1,3-dipropylxanthine</td>\n",
       "      <td>Treatment of cystic fibrosis.</td>\n",
       "      <td>03/24/1997</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q5280076</td>\n",
       "      <td>FFBDFADSZUINTG-UHFFFAOYSA-N</td>\n",
       "      <td>cystic fibrosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1485</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_586</td>\n",
       "      <td>D003550</td>\n",
       "      <td>Q178194</td>\n",
       "      <td>None</td>\n",
       "      <td>Q178194</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>290</th>\n",
       "      <td>8-(1-Hydroxy-ethyl)-2-methoxy-3-(4-methoxy-benzyloxy)-benzo[c]chromen-6-one</td>\n",
       "      <td>Treatment of glioblastoma multiforme</td>\n",
       "      <td>01/21/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27294013</td>\n",
       "      <td>YEAHTLOYHVWAKW-UHFFFAOYSA-N</td>\n",
       "      <td>glioblastoma multiforme</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_3068</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0012174</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_360</td>\n",
       "      <td>D005909</td>\n",
       "      <td>Q282142</td>\n",
       "      <td>None</td>\n",
       "      <td>Q18555280</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>311</th>\n",
       "      <td>Abetimus</td>\n",
       "      <td>Treatment of lupus nephritis.</td>\n",
       "      <td>07/28/2000</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4667244</td>\n",
       "      <td>None</td>\n",
       "      <td>lupus nephritis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0080162</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D008181</td>\n",
       "      <td>Q1621830</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1621830</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>313</th>\n",
       "      <td>acadesine</td>\n",
       "      <td>Treatment of chronic lymphocytic leukemia</td>\n",
       "      <td>03/03/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4671562</td>\n",
       "      <td>None</td>\n",
       "      <td>chronic lymphocytic leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1040</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0005550</td>\n",
       "      <td>None</td>\n",
       "      <td>D015451</td>\n",
       "      <td>Q1088156</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1088156</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>314</th>\n",
       "      <td>acadesine</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>05/04/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4671562</td>\n",
       "      <td>None</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>315</th>\n",
       "      <td>acamprosate</td>\n",
       "      <td>Treatment of fragile X syndrome</td>\n",
       "      <td>03/25/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q337668</td>\n",
       "      <td>None</td>\n",
       "      <td>fragile x syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_14261</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_908</td>\n",
       "      <td>D005600</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>316</th>\n",
       "      <td>aceneuramic acid</td>\n",
       "      <td>Treatment of hereditary inclusion body myopathy</td>\n",
       "      <td>09/23/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27120624</td>\n",
       "      <td>None</td>\n",
       "      <td>hereditary inclusion body myopathy</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_3429</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1848471</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>319</th>\n",
       "      <td>acetyl-l-carnitine</td>\n",
       "      <td>Treatment of Fragile X syndrome</td>\n",
       "      <td>07/24/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q311992</td>\n",
       "      <td>GJTJQSPLLQWKMB-SECBINFHSA-N</td>\n",
       "      <td>fragile x syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_14261</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_908</td>\n",
       "      <td>D005600</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>324</th>\n",
       "      <td>Aconiazide</td>\n",
       "      <td>Treatment of tuberculosis.</td>\n",
       "      <td>06/20/1988</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q15633956</td>\n",
       "      <td>None</td>\n",
       "      <td>tuberculosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_399</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_3389</td>\n",
       "      <td>D014376</td>\n",
       "      <td>Q12204</td>\n",
       "      <td>None</td>\n",
       "      <td>Q12204</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>331</th>\n",
       "      <td>adalimumab</td>\n",
       "      <td>Treatment of juvenile rheumatoid arthritis</td>\n",
       "      <td>03/21/2005</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q348260</td>\n",
       "      <td>None</td>\n",
       "      <td>juvenile rheumatoid arthritis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_676</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0005681</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_92</td>\n",
       "      <td>D001171</td>\n",
       "      <td>Q861224</td>\n",
       "      <td>Q861224</td>\n",
       "      <td>Q861224</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3779</th>\n",
       "      <td>tigecycline</td>\n",
       "      <td>Treatment of acute myeloid leukemia.</td>\n",
       "      <td>10/23/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q420595</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3782</th>\n",
       "      <td>tinidazole</td>\n",
       "      <td>Treatment of giardiasis</td>\n",
       "      <td>04/18/2002</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q1321320</td>\n",
       "      <td>None</td>\n",
       "      <td>giardiasis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_10718</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D005873</td>\n",
       "      <td>Q326071</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q326071</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3783</th>\n",
       "      <td>Tinidazole</td>\n",
       "      <td>Treatment of amebiasis</td>\n",
       "      <td>08/20/2003</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q1321320</td>\n",
       "      <td>None</td>\n",
       "      <td>amebiasis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9181</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D000562</td>\n",
       "      <td>Q949694</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q949694</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3786</th>\n",
       "      <td>tipelukast</td>\n",
       "      <td>Treatment of idiopathic pulmonary fibrosis</td>\n",
       "      <td>10/20/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27236352</td>\n",
       "      <td>None</td>\n",
       "      <td>idiopathic pulmonary fibrosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050156</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_2032</td>\n",
       "      <td>D054990</td>\n",
       "      <td>Q2290446</td>\n",
       "      <td>None</td>\n",
       "      <td>Q2290446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3787</th>\n",
       "      <td>Tipifarnib</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>07/06/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7808830</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3789</th>\n",
       "      <td>tirapazamine</td>\n",
       "      <td>Treatment of hepatocellular carcinoma</td>\n",
       "      <td>11/30/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q3529346</td>\n",
       "      <td>None</td>\n",
       "      <td>hepatocellular carcinoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_684</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0001402</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_88673</td>\n",
       "      <td>D006528</td>\n",
       "      <td>Q1148337</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1148337</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3790</th>\n",
       "      <td>tirapazamine</td>\n",
       "      <td>Treatment of head and neck cancer</td>\n",
       "      <td>10/23/2002</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q3529346</td>\n",
       "      <td>None</td>\n",
       "      <td>head and neck cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_11934</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0012288</td>\n",
       "      <td>None</td>\n",
       "      <td>D006258</td>\n",
       "      <td>Q1783924</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1783924</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3804</th>\n",
       "      <td>tocilizumab</td>\n",
       "      <td>Treatment of systemic sclerosis</td>\n",
       "      <td>04/17/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q425154</td>\n",
       "      <td>None</td>\n",
       "      <td>systemic sclerosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_418</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_90291</td>\n",
       "      <td>D012595</td>\n",
       "      <td>Q5340515</td>\n",
       "      <td>None</td>\n",
       "      <td>Q5340515</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3807</th>\n",
       "      <td>Tolcapone</td>\n",
       "      <td>Treatment of transthyretin amyloidosis</td>\n",
       "      <td>12/24/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q413840</td>\n",
       "      <td>None</td>\n",
       "      <td>transthyretin amyloidosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050638</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q2844603</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3809</th>\n",
       "      <td>tolfenamic acid</td>\n",
       "      <td>Treatment of progressive supranuclear palsy</td>\n",
       "      <td>07/13/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q59412</td>\n",
       "      <td>None</td>\n",
       "      <td>progressive supranuclear palsy</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_678</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_683</td>\n",
       "      <td>D013494</td>\n",
       "      <td>Q945930</td>\n",
       "      <td>Q945930</td>\n",
       "      <td>Q945930</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3810</th>\n",
       "      <td>tolfenamic acid</td>\n",
       "      <td>Treatment of Frontotemporal Dementia</td>\n",
       "      <td>07/13/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q59412</td>\n",
       "      <td>None</td>\n",
       "      <td>frontotemporal dementia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9255</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0002145</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_282</td>\n",
       "      <td>D057180</td>\n",
       "      <td>Q18592</td>\n",
       "      <td>Q18592</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3812</th>\n",
       "      <td>Topiramate</td>\n",
       "      <td>Treatment of Lennox-Gastaut syndrome.</td>\n",
       "      <td>11/25/1992</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q221174</td>\n",
       "      <td>None</td>\n",
       "      <td>lennox-gastaut syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050561</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_2382</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1544884</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3817</th>\n",
       "      <td>Tosedostat</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>12/10/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27166812</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3824</th>\n",
       "      <td>tralokinumab</td>\n",
       "      <td>Treatment of idiopathic pulmonary fibrosis</td>\n",
       "      <td>07/24/2012</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q7833105</td>\n",
       "      <td>None</td>\n",
       "      <td>idiopathic pulmonary fibrosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0050156</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_2032</td>\n",
       "      <td>D054990</td>\n",
       "      <td>Q2290446</td>\n",
       "      <td>None</td>\n",
       "      <td>Q2290446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3844</th>\n",
       "      <td>tremelimumab</td>\n",
       "      <td>Treatment of malignant mesothelioma</td>\n",
       "      <td>03/18/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7838098</td>\n",
       "      <td>None</td>\n",
       "      <td>malignant mesothelioma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1790</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0100001</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1077603</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3847</th>\n",
       "      <td>Treosulfan</td>\n",
       "      <td>Treatment of ovarian cancer.</td>\n",
       "      <td>05/16/1994</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7838652</td>\n",
       "      <td>None</td>\n",
       "      <td>ovarian cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_2394</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_213500</td>\n",
       "      <td>D010051</td>\n",
       "      <td>Q172341</td>\n",
       "      <td>None</td>\n",
       "      <td>Q172341</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3854</th>\n",
       "      <td>Tretinoin</td>\n",
       "      <td>Treatment of acute promyelocytic leukemia.</td>\n",
       "      <td>10/24/1990</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q29417</td>\n",
       "      <td>None</td>\n",
       "      <td>acute promyelocytic leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_0060318</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004836</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_520</td>\n",
       "      <td>D015473</td>\n",
       "      <td>Q612108</td>\n",
       "      <td>Q612108</td>\n",
       "      <td>Q612108</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3856</th>\n",
       "      <td>triciribine</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>02/01/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27887003</td>\n",
       "      <td>None</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3857</th>\n",
       "      <td>triclabendazole</td>\n",
       "      <td>Treatment of fascioliasis.</td>\n",
       "      <td>06/27/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q419739</td>\n",
       "      <td>None</td>\n",
       "      <td>fascioliasis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_885</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D005211</td>\n",
       "      <td>Q719656</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q719656</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3867</th>\n",
       "      <td>Trimetrexate glucuronate</td>\n",
       "      <td>Treatment of pancreatic adenocarcinoma.</td>\n",
       "      <td>07/25/1985</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27282570</td>\n",
       "      <td>None</td>\n",
       "      <td>pancreatic adenocarcinoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_4074</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006725</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Q18556189</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3880</th>\n",
       "      <td>Troxacitabine</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>04/04/2005</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q7846702</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3886</th>\n",
       "      <td>Tyloxapol</td>\n",
       "      <td>Treatment of cystic fibrosis.</td>\n",
       "      <td>03/08/1995</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7860340</td>\n",
       "      <td>None</td>\n",
       "      <td>cystic fibrosis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1485</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_586</td>\n",
       "      <td>D003550</td>\n",
       "      <td>Q178194</td>\n",
       "      <td>None</td>\n",
       "      <td>Q178194</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3889</th>\n",
       "      <td>ubiquinol</td>\n",
       "      <td>Treatment of Huntington's Disease</td>\n",
       "      <td>04/12/2004</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q411963</td>\n",
       "      <td>None</td>\n",
       "      <td>huntington's disease</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_12858</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D006816</td>\n",
       "      <td>Q190564</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q190564</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3892</th>\n",
       "      <td>ublituximab</td>\n",
       "      <td>Treatment of chronic lymphocytic leukemia</td>\n",
       "      <td>08/06/2010</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7876570</td>\n",
       "      <td>None</td>\n",
       "      <td>chronic lymphocytic leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1040</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0005550</td>\n",
       "      <td>None</td>\n",
       "      <td>D015451</td>\n",
       "      <td>Q1088156</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1088156</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3899</th>\n",
       "      <td>ulocuplumab</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>01/12/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q21098907</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3900</th>\n",
       "      <td>unoprostone isopropyl</td>\n",
       "      <td>Treatment of retinitis pigmentosa</td>\n",
       "      <td>09/16/2010</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q27089094</td>\n",
       "      <td>None</td>\n",
       "      <td>retinitis pigmentosa</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_10584</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0000510</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_791</td>\n",
       "      <td>D012174</td>\n",
       "      <td>Q847057</td>\n",
       "      <td>Q847057</td>\n",
       "      <td>Q847057</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3920</th>\n",
       "      <td>vadastuximab talirine</td>\n",
       "      <td>Treatment of acute myeloid leukemia.</td>\n",
       "      <td>11/10/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q17044502</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3923</th>\n",
       "      <td>Valproate</td>\n",
       "      <td>Treatment of fragile X syndrome</td>\n",
       "      <td>05/05/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27104876</td>\n",
       "      <td>NIJJYAXOARWZEE-UHFFFAOYSA-M</td>\n",
       "      <td>fragile x syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_14261</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_908</td>\n",
       "      <td>D005600</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "      <td>Q221472</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3927</th>\n",
       "      <td>vamorolone</td>\n",
       "      <td>Treatment of Duchenne muscular dystrophy</td>\n",
       "      <td>12/02/2011</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27089127</td>\n",
       "      <td>None</td>\n",
       "      <td>duchenne muscular dystrophy</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_11723</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_98896</td>\n",
       "      <td>D020388</td>\n",
       "      <td>Q1648484</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1648484</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3928</th>\n",
       "      <td>vancomycin</td>\n",
       "      <td>Treatment of endophthalmitis</td>\n",
       "      <td>12/27/2012</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q424027</td>\n",
       "      <td>None</td>\n",
       "      <td>endophthalmitis</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_4692</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_199323</td>\n",
       "      <td>D009877</td>\n",
       "      <td>Q1294912</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1294912</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3936</th>\n",
       "      <td>vapreotide</td>\n",
       "      <td>Treatment of acromegaly</td>\n",
       "      <td>11/04/2003</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4008670</td>\n",
       "      <td>None</td>\n",
       "      <td>acromegaly</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_2449</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0000845</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_963</td>\n",
       "      <td>D000172</td>\n",
       "      <td>Q189580</td>\n",
       "      <td>None</td>\n",
       "      <td>Q189580</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3940</th>\n",
       "      <td>Varlitinib</td>\n",
       "      <td>Treatment of cholangiocarcinoma.</td>\n",
       "      <td>08/05/2015</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27089126</td>\n",
       "      <td>None</td>\n",
       "      <td>cholangiocarcinoma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_4947</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0030153</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_70567</td>\n",
       "      <td>D018281</td>\n",
       "      <td>Q124292</td>\n",
       "      <td>None</td>\n",
       "      <td>Q18556554</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3947</th>\n",
       "      <td>vatiquinone</td>\n",
       "      <td>Treatment of Friedreich's ataxia</td>\n",
       "      <td>01/31/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27265220</td>\n",
       "      <td>None</td>\n",
       "      <td>friedreich's ataxia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_12705</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D005621</td>\n",
       "      <td>Q913856</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q913856</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3948</th>\n",
       "      <td>vatiquinone</td>\n",
       "      <td>Treatment of Leigh Syndrome</td>\n",
       "      <td>06/04/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27265220</td>\n",
       "      <td>None</td>\n",
       "      <td>leigh syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_3652</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_506</td>\n",
       "      <td>D007888</td>\n",
       "      <td>Q1815019</td>\n",
       "      <td>Q1815019</td>\n",
       "      <td>Q1815019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3949</th>\n",
       "      <td>vatiquinone</td>\n",
       "      <td>Treatment of Rett syndrome</td>\n",
       "      <td>11/17/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27265220</td>\n",
       "      <td>None</td>\n",
       "      <td>rett syndrome</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1206</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_778</td>\n",
       "      <td>D015518</td>\n",
       "      <td>Q917357</td>\n",
       "      <td>None</td>\n",
       "      <td>Q917357</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3957</th>\n",
       "      <td>veltuzumab</td>\n",
       "      <td>Treatment of pemphigus</td>\n",
       "      <td>11/17/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4009438</td>\n",
       "      <td>None</td>\n",
       "      <td>pemphigus</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9182</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D010392</td>\n",
       "      <td>Q1483214</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1483214</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3959</th>\n",
       "      <td>veltuzumab</td>\n",
       "      <td>Treatment of chronic lymphocytic leukemia</td>\n",
       "      <td>08/28/2008</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q4009438</td>\n",
       "      <td>None</td>\n",
       "      <td>chronic lymphocytic leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1040</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0005550</td>\n",
       "      <td>None</td>\n",
       "      <td>D015451</td>\n",
       "      <td>Q1088156</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1088156</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3960</th>\n",
       "      <td>vemurafenib</td>\n",
       "      <td>Treatment of Erdheim-Chester Disease</td>\n",
       "      <td>08/02/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q423111</td>\n",
       "      <td>None</td>\n",
       "      <td>erdheim-chester disease</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_4329</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_35687</td>\n",
       "      <td>D031249</td>\n",
       "      <td>Q1349259</td>\n",
       "      <td>None</td>\n",
       "      <td>Q1349259</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3965</th>\n",
       "      <td>Venetoclax</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>08/29/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>None</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3966</th>\n",
       "      <td>venetoclax</td>\n",
       "      <td>Treatment of chronic lymphocytic leukemia</td>\n",
       "      <td>09/20/2012</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>None</td>\n",
       "      <td>chronic lymphocytic leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_1040</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0005550</td>\n",
       "      <td>None</td>\n",
       "      <td>D015451</td>\n",
       "      <td>Q1088156</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q1088156</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3967</th>\n",
       "      <td>venetoclax</td>\n",
       "      <td>Treatment of acute myeloid leukemia.</td>\n",
       "      <td>02/04/2016</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q23671272</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3975</th>\n",
       "      <td>vintafolide</td>\n",
       "      <td>Treatment of ovarian cancer</td>\n",
       "      <td>12/16/2013</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7932801</td>\n",
       "      <td>None</td>\n",
       "      <td>ovarian cancer</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_2394</td>\n",
       "      <td>None</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_213500</td>\n",
       "      <td>D010051</td>\n",
       "      <td>Q172341</td>\n",
       "      <td>None</td>\n",
       "      <td>Q172341</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3979</th>\n",
       "      <td>volasertib</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>04/14/2014</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q7939986</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3981</th>\n",
       "      <td>vorinostat</td>\n",
       "      <td>Treatment of multiple myeloma</td>\n",
       "      <td>06/12/2003</td>\n",
       "      <td>Designated/Withdrawn</td>\n",
       "      <td>Q905901</td>\n",
       "      <td>None</td>\n",
       "      <td>multiple myeloma</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9538</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0006775</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_29073</td>\n",
       "      <td>D009101</td>\n",
       "      <td>Q467635</td>\n",
       "      <td>None</td>\n",
       "      <td>Q467635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3985</th>\n",
       "      <td>vosaroxin</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>10/28/2009</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q18395775</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3995</th>\n",
       "      <td>Zalcitabine</td>\n",
       "      <td>Treatment of AIDS.</td>\n",
       "      <td>06/28/1988</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q2344582</td>\n",
       "      <td>None</td>\n",
       "      <td>aids</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_635</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D000163</td>\n",
       "      <td>Q12199</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q12199</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3996</th>\n",
       "      <td>Zalcitabine</td>\n",
       "      <td>Treatment of AIDS.</td>\n",
       "      <td>12/09/1986</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q2344582</td>\n",
       "      <td>None</td>\n",
       "      <td>aids</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_635</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D000163</td>\n",
       "      <td>Q12199</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q12199</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3997</th>\n",
       "      <td>zidovudine</td>\n",
       "      <td>Treatment of AIDS</td>\n",
       "      <td>07/17/1985</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q198504</td>\n",
       "      <td>None</td>\n",
       "      <td>aids</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_635</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D000163</td>\n",
       "      <td>Q12199</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q12199</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3998</th>\n",
       "      <td>Zinc acetate</td>\n",
       "      <td>Treatment of Wilson's disease.</td>\n",
       "      <td>11/06/1985</td>\n",
       "      <td>Designated/Approved</td>\n",
       "      <td>Q204639</td>\n",
       "      <td>DJWUNCQRNNEAKC-UHFFFAOYSA-L</td>\n",
       "      <td>wilson's disease</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_893</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>D006527</td>\n",
       "      <td>Q117121</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Q117121</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4002</th>\n",
       "      <td>Zosuquidar trihydrochloride</td>\n",
       "      <td>Treatment of acute myeloid leukemia</td>\n",
       "      <td>12/15/2005</td>\n",
       "      <td>Designated</td>\n",
       "      <td>Q27269191</td>\n",
       "      <td>None</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>http://purl.obolibrary.org/obo/DOID_9119</td>\n",
       "      <td>http://purl.obolibrary.org/obo/HP_0004808</td>\n",
       "      <td>http://www.orpha.net/ORDO/Orphanet_519</td>\n",
       "      <td>D015470</td>\n",
       "      <td>Q264118</td>\n",
       "      <td>None</td>\n",
       "      <td>Q264118</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>677 rows × 14 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                            Generic Name  \\\n",
       "4     (-)-(3aR,4S,7aR)-4-Hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester                                                                                                                          \n",
       "16    (2,2-diphenyl-tetrahydro-furan-3-yl-methyl)-dimethylamine hydrochloride                                                                                                                                              \n",
       "17    (2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide)                                                                                                                         \n",
       "18    (2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo [4,3-c] pyridine-3,6(2h,5h)-dione)                                                                                                              \n",
       "30    (3S)-1-azabicyclo[2.2.2]oct-3-yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate                                                                                                                       \n",
       "40    (5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride                                                                                                                                          \n",
       "57    (R)-2-methyl-6-nitro-2-{4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole                                                                                               \n",
       "58    (R)-4-(3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enylmethyl]-piperazin-1-yl}-benzoyl)-3-trifluoromethanesulfonylbenzenesulfonamide bis-hydrochloride   \n",
       "65    (S)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine                                                   \n",
       "70    (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one                                                                                                                                           \n",
       "74    (S)-4-(8-amino-3-(1-but-2-ynoylpyrrolidin-2-yl)-imidazo[1,5-a]pyrazine-1-yl)-N-(pyridine-2-yl)-benzamide                                                                                                             \n",
       "76    (S)-7-(1-(9H-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one                                                                                                                    \n",
       "102   1-(6-benzothiazolylsulfonyl)-5-chloro-1H-indole-2-butanoic acid                                                                                                                                                      \n",
       "103   1-Cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea                                                                                                                              \n",
       "129   2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione                                                                                                                  \n",
       "150   2-chloroethyl-3-sarcosinamide-1-nitrosourea                                                                                                                                                                          \n",
       "157   2-methoxyestradiol                                                                                                                                                                                                   \n",
       "158   2-methoxyestradiol                                                                                                                                                                                                   \n",
       "160   2-[(3-methyl-4-(2,2,2-trifluoroethoxy) pyridin-2-yl)methylsulfinyl] -1H-benzoimidazole                                                                                                                               \n",
       "182   3'-azido-2',3'dideoxyuridine                                                                                                                                                                                         \n",
       "184   3,4-diaminopyridine                                                                                                                                                                                                  \n",
       "186   3,5-diiodothyropropionic acid                                                                                                                                                                                        \n",
       "194   3-aminopropyl-butyl phosphinic acid                                                                                                                                                                                  \n",
       "195   3-bromopyruvate                                                                                                                                                                                                      \n",
       "197   3-chloro-4-fluorophenyl-[4-fluoro-4-[[(5-methylpyrimidin-2-ylmethyl)amino]methyl]piperidin-1yl]methanone                                                                                                             \n",
       "208   4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol                                                                                                                                                                       \n",
       "212   4-(3-Methanesulfonyl-phenyl)-1-propylpiperidine HCl                                                                                                                                                                  \n",
       "214   4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide                  \n",
       "230   4-[131I]iodo-L-phenylalanine                                                                                                                                                                                         \n",
       "236   4-{[(2R,3S,4R,5S)-4-(4-Chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic acid                                                    \n",
       "244   5,6-dihydro-5-azacytidine                                                                                                                                                                                            \n",
       "248   5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine hydrochloride                                                                                                                                          \n",
       "253   5-aza-2'-deoxycytidine                                                                                                                                                                                               \n",
       "258   5-[(E)-2-(4-hydroxyphenyl)-ethenyl] benzene-1,3 diol                                                                                                                                                                 \n",
       "259   5-[1-(2,6-Dichlorobenzyl)-piperidin-4-yl]methoxyquinazoline-2,4-diamine                                                                                                                                              \n",
       "260   5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6yl]-2-pyrimidinamine                                                                                                                                       \n",
       "265   6,8-bis-benzylsulfanyl-octanoic acid                                                                                                                                                                                 \n",
       "266   6,8-bis-benzylsulfanyl-octanoic acid                                                                                                                                                                                 \n",
       "267   6,8-bis-benzylsulfanyl-octanoic acid                                                                                                                                                                                 \n",
       "278   6-methoxy-3-(3',4',5'-trimethoxybenzoyl) indole                                                                                                                                                                      \n",
       "289   8 Cyclopentyl 1,3-dipropylxanthine                                                                                                                                                                                   \n",
       "290   8-(1-Hydroxy-ethyl)-2-methoxy-3-(4-methoxy-benzyloxy)-benzo[c]chromen-6-one                                                                                                                                          \n",
       "311   Abetimus                                                                                                                                                                                                             \n",
       "313   acadesine                                                                                                                                                                                                            \n",
       "314   acadesine                                                                                                                                                                                                            \n",
       "315   acamprosate                                                                                                                                                                                                          \n",
       "316   aceneuramic acid                                                                                                                                                                                                     \n",
       "319   acetyl-l-carnitine                                                                                                                                                                                                   \n",
       "324   Aconiazide                                                                                                                                                                                                           \n",
       "331   adalimumab                                                                                                                                                                                                           \n",
       "...          ...                                                                                                                                                                                                           \n",
       "3779  tigecycline                                                                                                                                                                                                          \n",
       "3782  tinidazole                                                                                                                                                                                                           \n",
       "3783  Tinidazole                                                                                                                                                                                                           \n",
       "3786  tipelukast                                                                                                                                                                                                           \n",
       "3787  Tipifarnib                                                                                                                                                                                                           \n",
       "3789  tirapazamine                                                                                                                                                                                                         \n",
       "3790  tirapazamine                                                                                                                                                                                                         \n",
       "3804  tocilizumab                                                                                                                                                                                                          \n",
       "3807  Tolcapone                                                                                                                                                                                                            \n",
       "3809  tolfenamic acid                                                                                                                                                                                                      \n",
       "3810  tolfenamic acid                                                                                                                                                                                                      \n",
       "3812  Topiramate                                                                                                                                                                                                           \n",
       "3817  Tosedostat                                                                                                                                                                                                           \n",
       "3824  tralokinumab                                                                                                                                                                                                         \n",
       "3844  tremelimumab                                                                                                                                                                                                         \n",
       "3847  Treosulfan                                                                                                                                                                                                           \n",
       "3854  Tretinoin                                                                                                                                                                                                            \n",
       "3856  triciribine                                                                                                                                                                                                          \n",
       "3857  triclabendazole                                                                                                                                                                                                      \n",
       "3867  Trimetrexate glucuronate                                                                                                                                                                                             \n",
       "3880  Troxacitabine                                                                                                                                                                                                        \n",
       "3886  Tyloxapol                                                                                                                                                                                                            \n",
       "3889  ubiquinol                                                                                                                                                                                                            \n",
       "3892  ublituximab                                                                                                                                                                                                          \n",
       "3899  ulocuplumab                                                                                                                                                                                                          \n",
       "3900  unoprostone isopropyl                                                                                                                                                                                                \n",
       "3920  vadastuximab talirine                                                                                                                                                                                                \n",
       "3923  Valproate                                                                                                                                                                                                            \n",
       "3927  vamorolone                                                                                                                                                                                                           \n",
       "3928  vancomycin                                                                                                                                                                                                           \n",
       "3936  vapreotide                                                                                                                                                                                                           \n",
       "3940  Varlitinib                                                                                                                                                                                                           \n",
       "3947  vatiquinone                                                                                                                                                                                                          \n",
       "3948  vatiquinone                                                                                                                                                                                                          \n",
       "3949  vatiquinone                                                                                                                                                                                                          \n",
       "3957  veltuzumab                                                                                                                                                                                                           \n",
       "3959  veltuzumab                                                                                                                                                                                                           \n",
       "3960  vemurafenib                                                                                                                                                                                                          \n",
       "3965  Venetoclax                                                                                                                                                                                                           \n",
       "3966  venetoclax                                                                                                                                                                                                           \n",
       "3967  venetoclax                                                                                                                                                                                                           \n",
       "3975  vintafolide                                                                                                                                                                                                          \n",
       "3979  volasertib                                                                                                                                                                                                           \n",
       "3981  vorinostat                                                                                                                                                                                                           \n",
       "3985  vosaroxin                                                                                                                                                                                                            \n",
       "3995  Zalcitabine                                                                                                                                                                                                          \n",
       "3996  Zalcitabine                                                                                                                                                                                                          \n",
       "3997  zidovudine                                                                                                                                                                                                           \n",
       "3998  Zinc acetate                                                                                                                                                                                                         \n",
       "4002  Zosuquidar trihydrochloride                                                                                                                                                                                          \n",
       "\n",
       "                                                Orphan Designation  \\\n",
       "4     Treatment of Fragile X syndrome                                \n",
       "16    Treatment of Rett Syndrome.                                    \n",
       "17    Treatment of multiple myeloma                                  \n",
       "18    Treatment of systemic sclerosis.                               \n",
       "30    Treatment of Gaucher disease                                   \n",
       "40    Treatment of erythromelalgia                                   \n",
       "57    Treatment of pulmonary tuberculosis.                           \n",
       "58    Treatment of multiple myeloma                                  \n",
       "65    Treatment of acute myeloid leukemia                            \n",
       "70    Treatment of follicular lymphoma                               \n",
       "74    Treatment of mantle cell lymphoma.                             \n",
       "76    Treatment of Hodgkin lymphoma                                  \n",
       "102   Treatment of systemic sclerosis                                \n",
       "103   Treatment of acute myeloid leukemia                            \n",
       "129   Treatment of idiopathic pulmonary fibrosis.                    \n",
       "150   Treatment for malignant glioma                                 \n",
       "157   Treatment of multiple myeloma                                  \n",
       "158   Treatment of ovarian cancer                                    \n",
       "160   Treatment of hepatocellular carcinoma.                         \n",
       "182   Treatment of acquired immunodeficiency syndrome.               \n",
       "184   Treatment of Lambert-Eaton myasthenic syndrome.                \n",
       "186   Treatment of Allan-Herndon-Dudley syndrome                     \n",
       "194   Treatment of succinic semialdehyde dehydrogenase deficiency.   \n",
       "195   Treatment of pancreatic cancer                                 \n",
       "197   Treatment of Rett syndrome                                     \n",
       "208   Treatment of Angelman syndrome.                                \n",
       "212   Treatment of Huntington's disease.                             \n",
       "214   Treatment of diffuse large B-cell lymphoma.                    \n",
       "230   Treatment of glioma.                                           \n",
       "236   Treatment of Acute Myeloid Leukemia                            \n",
       "244   Treatment of malignant mesothelioma.                           \n",
       "248   Treatment of progressive supranuclear palsy.                   \n",
       "253   Treatment of acute leukemia.                                   \n",
       "258   Treatment of MELAS syndrome                                    \n",
       "259   Treatment of spinal muscular atrophy                           \n",
       "260   Treatment of malignant mesothelioma                            \n",
       "265   Treatment of acute myeloid leukemia.                           \n",
       "266   Treatment of pancreatic cancer                                 \n",
       "267   Treatment of myelodysplastic syndrome                          \n",
       "278   Treatment of cholangiocarcinoma                                \n",
       "289   Treatment of cystic fibrosis.                                  \n",
       "290   Treatment of glioblastoma multiforme                           \n",
       "311   Treatment of lupus nephritis.                                  \n",
       "313   Treatment of chronic lymphocytic leukemia                      \n",
       "314   Treatment of multiple myeloma                                  \n",
       "315   Treatment of fragile X syndrome                                \n",
       "316   Treatment of hereditary inclusion body myopathy                \n",
       "319   Treatment of Fragile X syndrome                                \n",
       "324   Treatment of tuberculosis.                                     \n",
       "331   Treatment of juvenile rheumatoid arthritis                     \n",
       "...                                          ...                     \n",
       "3779  Treatment of acute myeloid leukemia.                           \n",
       "3782  Treatment of giardiasis                                        \n",
       "3783  Treatment of amebiasis                                         \n",
       "3786  Treatment of idiopathic pulmonary fibrosis                     \n",
       "3787  Treatment of acute myeloid leukemia                            \n",
       "3789  Treatment of hepatocellular carcinoma                          \n",
       "3790  Treatment of head and neck cancer                              \n",
       "3804  Treatment of systemic sclerosis                                \n",
       "3807  Treatment of transthyretin amyloidosis                         \n",
       "3809  Treatment of progressive supranuclear palsy                    \n",
       "3810  Treatment of Frontotemporal Dementia                           \n",
       "3812  Treatment of Lennox-Gastaut syndrome.                          \n",
       "3817  Treatment of acute myeloid leukemia                            \n",
       "3824  Treatment of idiopathic pulmonary fibrosis                     \n",
       "3844  Treatment of malignant mesothelioma                            \n",
       "3847  Treatment of ovarian cancer.                                   \n",
       "3854  Treatment of acute promyelocytic leukemia.                     \n",
       "3856  Treatment of multiple myeloma                                  \n",
       "3857  Treatment of fascioliasis.                                     \n",
       "3867  Treatment of pancreatic adenocarcinoma.                        \n",
       "3880  Treatment of acute myeloid leukemia                            \n",
       "3886  Treatment of cystic fibrosis.                                  \n",
       "3889  Treatment of Huntington's Disease                              \n",
       "3892  Treatment of chronic lymphocytic leukemia                      \n",
       "3899  Treatment of acute myeloid leukemia                            \n",
       "3900  Treatment of retinitis pigmentosa                              \n",
       "3920  Treatment of acute myeloid leukemia.                           \n",
       "3923  Treatment of fragile X syndrome                                \n",
       "3927  Treatment of Duchenne muscular dystrophy                       \n",
       "3928  Treatment of endophthalmitis                                   \n",
       "3936  Treatment of acromegaly                                        \n",
       "3940  Treatment of cholangiocarcinoma.                               \n",
       "3947  Treatment of Friedreich's ataxia                               \n",
       "3948  Treatment of Leigh Syndrome                                    \n",
       "3949  Treatment of Rett syndrome                                     \n",
       "3957  Treatment of pemphigus                                         \n",
       "3959  Treatment of chronic lymphocytic leukemia                      \n",
       "3960  Treatment of Erdheim-Chester Disease                           \n",
       "3965  Treatment of multiple myeloma                                  \n",
       "3966  Treatment of chronic lymphocytic leukemia                      \n",
       "3967  Treatment of acute myeloid leukemia.                           \n",
       "3975  Treatment of ovarian cancer                                    \n",
       "3979  Treatment of acute myeloid leukemia                            \n",
       "3981  Treatment of multiple myeloma                                  \n",
       "3985  Treatment of acute myeloid leukemia                            \n",
       "3995  Treatment of AIDS.                                             \n",
       "3996  Treatment of AIDS.                                             \n",
       "3997  Treatment of AIDS                                              \n",
       "3998  Treatment of Wilson's disease.                                 \n",
       "4002  Treatment of acute myeloid leukemia                            \n",
       "\n",
       "     Designation Date    Designation Status   drug_qid  \\\n",
       "4     10/12/2011       Designated            Q6589598    \n",
       "16    05/18/2016       Designated            Q27252594   \n",
       "17    11/29/2016       Designated            Q27258687   \n",
       "18    10/14/2015       Designated            Q27258840   \n",
       "30    09/11/2014       Designated            Q27274745   \n",
       "40    01/30/2017       Designated            Q27268497   \n",
       "57    07/12/2007       Designated            Q15408413   \n",
       "58    05/05/2008       Designated/Withdrawn  Q27292463   \n",
       "65    11/05/2014       Designated            Q27236818   \n",
       "70    08/01/2013       Designated            Q27077129   \n",
       "74    09/21/2015       Designated            Q23668732   \n",
       "76    04/29/2015       Designated            Q27254856   \n",
       "102   03/31/2015       Designated            Q27896056   \n",
       "103   11/12/2009       Designated            Q27453557   \n",
       "129   09/21/2010       Designated            Q27258840   \n",
       "150   11/15/2001       Designated            Q27274664   \n",
       "157   07/10/2001       Designated/Withdrawn  Q4596897    \n",
       "158   04/04/2005       Designated/Withdrawn  Q4596897    \n",
       "160   08/27/2008       Designated            Q254296     \n",
       "182   11/20/1989       Designated/Withdrawn  Q27286725   \n",
       "184   12/18/1990       Designated            Q411707     \n",
       "186   05/14/2013       Designated            Q27252433   \n",
       "194   12/13/2016       Designated            Q27075900   \n",
       "195   04/29/2014       Designated            Q27073726   \n",
       "197   10/25/2013       Designated            Q5423588    \n",
       "208   09/06/2016       Designated            Q4130924    \n",
       "212   12/12/2005       Designated            Q27287263   \n",
       "214   03/27/2014       Designated            Q23671272   \n",
       "230   01/04/2011       Designated            Q27263179   \n",
       "236   05/19/2014       Designated            Q27287480   \n",
       "244   05/11/1992       Designated            Q27236168   \n",
       "248   04/18/2011       Designated            Q27265266   \n",
       "253   08/03/1987       Designated            Q1181878    \n",
       "258   03/13/2008       Designated            Q407329     \n",
       "259   08/25/2009       Designated            Q27282418   \n",
       "260   02/10/2015       Designated/Withdrawn  Q27089164   \n",
       "265   08/22/2011       Designated            Q27276958   \n",
       "266   02/06/2006       Designated            Q27276958   \n",
       "267   09/26/2013       Designated            Q27276958   \n",
       "278   05/11/2016       Designated            Q27292488   \n",
       "289   03/24/1997       Designated/Withdrawn  Q5280076    \n",
       "290   01/21/2015       Designated            Q27294013   \n",
       "311   07/28/2000       Designated            Q4667244    \n",
       "313   03/03/2011       Designated            Q4671562    \n",
       "314   05/04/2011       Designated            Q4671562    \n",
       "315   03/25/2013       Designated            Q337668     \n",
       "316   09/23/2011       Designated            Q27120624   \n",
       "319   07/24/2012       Designated            Q311992     \n",
       "324   06/20/1988       Designated/Withdrawn  Q15633956   \n",
       "331   03/21/2005       Designated/Approved   Q348260     \n",
       "...          ...                       ...       ...     \n",
       "3779  10/23/2013       Designated            Q420595     \n",
       "3782  04/18/2002       Designated/Approved   Q1321320    \n",
       "3783  08/20/2003       Designated/Approved   Q1321320    \n",
       "3786  10/20/2014       Designated            Q27236352   \n",
       "3787  07/06/2004       Designated            Q7808830    \n",
       "3789  11/30/2015       Designated            Q3529346    \n",
       "3790  10/23/2002       Designated            Q3529346    \n",
       "3804  04/17/2013       Designated            Q425154     \n",
       "3807  12/24/2013       Designated            Q413840     \n",
       "3809  07/13/2016       Designated            Q59412      \n",
       "3810  07/13/2016       Designated            Q59412      \n",
       "3812  11/25/1992       Designated/Approved   Q221174     \n",
       "3817  12/10/2008       Designated            Q27166812   \n",
       "3824  07/24/2012       Designated/Withdrawn  Q7833105    \n",
       "3844  03/18/2015       Designated            Q7838098    \n",
       "3847  05/16/1994       Designated            Q7838652    \n",
       "3854  10/24/1990       Designated/Approved   Q29417      \n",
       "3856  02/01/2008       Designated            Q27887003   \n",
       "3857  06/27/2016       Designated            Q419739     \n",
       "3867  07/25/1985       Designated/Withdrawn  Q27282570   \n",
       "3880  04/04/2005       Designated/Withdrawn  Q7846702    \n",
       "3886  03/08/1995       Designated            Q7860340    \n",
       "3889  04/12/2004       Designated            Q411963     \n",
       "3892  08/06/2010       Designated            Q7876570    \n",
       "3899  01/12/2015       Designated            Q21098907   \n",
       "3900  09/16/2010       Designated/Withdrawn  Q27089094   \n",
       "3920  11/10/2015       Designated            Q17044502   \n",
       "3923  05/05/2008       Designated            Q27104876   \n",
       "3927  12/02/2011       Designated            Q27089127   \n",
       "3928  12/27/2012       Designated            Q424027     \n",
       "3936  11/04/2003       Designated            Q4008670    \n",
       "3940  08/05/2015       Designated            Q27089126   \n",
       "3947  01/31/2014       Designated            Q27265220   \n",
       "3948  06/04/2014       Designated            Q27265220   \n",
       "3949  11/17/2014       Designated            Q27265220   \n",
       "3957  11/17/2014       Designated            Q4009438    \n",
       "3959  08/28/2008       Designated            Q4009438    \n",
       "3960  08/02/2016       Designated            Q423111     \n",
       "3965  08/29/2016       Designated            Q23671272   \n",
       "3966  09/20/2012       Designated/Approved   Q23671272   \n",
       "3967  02/04/2016       Designated            Q23671272   \n",
       "3975  12/16/2013       Designated            Q7932801    \n",
       "3979  04/14/2014       Designated            Q7939986    \n",
       "3981  06/12/2003       Designated/Withdrawn  Q905901     \n",
       "3985  10/28/2009       Designated            Q18395775   \n",
       "3995  06/28/1988       Designated/Approved   Q2344582    \n",
       "3996  12/09/1986       Designated            Q2344582    \n",
       "3997  07/17/1985       Designated/Approved   Q198504     \n",
       "3998  11/06/1985       Designated/Approved   Q204639     \n",
       "4002  12/15/2005       Designated            Q27269191   \n",
       "\n",
       "                            inchi  \\\n",
       "4     ZFPZEYHRWGMJCV-ZHALLVOQSA-N   \n",
       "16    FEQOLYDPQKHFTD-UHFFFAOYSA-N   \n",
       "17    VLIUIBXPEDFJRF-UHFFFAOYSA-N   \n",
       "18    RGYQPQARIQKJKH-UHFFFAOYSA-N   \n",
       "30    YFHRCLAKZBDRHN-MRXNPFEDSA-N   \n",
       "40    HEPUBAGOKRIZEO-PPPUBMIESA-N   \n",
       "57    XDAOLTSRNUSPPH-XMMPIXPASA-N   \n",
       "58    WDVGRPCSLPVWKC-VROLVAQFSA-N   \n",
       "65    KXMZDGSRSGHMMK-VWLOTQADSA-N   \n",
       "70    SJVQHLPISAIATJ-ZDUSSCGKSA-N   \n",
       "74    WDENQIQQYWYTPO-IBGZPJMESA-N   \n",
       "76    RSIWALKZYXPAGW-NSHDSACASA-N   \n",
       "102   OQDQIFQRNZIEEJ-UHFFFAOYSA-N   \n",
       "103   LOLPPWBBNUVNQZ-UHFFFAOYSA-N   \n",
       "129   RGYQPQARIQKJKH-UHFFFAOYSA-N   \n",
       "150   None                          \n",
       "157   None                          \n",
       "158   None                          \n",
       "160   MJIHNNLFOKEZEW-UHFFFAOYSA-N   \n",
       "182   ZSNNBSPEFVIUDS-SHYZEUOFSA-N   \n",
       "184   OYTKINVCDFNREN-UHFFFAOYSA-N   \n",
       "186   None                          \n",
       "194   ONNMDRQRSGKZCN-UHFFFAOYSA-N   \n",
       "195   PRRZDZJYSJLDBS-UHFFFAOYSA-M   \n",
       "197   WAAXKNFGOFTGLP-UHFFFAOYSA-N   \n",
       "208   ZXRVKCBLGJOCEE-UHFFFAOYSA-N   \n",
       "212   YGRHOYQMBLLGEV-UHFFFAOYSA-N   \n",
       "214   LQBVNQSMGBZMKD-UHFFFAOYSA-N   \n",
       "230   PZNQZSRPDOEBMS-WPUCPVGPSA-N   \n",
       "236   TVTXCJFHQKSQQM-LJQIRTBHSA-N   \n",
       "244   LJIRBXZDQGQUOO-KVTDHHQDSA-N   \n",
       "248   FVWAMONNJGNNHY-UHFFFAOYSA-N   \n",
       "253   XAUDJQYHKZQPEU-KVQBGUIXSA-N   \n",
       "258   LUKBXSAWLPMMSZ-OWOJBTEDSA-N   \n",
       "259   MNLHFGXIUJNDAF-UHFFFAOYSA-N   \n",
       "260   QYBGBLQCOOISAR-UHFFFAOYSA-N   \n",
       "265   ZYRLHJIMTROTBO-UHFFFAOYSA-N   \n",
       "266   ZYRLHJIMTROTBO-UHFFFAOYSA-N   \n",
       "267   ZYRLHJIMTROTBO-UHFFFAOYSA-N   \n",
       "278   UZJVBXKFBQNDTQ-UHFFFAOYSA-N   \n",
       "289   FFBDFADSZUINTG-UHFFFAOYSA-N   \n",
       "290   YEAHTLOYHVWAKW-UHFFFAOYSA-N   \n",
       "311   None                          \n",
       "313   None                          \n",
       "314   None                          \n",
       "315   None                          \n",
       "316   None                          \n",
       "319   GJTJQSPLLQWKMB-SECBINFHSA-N   \n",
       "324   None                          \n",
       "331   None                          \n",
       "...    ...                          \n",
       "3779  None                          \n",
       "3782  None                          \n",
       "3783  None                          \n",
       "3786  None                          \n",
       "3787  None                          \n",
       "3789  None                          \n",
       "3790  None                          \n",
       "3804  None                          \n",
       "3807  None                          \n",
       "3809  None                          \n",
       "3810  None                          \n",
       "3812  None                          \n",
       "3817  None                          \n",
       "3824  None                          \n",
       "3844  None                          \n",
       "3847  None                          \n",
       "3854  None                          \n",
       "3856  None                          \n",
       "3857  None                          \n",
       "3867  None                          \n",
       "3880  None                          \n",
       "3886  None                          \n",
       "3889  None                          \n",
       "3892  None                          \n",
       "3899  None                          \n",
       "3900  None                          \n",
       "3920  None                          \n",
       "3923  NIJJYAXOARWZEE-UHFFFAOYSA-M   \n",
       "3927  None                          \n",
       "3928  None                          \n",
       "3936  None                          \n",
       "3940  None                          \n",
       "3947  None                          \n",
       "3948  None                          \n",
       "3949  None                          \n",
       "3957  None                          \n",
       "3959  None                          \n",
       "3960  None                          \n",
       "3965  None                          \n",
       "3966  None                          \n",
       "3967  None                          \n",
       "3975  None                          \n",
       "3979  None                          \n",
       "3981  None                          \n",
       "3985  None                          \n",
       "3995  None                          \n",
       "3996  None                          \n",
       "3997  None                          \n",
       "3998  DJWUNCQRNNEAKC-UHFFFAOYSA-L   \n",
       "4002  None                          \n",
       "\n",
       "                                          indication  \\\n",
       "4     fragile x syndrome                               \n",
       "16    rett syndrome                                    \n",
       "17    multiple myeloma                                 \n",
       "18    systemic sclerosis                               \n",
       "30    gaucher disease                                  \n",
       "40    erythromelalgia                                  \n",
       "57    pulmonary tuberculosis                           \n",
       "58    multiple myeloma                                 \n",
       "65    acute myeloid leukemia                           \n",
       "70    follicular lymphoma                              \n",
       "74    mantle cell lymphoma                             \n",
       "76    hodgkin lymphoma                                 \n",
       "102   systemic sclerosis                               \n",
       "103   acute myeloid leukemia                           \n",
       "129   idiopathic pulmonary fibrosis                    \n",
       "150   malignant glioma                                 \n",
       "157   multiple myeloma                                 \n",
       "158   ovarian cancer                                   \n",
       "160   hepatocellular carcinoma                         \n",
       "182   acquired immunodeficiency syndrome               \n",
       "184   lambert-eaton myasthenic syndrome                \n",
       "186   allan-herndon-dudley syndrome                    \n",
       "194   succinic semialdehyde dehydrogenase deficiency   \n",
       "195   pancreatic cancer                                \n",
       "197   rett syndrome                                    \n",
       "208   angelman syndrome                                \n",
       "212   huntington's disease                             \n",
       "214   diffuse large b-cell lymphoma                    \n",
       "230   glioma                                           \n",
       "236   acute myeloid leukemia                           \n",
       "244   malignant mesothelioma                           \n",
       "248   progressive supranuclear palsy                   \n",
       "253   acute leukemia                                   \n",
       "258   melas syndrome                                   \n",
       "259   spinal muscular atrophy                          \n",
       "260   malignant mesothelioma                           \n",
       "265   acute myeloid leukemia                           \n",
       "266   pancreatic cancer                                \n",
       "267   myelodysplastic syndrome                         \n",
       "278   cholangiocarcinoma                               \n",
       "289   cystic fibrosis                                  \n",
       "290   glioblastoma multiforme                          \n",
       "311   lupus nephritis                                  \n",
       "313   chronic lymphocytic leukemia                     \n",
       "314   multiple myeloma                                 \n",
       "315   fragile x syndrome                               \n",
       "316   hereditary inclusion body myopathy               \n",
       "319   fragile x syndrome                               \n",
       "324   tuberculosis                                     \n",
       "331   juvenile rheumatoid arthritis                    \n",
       "...                             ...                    \n",
       "3779  acute myeloid leukemia                           \n",
       "3782  giardiasis                                       \n",
       "3783  amebiasis                                        \n",
       "3786  idiopathic pulmonary fibrosis                    \n",
       "3787  acute myeloid leukemia                           \n",
       "3789  hepatocellular carcinoma                         \n",
       "3790  head and neck cancer                             \n",
       "3804  systemic sclerosis                               \n",
       "3807  transthyretin amyloidosis                        \n",
       "3809  progressive supranuclear palsy                   \n",
       "3810  frontotemporal dementia                          \n",
       "3812  lennox-gastaut syndrome                          \n",
       "3817  acute myeloid leukemia                           \n",
       "3824  idiopathic pulmonary fibrosis                    \n",
       "3844  malignant mesothelioma                           \n",
       "3847  ovarian cancer                                   \n",
       "3854  acute promyelocytic leukemia                     \n",
       "3856  multiple myeloma                                 \n",
       "3857  fascioliasis                                     \n",
       "3867  pancreatic adenocarcinoma                        \n",
       "3880  acute myeloid leukemia                           \n",
       "3886  cystic fibrosis                                  \n",
       "3889  huntington's disease                             \n",
       "3892  chronic lymphocytic leukemia                     \n",
       "3899  acute myeloid leukemia                           \n",
       "3900  retinitis pigmentosa                             \n",
       "3920  acute myeloid leukemia                           \n",
       "3923  fragile x syndrome                               \n",
       "3927  duchenne muscular dystrophy                      \n",
       "3928  endophthalmitis                                  \n",
       "3936  acromegaly                                       \n",
       "3940  cholangiocarcinoma                               \n",
       "3947  friedreich's ataxia                              \n",
       "3948  leigh syndrome                                   \n",
       "3949  rett syndrome                                    \n",
       "3957  pemphigus                                        \n",
       "3959  chronic lymphocytic leukemia                     \n",
       "3960  erdheim-chester disease                          \n",
       "3965  multiple myeloma                                 \n",
       "3966  chronic lymphocytic leukemia                     \n",
       "3967  acute myeloid leukemia                           \n",
       "3975  ovarian cancer                                   \n",
       "3979  acute myeloid leukemia                           \n",
       "3981  multiple myeloma                                 \n",
       "3985  acute myeloid leukemia                           \n",
       "3995  aids                                             \n",
       "3996  aids                                             \n",
       "3997  aids                                             \n",
       "3998  wilson's disease                                 \n",
       "4002  acute myeloid leukemia                           \n",
       "\n",
       "                                             doid  \\\n",
       "4     http://purl.obolibrary.org/obo/DOID_14261     \n",
       "16    http://purl.obolibrary.org/obo/DOID_1206      \n",
       "17    http://purl.obolibrary.org/obo/DOID_9538      \n",
       "18    http://purl.obolibrary.org/obo/DOID_418       \n",
       "30    http://purl.obolibrary.org/obo/DOID_1926      \n",
       "40    http://purl.obolibrary.org/obo/DOID_9240      \n",
       "57    http://purl.obolibrary.org/obo/DOID_2957      \n",
       "58    http://purl.obolibrary.org/obo/DOID_9538      \n",
       "65    http://purl.obolibrary.org/obo/DOID_9119      \n",
       "70    http://purl.obolibrary.org/obo/DOID_0050873   \n",
       "74    http://purl.obolibrary.org/obo/DOID_0050746   \n",
       "76    http://purl.obolibrary.org/obo/DOID_8567      \n",
       "102   http://purl.obolibrary.org/obo/DOID_418       \n",
       "103   http://purl.obolibrary.org/obo/DOID_9119      \n",
       "129   http://purl.obolibrary.org/obo/DOID_0050156   \n",
       "150   http://purl.obolibrary.org/obo/DOID_3070      \n",
       "157   http://purl.obolibrary.org/obo/DOID_9538      \n",
       "158   http://purl.obolibrary.org/obo/DOID_2394      \n",
       "160   http://purl.obolibrary.org/obo/DOID_684       \n",
       "182   http://purl.obolibrary.org/obo/DOID_635       \n",
       "184   http://purl.obolibrary.org/obo/DOID_0050214   \n",
       "186   http://purl.obolibrary.org/obo/DOID_0050631   \n",
       "194   http://purl.obolibrary.org/obo/DOID_0060175   \n",
       "195   http://purl.obolibrary.org/obo/DOID_1793      \n",
       "197   http://purl.obolibrary.org/obo/DOID_1206      \n",
       "208   http://purl.obolibrary.org/obo/DOID_1932      \n",
       "212   http://purl.obolibrary.org/obo/DOID_12858     \n",
       "214   http://purl.obolibrary.org/obo/DOID_0050745   \n",
       "230   http://purl.obolibrary.org/obo/DOID_3070      \n",
       "236   http://purl.obolibrary.org/obo/DOID_9119      \n",
       "244   http://purl.obolibrary.org/obo/DOID_1790      \n",
       "248   http://purl.obolibrary.org/obo/DOID_678       \n",
       "253   http://purl.obolibrary.org/obo/DOID_12603     \n",
       "258   http://purl.obolibrary.org/obo/DOID_3687      \n",
       "259   http://purl.obolibrary.org/obo/DOID_12377     \n",
       "260   http://purl.obolibrary.org/obo/DOID_1790      \n",
       "265   http://purl.obolibrary.org/obo/DOID_9119      \n",
       "266   http://purl.obolibrary.org/obo/DOID_1793      \n",
       "267   http://purl.obolibrary.org/obo/DOID_0050908   \n",
       "278   http://purl.obolibrary.org/obo/DOID_4947      \n",
       "289   http://purl.obolibrary.org/obo/DOID_1485      \n",
       "290   http://purl.obolibrary.org/obo/DOID_3068      \n",
       "311   http://purl.obolibrary.org/obo/DOID_0080162   \n",
       "313   http://purl.obolibrary.org/obo/DOID_1040      \n",
       "314   http://purl.obolibrary.org/obo/DOID_9538      \n",
       "315   http://purl.obolibrary.org/obo/DOID_14261     \n",
       "316   http://purl.obolibrary.org/obo/DOID_3429      \n",
       "319   http://purl.obolibrary.org/obo/DOID_14261     \n",
       "324   http://purl.obolibrary.org/obo/DOID_399       \n",
       "331   http://purl.obolibrary.org/obo/DOID_676       \n",
       "...                                       ...       \n",
       "3779  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3782  http://purl.obolibrary.org/obo/DOID_10718     \n",
       "3783  http://purl.obolibrary.org/obo/DOID_9181      \n",
       "3786  http://purl.obolibrary.org/obo/DOID_0050156   \n",
       "3787  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3789  http://purl.obolibrary.org/obo/DOID_684       \n",
       "3790  http://purl.obolibrary.org/obo/DOID_11934     \n",
       "3804  http://purl.obolibrary.org/obo/DOID_418       \n",
       "3807  http://purl.obolibrary.org/obo/DOID_0050638   \n",
       "3809  http://purl.obolibrary.org/obo/DOID_678       \n",
       "3810  http://purl.obolibrary.org/obo/DOID_9255      \n",
       "3812  http://purl.obolibrary.org/obo/DOID_0050561   \n",
       "3817  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3824  http://purl.obolibrary.org/obo/DOID_0050156   \n",
       "3844  http://purl.obolibrary.org/obo/DOID_1790      \n",
       "3847  http://purl.obolibrary.org/obo/DOID_2394      \n",
       "3854  http://purl.obolibrary.org/obo/DOID_0060318   \n",
       "3856  http://purl.obolibrary.org/obo/DOID_9538      \n",
       "3857  http://purl.obolibrary.org/obo/DOID_885       \n",
       "3867  http://purl.obolibrary.org/obo/DOID_4074      \n",
       "3880  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3886  http://purl.obolibrary.org/obo/DOID_1485      \n",
       "3889  http://purl.obolibrary.org/obo/DOID_12858     \n",
       "3892  http://purl.obolibrary.org/obo/DOID_1040      \n",
       "3899  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3900  http://purl.obolibrary.org/obo/DOID_10584     \n",
       "3920  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3923  http://purl.obolibrary.org/obo/DOID_14261     \n",
       "3927  http://purl.obolibrary.org/obo/DOID_11723     \n",
       "3928  http://purl.obolibrary.org/obo/DOID_4692      \n",
       "3936  http://purl.obolibrary.org/obo/DOID_2449      \n",
       "3940  http://purl.obolibrary.org/obo/DOID_4947      \n",
       "3947  http://purl.obolibrary.org/obo/DOID_12705     \n",
       "3948  http://purl.obolibrary.org/obo/DOID_3652      \n",
       "3949  http://purl.obolibrary.org/obo/DOID_1206      \n",
       "3957  http://purl.obolibrary.org/obo/DOID_9182      \n",
       "3959  http://purl.obolibrary.org/obo/DOID_1040      \n",
       "3960  http://purl.obolibrary.org/obo/DOID_4329      \n",
       "3965  http://purl.obolibrary.org/obo/DOID_9538      \n",
       "3966  http://purl.obolibrary.org/obo/DOID_1040      \n",
       "3967  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3975  http://purl.obolibrary.org/obo/DOID_2394      \n",
       "3979  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3981  http://purl.obolibrary.org/obo/DOID_9538      \n",
       "3985  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "3995  http://purl.obolibrary.org/obo/DOID_635       \n",
       "3996  http://purl.obolibrary.org/obo/DOID_635       \n",
       "3997  http://purl.obolibrary.org/obo/DOID_635       \n",
       "3998  http://purl.obolibrary.org/obo/DOID_893       \n",
       "4002  http://purl.obolibrary.org/obo/DOID_9119      \n",
       "\n",
       "                                            hpo  \\\n",
       "4     None                                        \n",
       "16    None                                        \n",
       "17    http://purl.obolibrary.org/obo/HP_0006775   \n",
       "18    None                                        \n",
       "30    None                                        \n",
       "40    None                                        \n",
       "57    None                                        \n",
       "58    http://purl.obolibrary.org/obo/HP_0006775   \n",
       "65    http://purl.obolibrary.org/obo/HP_0004808   \n",
       "70    None                                        \n",
       "74    None                                        \n",
       "76    http://purl.obolibrary.org/obo/HP_0012189   \n",
       "102   None                                        \n",
       "103   http://purl.obolibrary.org/obo/HP_0004808   \n",
       "129   None                                        \n",
       "150   None                                        \n",
       "157   http://purl.obolibrary.org/obo/HP_0006775   \n",
       "158   None                                        \n",
       "160   http://purl.obolibrary.org/obo/HP_0001402   \n",
       "182   None                                        \n",
       "184   None                                        \n",
       "186   None                                        \n",
       "194   None                                        \n",
       "195   http://purl.obolibrary.org/obo/HP_0002894   \n",
       "197   None                                        \n",
       "208   None                                        \n",
       "212   None                                        \n",
       "214   None                                        \n",
       "230   http://purl.obolibrary.org/obo/HP_0009733   \n",
       "236   http://purl.obolibrary.org/obo/HP_0004808   \n",
       "244   http://purl.obolibrary.org/obo/HP_0100001   \n",
       "248   None                                        \n",
       "253   http://purl.obolibrary.org/obo/HP_0002488   \n",
       "258   None                                        \n",
       "259   http://purl.obolibrary.org/obo/HP_0007269   \n",
       "260   http://purl.obolibrary.org/obo/HP_0100001   \n",
       "265   http://purl.obolibrary.org/obo/HP_0004808   \n",
       "266   http://purl.obolibrary.org/obo/HP_0002894   \n",
       "267   http://purl.obolibrary.org/obo/HP_0002863   \n",
       "278   http://purl.obolibrary.org/obo/HP_0030153   \n",
       "289   None                                        \n",
       "290   http://purl.obolibrary.org/obo/HP_0012174   \n",
       "311   None                                        \n",
       "313   http://purl.obolibrary.org/obo/HP_0005550   \n",
       "314   http://purl.obolibrary.org/obo/HP_0006775   \n",
       "315   None                                        \n",
       "316   None                                        \n",
       "319   None                                        \n",
       "324   None                                        \n",
       "331   http://purl.obolibrary.org/obo/HP_0005681   \n",
       "...                                         ...   \n",
       "3779  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3782  None                                        \n",
       "3783  None                                        \n",
       "3786  None                                        \n",
       "3787  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3789  http://purl.obolibrary.org/obo/HP_0001402   \n",
       "3790  http://purl.obolibrary.org/obo/HP_0012288   \n",
       "3804  None                                        \n",
       "3807  None                                        \n",
       "3809  None                                        \n",
       "3810  http://purl.obolibrary.org/obo/HP_0002145   \n",
       "3812  None                                        \n",
       "3817  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3824  None                                        \n",
       "3844  http://purl.obolibrary.org/obo/HP_0100001   \n",
       "3847  None                                        \n",
       "3854  http://purl.obolibrary.org/obo/HP_0004836   \n",
       "3856  http://purl.obolibrary.org/obo/HP_0006775   \n",
       "3857  None                                        \n",
       "3867  http://purl.obolibrary.org/obo/HP_0006725   \n",
       "3880  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3886  None                                        \n",
       "3889  None                                        \n",
       "3892  http://purl.obolibrary.org/obo/HP_0005550   \n",
       "3899  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3900  http://purl.obolibrary.org/obo/HP_0000510   \n",
       "3920  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3923  None                                        \n",
       "3927  None                                        \n",
       "3928  None                                        \n",
       "3936  http://purl.obolibrary.org/obo/HP_0000845   \n",
       "3940  http://purl.obolibrary.org/obo/HP_0030153   \n",
       "3947  None                                        \n",
       "3948  None                                        \n",
       "3949  None                                        \n",
       "3957  None                                        \n",
       "3959  http://purl.obolibrary.org/obo/HP_0005550   \n",
       "3960  None                                        \n",
       "3965  http://purl.obolibrary.org/obo/HP_0006775   \n",
       "3966  http://purl.obolibrary.org/obo/HP_0005550   \n",
       "3967  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3975  None                                        \n",
       "3979  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3981  http://purl.obolibrary.org/obo/HP_0006775   \n",
       "3985  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "3995  None                                        \n",
       "3996  None                                        \n",
       "3997  None                                        \n",
       "3998  None                                        \n",
       "4002  http://purl.obolibrary.org/obo/HP_0004808   \n",
       "\n",
       "                                           ordo     mesh indication_qid_doid  \\\n",
       "4     http://www.orpha.net/ORDO/Orphanet_908     D005600  Q221472              \n",
       "16    http://www.orpha.net/ORDO/Orphanet_778     D015518  Q917357              \n",
       "17    http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "18    http://www.orpha.net/ORDO/Orphanet_90291   D012595  Q5340515             \n",
       "30    http://www.orpha.net/ORDO/Orphanet_355     D005776  Q861645              \n",
       "40    http://www.orpha.net/ORDO/Orphanet_1956    D004916  Q524353              \n",
       "57    None                                       D014397  Q18555243            \n",
       "58    http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "65    http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "70    http://www.orpha.net/ORDO/Orphanet_545     D008224  Q123251              \n",
       "74    http://www.orpha.net/ORDO/Orphanet_52416   D020522  Q268713              \n",
       "76    http://www.orpha.net/ORDO/Orphanet_98293   D006689  Q209369              \n",
       "102   http://www.orpha.net/ORDO/Orphanet_90291   D012595  Q5340515             \n",
       "103   http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "129   http://www.orpha.net/ORDO/Orphanet_2032    D054990  Q2290446             \n",
       "150   None                                       D005910  Q1365309             \n",
       "157   http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "158   http://www.orpha.net/ORDO/Orphanet_213500  D010051  Q172341              \n",
       "160   http://www.orpha.net/ORDO/Orphanet_88673   D006528  Q1148337             \n",
       "182   None                                       D000163  Q12199               \n",
       "184   http://www.orpha.net/ORDO/Orphanet_43393   D015624  Q1756898             \n",
       "186   http://www.orpha.net/ORDO/Orphanet_59      None     Q4731121             \n",
       "194   http://www.orpha.net/ORDO/Orphanet_22      None     Q2823333             \n",
       "195   None                                       D010190  Q212961              \n",
       "197   http://www.orpha.net/ORDO/Orphanet_778     D015518  Q917357              \n",
       "208   http://www.orpha.net/ORDO/Orphanet_120365  D017204  Q535364              \n",
       "212   None                                       D006816  Q190564              \n",
       "214   http://www.orpha.net/ORDO/Orphanet_544     None     Q2626074             \n",
       "230   http://www.orpha.net/ORDO/Orphanet_182067  D005910  Q1365309             \n",
       "236   http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "244   None                                       None     Q1077603             \n",
       "248   http://www.orpha.net/ORDO/Orphanet_683     D013494  Q945930              \n",
       "253   None                                       None     Q976388              \n",
       "258   None                                       D017241  Q2666433             \n",
       "259   None                                       D009134  Q580290              \n",
       "260   None                                       None     Q1077603             \n",
       "265   http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "266   None                                       D010190  Q212961              \n",
       "267   http://www.orpha.net/ORDO/Orphanet_52688   D009190  Q954625              \n",
       "278   http://www.orpha.net/ORDO/Orphanet_70567   D018281  Q124292              \n",
       "289   http://www.orpha.net/ORDO/Orphanet_586     D003550  Q178194              \n",
       "290   http://www.orpha.net/ORDO/Orphanet_360     D005909  Q282142              \n",
       "311   None                                       D008181  Q1621830             \n",
       "313   None                                       D015451  Q1088156             \n",
       "314   http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "315   http://www.orpha.net/ORDO/Orphanet_908     D005600  Q221472              \n",
       "316   None                                       None     Q1848471             \n",
       "319   http://www.orpha.net/ORDO/Orphanet_908     D005600  Q221472              \n",
       "324   http://www.orpha.net/ORDO/Orphanet_3389    D014376  Q12204               \n",
       "331   http://www.orpha.net/ORDO/Orphanet_92      D001171  Q861224              \n",
       "...                                     ...          ...      ...              \n",
       "3779  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3782  None                                       D005873  Q326071              \n",
       "3783  None                                       D000562  Q949694              \n",
       "3786  http://www.orpha.net/ORDO/Orphanet_2032    D054990  Q2290446             \n",
       "3787  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3789  http://www.orpha.net/ORDO/Orphanet_88673   D006528  Q1148337             \n",
       "3790  None                                       D006258  Q1783924             \n",
       "3804  http://www.orpha.net/ORDO/Orphanet_90291   D012595  Q5340515             \n",
       "3807  None                                       None     Q2844603             \n",
       "3809  http://www.orpha.net/ORDO/Orphanet_683     D013494  Q945930              \n",
       "3810  http://www.orpha.net/ORDO/Orphanet_282     D057180  Q18592               \n",
       "3812  http://www.orpha.net/ORDO/Orphanet_2382    None     Q1544884             \n",
       "3817  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3824  http://www.orpha.net/ORDO/Orphanet_2032    D054990  Q2290446             \n",
       "3844  None                                       None     Q1077603             \n",
       "3847  http://www.orpha.net/ORDO/Orphanet_213500  D010051  Q172341              \n",
       "3854  http://www.orpha.net/ORDO/Orphanet_520     D015473  Q612108              \n",
       "3856  http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "3857  None                                       D005211  Q719656              \n",
       "3867  None                                       None     Q18556189            \n",
       "3880  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3886  http://www.orpha.net/ORDO/Orphanet_586     D003550  Q178194              \n",
       "3889  None                                       D006816  Q190564              \n",
       "3892  None                                       D015451  Q1088156             \n",
       "3899  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3900  http://www.orpha.net/ORDO/Orphanet_791     D012174  Q847057              \n",
       "3920  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3923  http://www.orpha.net/ORDO/Orphanet_908     D005600  Q221472              \n",
       "3927  http://www.orpha.net/ORDO/Orphanet_98896   D020388  Q1648484             \n",
       "3928  http://www.orpha.net/ORDO/Orphanet_199323  D009877  Q1294912             \n",
       "3936  http://www.orpha.net/ORDO/Orphanet_963     D000172  Q189580              \n",
       "3940  http://www.orpha.net/ORDO/Orphanet_70567   D018281  Q124292              \n",
       "3947  None                                       D005621  Q913856              \n",
       "3948  http://www.orpha.net/ORDO/Orphanet_506     D007888  Q1815019             \n",
       "3949  http://www.orpha.net/ORDO/Orphanet_778     D015518  Q917357              \n",
       "3957  None                                       D010392  Q1483214             \n",
       "3959  None                                       D015451  Q1088156             \n",
       "3960  http://www.orpha.net/ORDO/Orphanet_35687   D031249  Q1349259             \n",
       "3965  http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "3966  None                                       D015451  Q1088156             \n",
       "3967  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3975  http://www.orpha.net/ORDO/Orphanet_213500  D010051  Q172341              \n",
       "3979  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3981  http://www.orpha.net/ORDO/Orphanet_29073   D009101  Q467635              \n",
       "3985  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "3995  None                                       D000163  Q12199               \n",
       "3996  None                                       D000163  Q12199               \n",
       "3997  None                                       D000163  Q12199               \n",
       "3998  None                                       D006527  Q117121              \n",
       "4002  http://www.orpha.net/ORDO/Orphanet_519     D015470  Q264118              \n",
       "\n",
       "     indication_qid_ordo indication_qid_mesh  \n",
       "4     Q221472             Q221472             \n",
       "16    None                Q917357             \n",
       "17    None                Q467635             \n",
       "18    None                Q5340515            \n",
       "30    Q861645             Q861645             \n",
       "40    None                Q524353             \n",
       "57    NaN                 Q18555243           \n",
       "58    None                Q467635             \n",
       "65    None                Q264118             \n",
       "70    None                None                \n",
       "74    None                None                \n",
       "76    Q209369             Q18557991           \n",
       "102   None                Q5340515            \n",
       "103   None                Q264118             \n",
       "129   None                Q2290446            \n",
       "150   NaN                 Q18556612           \n",
       "157   None                Q467635             \n",
       "158   None                Q172341             \n",
       "160   None                Q1148337            \n",
       "182   NaN                 Q12199              \n",
       "184   None                Q1756898            \n",
       "186   Q4731121            NaN                 \n",
       "194   Q2823333            NaN                 \n",
       "195   NaN                 Q212961             \n",
       "197   None                Q917357             \n",
       "208   None                Q535364             \n",
       "212   NaN                 Q190564             \n",
       "214   None                NaN                 \n",
       "230   Q1365309            Q18556612           \n",
       "236   None                Q264118             \n",
       "244   NaN                 NaN                 \n",
       "248   Q945930             Q945930             \n",
       "253   NaN                 NaN                 \n",
       "258   NaN                 Q2666433            \n",
       "259   NaN                 Q7577466            \n",
       "260   NaN                 NaN                 \n",
       "265   None                Q264118             \n",
       "266   NaN                 Q212961             \n",
       "267   None                Q954625             \n",
       "278   None                Q18556554           \n",
       "289   None                Q178194             \n",
       "290   None                Q18555280           \n",
       "311   NaN                 Q1621830            \n",
       "313   NaN                 Q1088156            \n",
       "314   None                Q467635             \n",
       "315   Q221472             Q221472             \n",
       "316   NaN                 NaN                 \n",
       "319   Q221472             Q221472             \n",
       "324   None                Q12204              \n",
       "331   Q861224             Q861224             \n",
       "...       ...                 ...             \n",
       "3779  None                Q264118             \n",
       "3782  NaN                 Q326071             \n",
       "3783  NaN                 Q949694             \n",
       "3786  None                Q2290446            \n",
       "3787  None                Q264118             \n",
       "3789  None                Q1148337            \n",
       "3790  NaN                 Q1783924            \n",
       "3804  None                Q5340515            \n",
       "3807  NaN                 NaN                 \n",
       "3809  Q945930             Q945930             \n",
       "3810  Q18592              None                \n",
       "3812  None                NaN                 \n",
       "3817  None                Q264118             \n",
       "3824  None                Q2290446            \n",
       "3844  NaN                 NaN                 \n",
       "3847  None                Q172341             \n",
       "3854  Q612108             Q612108             \n",
       "3856  None                Q467635             \n",
       "3857  NaN                 Q719656             \n",
       "3867  NaN                 NaN                 \n",
       "3880  None                Q264118             \n",
       "3886  None                Q178194             \n",
       "3889  NaN                 Q190564             \n",
       "3892  NaN                 Q1088156            \n",
       "3899  None                Q264118             \n",
       "3900  Q847057             Q847057             \n",
       "3920  None                Q264118             \n",
       "3923  Q221472             Q221472             \n",
       "3927  None                Q1648484            \n",
       "3928  None                Q1294912            \n",
       "3936  None                Q189580             \n",
       "3940  None                Q18556554           \n",
       "3947  NaN                 Q913856             \n",
       "3948  Q1815019            Q1815019            \n",
       "3949  None                Q917357             \n",
       "3957  NaN                 Q1483214            \n",
       "3959  NaN                 Q1088156            \n",
       "3960  None                Q1349259            \n",
       "3965  None                Q467635             \n",
       "3966  NaN                 Q1088156            \n",
       "3967  None                Q264118             \n",
       "3975  None                Q172341             \n",
       "3979  None                Q264118             \n",
       "3981  None                Q467635             \n",
       "3985  None                Q264118             \n",
       "3995  NaN                 Q12199              \n",
       "3996  NaN                 Q12199              \n",
       "3997  NaN                 Q12199              \n",
       "3998  NaN                 Q117121             \n",
       "4002  None                Q264118             \n",
       "\n",
       "[677 rows x 14 columns]"
      ]
     },
     "execution_count": 102,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "good_df=df[df.indication_qid_doid.notnull() & df.drug_qid.notnull()]\n",
    "good_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "677"
      ]
     },
     "execution_count": 103,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(good_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Generic Name           3474\n",
       "Orphan Designation     3474\n",
       "Designation Date       3474\n",
       "Designation Status     3474\n",
       "drug_qid               1542\n",
       "inchi                  279 \n",
       "indication             3474\n",
       "doid                   1486\n",
       "hpo                    901 \n",
       "ordo                   1292\n",
       "mesh                   1725\n",
       "indication_qid_doid    1486\n",
       "indication_qid_ordo    286 \n",
       "indication_qid_mesh    1627\n",
       "dtype: int64"
      ]
     },
     "execution_count": 104,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.count()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.5.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
